# num of genes	num of total genes	Log of odds ratio	P-value	Adjusted p-value	GO term ID	GO term name	GO type
5	5	4.32077599163	-	3.09e-07	GO:0055012	ventricular cardiac muscle cell differentiation	BP
4	4	4.32077599163	-	6.22e-06	GO:0060534	trachea cartilage development	BP
3	3	4.32077599163	-	1.25e-04	GO:2000074	regulation of type B pancreatic cell development	BP
3	3	4.32077599163	-	1.25e-04	GO:0060745	mammary gland branching involved in pregnancy	BP
3	3	4.32077599163	-	1.25e-04	GO:0072539	T-helper 17 cell differentiation	BP
3	3	4.32077599163	-	1.25e-04	GO:0010871	negative regulation of receptor biosynthetic process	BP
3	3	4.32077599163	-	1.25e-04	GO:0061198	fungiform papilla formation	BP
3	3	4.32077599163	-	1.25e-04	GO:0051097	negative regulation of helicase activity	BP
3	3	4.32077599163	-	1.25e-04	GO:0018076	N-terminal peptidyl-lysine acetylation	BP
3	3	4.32077599163	-	1.25e-04	GO:0002068	glandular epithelial cell development	BP
2	2	4.32077599163	-	2.50e-03	GO:0014740	negative regulation of muscle hyperplasia	BP
2	2	4.32077599163	-	2.50e-03	GO:0097252	oligodendrocyte apoptotic process	BP
2	2	4.32077599163	-	2.50e-03	GO:2001055	positive regulation of mesenchymal cell apoptotic process	BP
2	2	4.32077599163	-	2.50e-03	GO:0008050	female courtship behavior	BP
2	2	4.32077599163	-	2.50e-03	GO:0072182	regulation of nephron tubule epithelial cell differentiation	BP
2	2	4.32077599163	-	2.50e-03	GO:0090427	activation of meiosis	BP
2	2	4.32077599163	-	2.50e-03	GO:0051563	smooth endoplasmic reticulum calcium ion homeostasis	BP
2	2	4.32077599163	-	2.50e-03	GO:0036315	cellular response to sterol	BP
2	2	4.32077599163	-	2.50e-03	GO:0032916	positive regulation of transforming growth factor beta3 production	BP
2	2	4.32077599163	-	2.50e-03	GO:2000327	positive regulation of ligand-dependent nuclear receptor transcription coactivator activity	BP
2	2	4.32077599163	-	2.50e-03	GO:1905906	regulation of amyloid fibril formation	BP
2	2	4.32077599163	-	2.50e-03	GO:0061145	lung smooth muscle development	BP
2	2	4.32077599163	-	2.50e-03	GO:0048145	regulation of fibroblast proliferation	BP
2	2	4.32077599163	-	2.50e-03	GO:1901558	response to metformin	BP
2	2	4.32077599163	-	2.50e-03	GO:0035947	regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter	BP
2	2	4.32077599163	-	2.50e-03	GO:0061308	cardiac neural crest cell development involved in heart development	BP
2	2	4.32077599163	-	2.50e-03	GO:1904017	cellular response to Thyroglobulin triiodothyronine	BP
2	2	4.32077599163	-	2.50e-03	GO:0048340	paraxial mesoderm morphogenesis	BP
2	2	4.32077599163	-	2.50e-03	GO:2000017	positive regulation of determination of dorsal identity	BP
2	2	4.32077599163	-	2.50e-03	GO:0003057	regulation of the force of heart contraction by chemical signal	BP
2	2	4.32077599163	-	2.50e-03	GO:0060577	pulmonary vein morphogenesis	BP
2	2	4.32077599163	-	2.50e-03	GO:0002268	follicular dendritic cell differentiation	BP
2	2	4.32077599163	-	2.50e-03	GO:0038183	bile acid signaling pathway	BP
2	2	4.32077599163	-	2.50e-03	GO:0060532	bronchus cartilage development	BP
2	2	4.32077599163	-	2.50e-03	GO:0090107	regulation of high-density lipoprotein particle assembly	BP
2	2	4.32077599163	-	2.50e-03	GO:0060251	regulation of glial cell proliferation	BP
2	2	4.32077599163	-	2.50e-03	GO:1990791	dorsal root ganglion development	BP
2	2	4.32077599163	-	2.50e-03	GO:0060849	regulation of transcription involved in lymphatic endothelial cell fate commitment	BP
2	2	4.32077599163	-	2.50e-03	GO:0086098	angiotensin-activated signaling pathway involved in heart process	BP
1	1	4.32077599163	-	5.00e-02	GO:0090340	positive regulation of secretion of lysosomal enzymes	BP
1	1	4.32077599163	-	5.00e-02	GO:0006591	ornithine metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0061670	evoked neurotransmitter secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0090341	negative regulation of secretion of lysosomal enzymes	BP
1	1	4.32077599163	-	5.00e-02	GO:1903533	regulation of protein targeting	BP
1	1	4.32077599163	-	5.00e-02	GO:2000108	positive regulation of leukocyte apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:2000103	positive regulation of mammary stem cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0061085	regulation of histone H3-K27 methylation	BP
1	1	4.32077599163	-	5.00e-02	GO:1903988	ferrous iron export across plasma membrane	BP
1	1	4.32077599163	-	5.00e-02	GO:0071357	cellular response to type I interferon	BP
1	1	4.32077599163	-	5.00e-02	GO:0071351	cellular response to interleukin-18	BP
1	1	4.32077599163	-	5.00e-02	GO:1904899	positive regulation of hepatic stellate cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:1902253	regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	1	4.32077599163	-	5.00e-02	GO:1902251	negative regulation of erythrocyte apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0051238	sequestering of metal ion	BP
1	1	4.32077599163	-	5.00e-02	GO:0010714	positive regulation of collagen metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0046824	positive regulation of nucleocytoplasmic transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0019677	NAD catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0019676	ammonia assimilation cycle	BP
1	1	4.32077599163	-	5.00e-02	GO:0061326	renal tubule development	BP
1	1	4.32077599163	-	5.00e-02	GO:0061324	canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0072615	interleukin-17 secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0051729	germline cell cycle switching, mitotic to meiotic cell cycle	BP
1	1	4.32077599163	-	5.00e-02	GO:0034670	chemotaxis to arachidonic acid	BP
1	1	4.32077599163	-	5.00e-02	GO:1903002	positive regulation of lipid transport across blood brain barrier	BP
1	1	4.32077599163	-	5.00e-02	GO:0071387	cellular response to cortisol stimulus	BP
1	1	4.32077599163	-	5.00e-02	GO:0010522	regulation of calcium ion transport into cytosol	BP
1	1	4.32077599163	-	5.00e-02	GO:0003171	atrioventricular valve development	BP
1	1	4.32077599163	-	5.00e-02	GO:0003175	tricuspid valve development	BP
1	1	4.32077599163	-	5.00e-02	GO:0038097	positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:1901994	negative regulation of meiotic cell cycle phase transition	BP
1	1	4.32077599163	-	5.00e-02	GO:0060345	spleen trabecula formation	BP
1	1	4.32077599163	-	5.00e-02	GO:0042197	halogenated hydrocarbon metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1903788	positive regulation of glutathione biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0032776	DNA methylation on cytosine	BP
1	1	4.32077599163	-	5.00e-02	GO:0043618	regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	1	4.32077599163	-	5.00e-02	GO:0003138	primary heart field specification	BP
1	1	4.32077599163	-	5.00e-02	GO:1904998	negative regulation of leukocyte adhesion to arterial endothelial cell	BP
1	1	4.32077599163	-	5.00e-02	GO:0070407	oxidation-dependent protein catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0071250	cellular response to nitrite	BP
1	1	4.32077599163	-	5.00e-02	GO:1901628	positive regulation of postsynaptic membrane organization	BP
1	1	4.32077599163	-	5.00e-02	GO:1902396	protein localization to bicellular tight junction	BP
1	1	4.32077599163	-	5.00e-02	GO:0060552	positive regulation of fructose 1,6-bisphosphate metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0060550	positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0060558	regulation of calcidiol 1-monooxygenase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:1904828	positive regulation of hydrogen sulfide biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0072141	renal interstitial fibroblast development	BP
1	1	4.32077599163	-	5.00e-02	GO:0018885	carbon tetrachloride metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0000117	regulation of transcription involved in G2/M transition of mitotic cell cycle	BP
1	1	4.32077599163	-	5.00e-02	GO:1904793	regulation of euchromatin binding	BP
1	1	4.32077599163	-	5.00e-02	GO:0060517	epithelial cell proliferation involved in prostatic bud elongation	BP
1	1	4.32077599163	-	5.00e-02	GO:0051248	negative regulation of protein metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0010768	negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage	BP
1	1	4.32077599163	-	5.00e-02	GO:2000173	negative regulation of branching morphogenesis of a nerve	BP
1	1	4.32077599163	-	5.00e-02	GO:0060709	glycogen cell differentiation involved in embryonic placenta development	BP
1	1	4.32077599163	-	5.00e-02	GO:0051866	general adaptation syndrome	BP
1	1	4.32077599163	-	5.00e-02	GO:2000612	regulation of thyroid-stimulating hormone secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0021572	rhombomere 6 development	BP
1	1	4.32077599163	-	5.00e-02	GO:0051651	maintenance of location in cell	BP
1	1	4.32077599163	-	5.00e-02	GO:0033233	regulation of protein sumoylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0048561	establishment of animal organ orientation	BP
1	1	4.32077599163	-	5.00e-02	GO:0006117	acetaldehyde metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0035622	intrahepatic bile duct development	BP
1	1	4.32077599163	-	5.00e-02	GO:1990442	intrinsic apoptotic signaling pathway in response to nitrosative stress	BP
1	1	4.32077599163	-	5.00e-02	GO:0035627	ceramide transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0035624	receptor transactivation	BP
1	1	4.32077599163	-	5.00e-02	GO:2000794	regulation of epithelial cell proliferation involved in lung morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0043954	cellular component maintenance	BP
1	1	4.32077599163	-	5.00e-02	GO:0019089	transmission of virus	BP
1	1	4.32077599163	-	5.00e-02	GO:2000655	negative regulation of cellular response to testosterone stimulus	BP
1	1	4.32077599163	-	5.00e-02	GO:2000657	negative regulation of apolipoprotein binding	BP
1	1	4.32077599163	-	5.00e-02	GO:1904797	negative regulation of core promoter binding	BP
1	1	4.32077599163	-	5.00e-02	GO:0043402	glucocorticoid mediated signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0061144	alveolar secondary septum development	BP
1	1	4.32077599163	-	5.00e-02	GO:0003144	embryonic heart tube formation	BP
1	1	4.32077599163	-	5.00e-02	GO:0003433	chondrocyte development involved in endochondral bone morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0010877	lipid transport involved in lipid storage	BP
1	1	4.32077599163	-	5.00e-02	GO:0000433	negative regulation of transcription from RNA polymerase II promoter by glucose	BP
1	1	4.32077599163	-	5.00e-02	GO:0000435	positive regulation of transcription from RNA polymerase II promoter by galactose	BP
1	1	4.32077599163	-	5.00e-02	GO:0032462	regulation of protein homooligomerization	BP
1	1	4.32077599163	-	5.00e-02	GO:0060784	regulation of cell proliferation involved in tissue homeostasis	BP
1	1	4.32077599163	-	5.00e-02	GO:2001250	positive regulation of ammonia assimilation cycle	BP
1	1	4.32077599163	-	5.00e-02	GO:0072308	negative regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0090049	regulation of cell migration involved in sprouting angiogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0038161	prolactin signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0001080	nitrogen catabolite activation of transcription from RNA polymerase II promoter	BP
1	1	4.32077599163	-	5.00e-02	GO:1903034	regulation of response to wounding	BP
1	1	4.32077599163	-	5.00e-02	GO:0061106	negative regulation of stomach neuroendocrine cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:1903755	positive regulation of SUMO transferase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0043063	intercellular bridge organization	BP
1	1	4.32077599163	-	5.00e-02	GO:0043603	cellular amide metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0046725	negative regulation by virus of viral protein levels in host cell	BP
1	1	4.32077599163	-	5.00e-02	GO:2000753	positive regulation of glucosylceramide catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:2000755	positive regulation of sphingomyelin catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0072303	positive regulation of glomerular metanephric mesangial cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0061889	negative regulation of astrocyte activation	BP
1	1	4.32077599163	-	5.00e-02	GO:2000256	positive regulation of male germ cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0048790	maintenance of presynaptic active zone structure	BP
1	1	4.32077599163	-	5.00e-02	GO:1905860	positive regulation of heparan sulfate proteoglycan binding	BP
1	1	4.32077599163	-	5.00e-02	GO:0035042	fertilization, exchange of chromosomal proteins	BP
1	1	4.32077599163	-	5.00e-02	GO:0072110	glomerular mesangial cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:2000213	positive regulation of glutamate metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1904353	regulation of telomere capping	BP
1	1	4.32077599163	-	5.00e-02	GO:0001544	initiation of primordial ovarian follicle growth	BP
1	1	4.32077599163	-	5.00e-02	GO:0001543	ovarian follicle rupture	BP
1	1	4.32077599163	-	5.00e-02	GO:0002778	antibacterial peptide production	BP
1	1	4.32077599163	-	5.00e-02	GO:1903464	negative regulation of mitotic cell cycle DNA replication	BP
1	1	4.32077599163	-	5.00e-02	GO:0010986	positive regulation of lipoprotein particle clearance	BP
1	1	4.32077599163	-	5.00e-02	GO:1903815	negative regulation of collecting lymphatic vessel constriction	BP
1	1	4.32077599163	-	5.00e-02	GO:0061550	cranial ganglion development	BP
1	1	4.32077599163	-	5.00e-02	GO:0009956	radial pattern formation	BP
1	1	4.32077599163	-	5.00e-02	GO:2001286	regulation of caveolin-mediated endocytosis	BP
1	1	4.32077599163	-	5.00e-02	GO:1905695	positive regulation of phosphatidic acid biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0045407	positive regulation of interleukin-5 biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0034255	regulation of urea metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0050975	sensory perception of touch	BP
1	1	4.32077599163	-	5.00e-02	GO:1905208	negative regulation of cardiocyte differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0098749	cerebellar neuron development	BP
1	1	4.32077599163	-	5.00e-02	GO:0098746	fast, calcium ion-dependent exocytosis of neurotransmitter	BP
1	1	4.32077599163	-	5.00e-02	GO:1904501	positive regulation of chromatin-mediated maintenance of transcription	BP
1	1	4.32077599163	-	5.00e-02	GO:0030421	defecation	BP
1	1	4.32077599163	-	5.00e-02	GO:1900163	positive regulation of phospholipid scramblase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0043380	regulation of memory T cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0030656	regulation of vitamin metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0090425	acinar cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0006343	establishment of chromatin silencing	BP
1	1	4.32077599163	-	5.00e-02	GO:0060127	prolactin secreting cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0046016	positive regulation of transcription by glucose	BP
1	1	4.32077599163	-	5.00e-02	GO:2000872	positive regulation of progesterone secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0043969	histone H2B acetylation	BP
1	1	4.32077599163	-	5.00e-02	GO:1900085	negative regulation of peptidyl-tyrosine autophosphorylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002572	pro-T cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:1905890	regulation of cellular response to very-low-density lipoprotein particle stimulus	BP
1	1	4.32077599163	-	5.00e-02	GO:0021872	forebrain generation of neurons	BP
1	1	4.32077599163	-	5.00e-02	GO:0021870	Cajal-Retzius cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002683	negative regulation of immune system process	BP
1	1	4.32077599163	-	5.00e-02	GO:0100057	regulation of phenotypic switching by transcription from RNA polymerase II promoter	BP
1	1	4.32077599163	-	5.00e-02	GO:0042659	regulation of cell fate specification	BP
1	1	4.32077599163	-	5.00e-02	GO:0045977	positive regulation of mitotic cell cycle, embryonic	BP
1	1	4.32077599163	-	5.00e-02	GO:0001840	neural plate development	BP
1	1	4.32077599163	-	5.00e-02	GO:0061114	branching involved in pancreas morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:1903766	positive regulation of potassium ion export across plasma membrane	BP
1	1	4.32077599163	-	5.00e-02	GO:2000979	positive regulation of forebrain neuron differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:2000971	negative regulation of detection of glucose	BP
1	1	4.32077599163	-	5.00e-02	GO:1905337	positive regulation of aggrephagy	BP
1	1	4.32077599163	-	5.00e-02	GO:0071471	cellular response to non-ionic osmotic stress	BP
1	1	4.32077599163	-	5.00e-02	GO:2000703	negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	4.32077599163	-	5.00e-02	GO:0031279	regulation of cyclase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0003185	sinoatrial valve morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0046223	aflatoxin catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0048621	post-embryonic digestive tract morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:1905643	positive regulation of DNA methylation	BP
1	1	4.32077599163	-	5.00e-02	GO:1905642	negative regulation of DNA methylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0001806	type IV hypersensitivity	BP
1	1	4.32077599163	-	5.00e-02	GO:0060479	lung cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0046521	sphingoid catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1901978	positive regulation of cell cycle checkpoint	BP
1	1	4.32077599163	-	5.00e-02	GO:1901976	regulation of cell cycle checkpoint	BP
1	1	4.32077599163	-	5.00e-02	GO:1905855	positive regulation of heparan sulfate binding	BP
1	1	4.32077599163	-	5.00e-02	GO:2000191	regulation of fatty acid transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0051541	elastin metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0019102	male somatic sex determination	BP
1	1	4.32077599163	-	5.00e-02	GO:2000227	negative regulation of pancreatic A cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002194	hepatocyte cell migration	BP
1	1	4.32077599163	-	5.00e-02	GO:0060578	superior vena cava morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:1904800	negative regulation of neuron remodeling	BP
1	1	4.32077599163	-	5.00e-02	GO:0060681	branch elongation involved in ureteric bud branching	BP
1	1	4.32077599163	-	5.00e-02	GO:1904635	positive regulation of glomerular visceral epithelial cell apoptotic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0072163	mesonephric epithelium development	BP
1	1	4.32077599163	-	5.00e-02	GO:1901291	negative regulation of double-strand break repair via single-strand annealing	BP
1	1	4.32077599163	-	5.00e-02	GO:0038185	intracellular bile acid receptor signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0098759	cellular response to interleukin-8	BP
1	1	4.32077599163	-	5.00e-02	GO:0090108	positive regulation of high-density lipoprotein particle assembly	BP
1	1	4.32077599163	-	5.00e-02	GO:0044111	development involved in symbiotic interaction	BP
1	1	4.32077599163	-	5.00e-02	GO:1904677	positive regulation of somatic stem cell division	BP
1	1	4.32077599163	-	5.00e-02	GO:0061395	positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	4.32077599163	-	5.00e-02	GO:0061394	regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance	BP
1	1	4.32077599163	-	5.00e-02	GO:0007403	glial cell fate determination	BP
1	1	4.32077599163	-	5.00e-02	GO:0030844	positive regulation of intermediate filament depolymerization	BP
1	1	4.32077599163	-	5.00e-02	GO:0050820	positive regulation of coagulation	BP
1	1	4.32077599163	-	5.00e-02	GO:1905920	positive regulation of CoA-transferase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0000414	regulation of histone H3-K36 methylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0000416	positive regulation of histone H3-K36 methylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0072599	establishment of protein localization to endoplasmic reticulum	BP
1	1	4.32077599163	-	5.00e-02	GO:0050865	regulation of cell activation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002154	thyroid hormone mediated signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0051884	regulation of timing of anagen	BP
1	1	4.32077599163	-	5.00e-02	GO:0061445	endocardial cushion cell fate commitment	BP
1	1	4.32077599163	-	5.00e-02	GO:0002561	basophil degranulation	BP
1	1	4.32077599163	-	5.00e-02	GO:0019627	urea metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0052547	regulation of peptidase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:1905344	prostaglandin catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:2000734	negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation	BP
1	1	4.32077599163	-	5.00e-02	GO:0071441	negative regulation of histone H3-K14 acetylation	BP
1	1	4.32077599163	-	5.00e-02	GO:1901863	positive regulation of muscle tissue development	BP
1	1	4.32077599163	-	5.00e-02	GO:0061767	negative regulation of lung blood pressure	BP
1	1	4.32077599163	-	5.00e-02	GO:0072362	regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	4.32077599163	-	5.00e-02	GO:0072363	regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	4.32077599163	-	5.00e-02	GO:0072366	regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter	BP
1	1	4.32077599163	-	5.00e-02	GO:0072365	regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter	BP
1	1	4.32077599163	-	5.00e-02	GO:0051341	regulation of oxidoreductase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0045083	negative regulation of interleukin-12 biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0010034	response to acetate	BP
1	1	4.32077599163	-	5.00e-02	GO:0071873	response to norepinephrine	BP
1	1	4.32077599163	-	5.00e-02	GO:0100002	negative regulation of protein kinase activity by protein phosphorylation	BP
1	1	4.32077599163	-	5.00e-02	GO:0043049	otic placode formation	BP
1	1	4.32077599163	-	5.00e-02	GO:0048370	lateral mesoderm formation	BP
1	1	4.32077599163	-	5.00e-02	GO:0002875	negative regulation of chronic inflammatory response to antigenic stimulus	BP
1	1	4.32077599163	-	5.00e-02	GO:0045713	low-density lipoprotein particle receptor biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0034377	plasma lipoprotein particle assembly	BP
1	1	4.32077599163	-	5.00e-02	GO:1902870	negative regulation of amacrine cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:1902691	respiratory basal cell differentiation	BP
1	1	4.32077599163	-	5.00e-02	GO:0018910	benzene metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1901630	negative regulation of presynaptic membrane organization	BP
1	1	4.32077599163	-	5.00e-02	GO:0061046	regulation of branching involved in lung morphogenesis	BP
1	1	4.32077599163	-	5.00e-02	GO:0007538	primary sex determination	BP
1	1	4.32077599163	-	5.00e-02	GO:2000683	regulation of cellular response to X-ray	BP
1	1	4.32077599163	-	5.00e-02	GO:0070377	negative regulation of ERK5 cascade	BP
1	1	4.32077599163	-	5.00e-02	GO:0035898	parathyroid hormone secretion	BP
1	1	4.32077599163	-	5.00e-02	GO:0060010	Sertoli cell fate commitment	BP
1	1	4.32077599163	-	5.00e-02	GO:2000184	positive regulation of progesterone biosynthetic process	BP
1	1	4.32077599163	-	5.00e-02	GO:2000230	negative regulation of pancreatic stellate cell proliferation	BP
1	1	4.32077599163	-	5.00e-02	GO:0036306	embryonic heart tube elongation	BP
1	1	4.32077599163	-	5.00e-02	GO:0060695	negative regulation of cholesterol transporter activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0060694	regulation of cholesterol transporter activity	BP
1	1	4.32077599163	-	5.00e-02	GO:0060697	positive regulation of phospholipid catabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:1901475	pyruvate transmembrane transport	BP
1	1	4.32077599163	-	5.00e-02	GO:0010232	vascular transport	BP
1	1	4.32077599163	-	5.00e-02	GO:1901860	positive regulation of mitochondrial DNA metabolic process	BP
1	1	4.32077599163	-	5.00e-02	GO:0021894	cerebral cortex GABAergic interneuron development	BP
1	1	4.32077599163	-	5.00e-02	GO:0021763	subthalamic nucleus development	BP
1	1	4.32077599163	-	5.00e-02	GO:0033567	DNA replication, Okazaki fragment processing	BP
1	1	4.32077599163	-	5.00e-02	GO:0009444	pyruvate oxidation	BP
1	1	4.32077599163	-	5.00e-02	GO:1902544	regulation of DNA N-glycosylase activity	BP
1	1	4.32077599163	-	5.00e-02	GO:2000607	negative regulation of cell proliferation involved in mesonephros development	BP
1	1	4.32077599163	-	5.00e-02	GO:0060520	activation of prostate induction by androgen receptor signaling pathway	BP
1	1	4.32077599163	-	5.00e-02	GO:0045992	negative regulation of embryonic development	BP
7	7	4.32077599163	-	7.63e-10	GO:0004887	thyroid hormone receptor activity	MF
5	5	4.32077599163	-	3.09e-07	GO:0003708	retinoic acid receptor activity	MF
3	3	4.32077599163	-	1.25e-04	GO:0008384	IkappaB kinase activity	MF
3	3	4.32077599163	-	1.25e-04	GO:0004886	9-cis retinoic acid receptor activity	MF
3	3	4.32077599163	-	1.25e-04	GO:0050692	DBD domain binding	MF
2	2	4.32077599163	-	2.50e-03	GO:0004666	prostaglandin-endoperoxide synthase activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0098531	transcription factor activity, direct ligand regulated sequence-specific DNA binding	MF
2	2	4.32077599163	-	2.50e-03	GO:0038052	RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding	MF
2	2	4.32077599163	-	2.50e-03	GO:0032810	sterol response element binding	MF
2	2	4.32077599163	-	2.50e-03	GO:0034212	peptide N-acetyltransferase activity	MF
2	2	4.32077599163	-	2.50e-03	GO:0001225	RNA polymerase II transcription coactivator binding	MF
2	2	4.32077599163	-	2.50e-03	GO:0050682	AF-2 domain binding	MF
1	1	4.32077599163	-	5.00e-02	GO:1990450	linear polyubiquitin binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0050649	testosterone 6-beta-hydroxylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0043924	suramin binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0005477	pyruvate secondary active transmembrane transporter activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0015068	glycine amidinotransferase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004955	prostaglandin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0038051	glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0001010	transcription factor activity, sequence-specific DNA binding transcription factor recruiting	MF
1	1	4.32077599163	-	5.00e-02	GO:0061507	cyclic-GMP-AMP binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0043997	histone acetyltransferase activity (H4-K12 specific)	MF
1	1	4.32077599163	-	5.00e-02	GO:0008434	calcitriol receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0008116	prostaglandin-I synthase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0036468	L-dopa decarboxylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0070539	linoleic acid binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0001128	RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly	MF
1	1	4.32077599163	-	5.00e-02	GO:0016615	malate dehydrogenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0044377	RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending	MF
1	1	4.32077599163	-	5.00e-02	GO:0031962	mineralocorticoid receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0102798	heptaldehyde:oxygen oxidoreductase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0102797	geranial:oxygen oxidoreductase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0044213	intronic transcription regulatory region DNA binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0097655	serpin family protein binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0035438	cyclic-di-GMP binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0000210	NAD+ diphosphatase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0071855	neuropeptide receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0033780	taurochenodeoxycholate 6alpha-hydroxylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0030504	inorganic diphosphate transmembrane transporter activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0000250	lanosterol synthase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004058	aromatic-L-amino-acid decarboxylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:1902121	lithocholic acid binding	MF
1	1	4.32077599163	-	5.00e-02	GO:1902122	chenodeoxycholic acid binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0030273	melanin-concentrating hormone receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:1990188	euchromatin binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0033204	ribonuclease P RNA binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0008106	alcohol dehydrogenase (NADP+) activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004361	glutaryl-CoA dehydrogenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004607	phosphatidylcholine-sterol O-acyltransferase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0061656	SUMO conjugating enzyme activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0043739	G/U mismatch-specific uracil-DNA glycosylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0001133	RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0004876	complement component C3a receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0050591	quinine 3-monooxygenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0102166	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0102167	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0071820	N-box binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0032841	calcitonin binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0004728	signal transducer, downstream of receptor, with protein tyrosine phosphatase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0070320	inward rectifier potassium channel inhibitor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0047638	albendazole monooxygenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0000990	transcription factor activity, core RNA polymerase binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0001226	RNA polymerase II transcription corepressor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0004883	glucocorticoid receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0001034	RNA polymerase III transcription factor activity, sequence-specific DNA binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0001595	angiotensin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0070361	mitochondrial light strand promoter anti-sense binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0070362	mitochondrial heavy strand promoter anti-sense binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0051427	hormone receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0034593	phosphatidylinositol bisphosphate phosphatase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0034040	lipid-transporting ATPase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0070974	POU domain binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0102571	[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0015126	canalicular bile acid transmembrane transporter activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0038186	lithocholic acid receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0008829	dCTP deaminase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0005133	interferon-gamma receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0016231	beta-N-acetylglucosaminidase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0102320	1,8-cineole 2-exo-monooxygenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0008554	sodium-exporting ATPase activity, phosphorylative mechanism	MF
1	1	4.32077599163	-	5.00e-02	GO:0002153	steroid receptor RNA activator RNA binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0036403	arachidonate 8(S)-lipoxygenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0004925	prolactin receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0010855	adenylate cyclase inhibitor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0003908	methylated-DNA-[protein]-cysteine S-methyltransferase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0032448	DNA hairpin binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0035258	steroid hormone receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0019969	interleukin-10 binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0017168	5-oxoprolinase (ATP-hydrolyzing) activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0001642	group III metabotropic glutamate receptor activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0050104	L-gulonate 3-dehydrogenase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0034039	8-oxo-7,8-dihydroguanine DNA N-glycosylase activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0046911	metal chelating activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0097689	iron channel activity	MF
1	1	4.32077599163	-	5.00e-02	GO:0005140	interleukin-9 receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0005141	interleukin-10 receptor binding	MF
1	1	4.32077599163	-	5.00e-02	GO:0035594	ganglioside binding	MF
1	1	4.32077599163	-	5.00e-02	GO:1902098	calcitriol binding	MF
15	16	4.22766658724	-	1.58e-11	GO:0046965	retinoid X receptor binding	MF
32	36	4.15085099019	-	5.54e-11	GO:0004879	RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding	MF
5	6	4.0577415858	-	3.09e-07	GO:0010887	negative regulation of cholesterol storage	BP
5	6	4.0577415858	-	1.78e-06	GO:0036003	positive regulation of transcription from RNA polymerase II promoter in response to stress	BP
5	6	4.0577415858	-	1.78e-06	GO:0050693	LBD domain binding	MF
43	53	4.01912029177	-	9.19e-11	GO:0003707	steroid hormone receptor activity	MF
4	5	3.99884789674	-	6.22e-06	GO:0060509	Type I pneumocyte differentiation	BP
4	5	3.99884789674	-	2.99e-05	GO:0060850	regulation of transcription involved in cell fate commitment	BP
4	5	3.99884789674	-	2.99e-05	GO:0010606	positive regulation of cytoplasmic mRNA processing body assembly	BP
31	39	3.98957008316	-	1.67e-11	GO:0030522	intracellular receptor signaling pathway	BP
40	53	3.91478363196	-	9.19e-11	GO:0043401	steroid hormone mediated signaling pathway	BP
3	4	3.90573849235	-	1.25e-04	GO:0048550	negative regulation of pinocytosis	BP
3	4	3.90573849235	-	1.25e-04	GO:0030641	regulation of cellular pH	BP
3	4	3.90573849235	-	4.80e-04	GO:0030578	PML body organization	BP
3	4	3.90573849235	-	4.80e-04	GO:0042159	lipoprotein catabolic process	BP
3	4	3.90573849235	-	4.80e-04	GO:0035948	positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter	BP
3	4	3.90573849235	-	4.80e-04	GO:0045064	T-helper 2 cell differentiation	BP
3	4	3.90573849235	-	4.80e-04	GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	BP
3	4	3.90573849235	-	4.80e-04	GO:0032375	negative regulation of cholesterol transport	BP
3	4	3.90573849235	-	4.80e-04	GO:0090170	regulation of Golgi inheritance	BP
3	4	3.90573849235	-	1.25e-04	GO:0034875	caffeine oxidase activity	MF
3	4	3.90573849235	-	1.25e-04	GO:0044323	retinoic acid-responsive element binding	MF
3	4	3.90573849235	-	4.80e-04	GO:0030375	thyroid hormone receptor coactivator activity	MF
3	4	3.90573849235	-	4.80e-04	GO:0034056	estrogen response element binding	MF
4	6	3.73581349091	-	8.60e-05	GO:0046321	positive regulation of fatty acid oxidation	BP
4	6	3.73581349091	-	8.60e-05	GO:0060440	trachea formation	BP
2	3	3.73581349091	-	2.50e-03	GO:0001547	antral ovarian follicle growth	BP
2	3	3.73581349091	-	2.50e-03	GO:1900164	nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
2	3	3.73581349091	-	2.50e-03	GO:0060164	regulation of timing of neuron differentiation	BP
2	3	3.73581349091	-	2.50e-03	GO:0060769	positive regulation of epithelial cell proliferation involved in prostate gland development	BP
2	3	3.73581349091	-	7.25e-03	GO:0055005	ventricular cardiac myofibril assembly	BP
2	3	3.73581349091	-	7.25e-03	GO:0070562	regulation of vitamin D receptor signaling pathway	BP
2	3	3.73581349091	-	7.25e-03	GO:0098903	regulation of membrane repolarization during action potential	BP
2	3	3.73581349091	-	7.25e-03	GO:0033590	response to cobalamin	BP
2	3	3.73581349091	-	7.25e-03	GO:0097720	calcineurin-mediated signaling	BP
2	3	3.73581349091	-	7.25e-03	GO:0097061	dendritic spine organization	BP
2	3	3.73581349091	-	7.25e-03	GO:0055098	response to low-density lipoprotein particle stimulus	BP
2	3	3.73581349091	-	7.25e-03	GO:1901896	positive regulation of calcium-transporting ATPase activity	BP
2	3	3.73581349091	-	7.25e-03	GO:0089700	protein kinase D signaling	BP
2	3	3.73581349091	-	7.25e-03	GO:0072574	hepatocyte proliferation	BP
2	3	3.73581349091	-	7.25e-03	GO:0060748	tertiary branching involved in mammary gland duct morphogenesis	BP
2	3	3.73581349091	-	7.25e-03	GO:0045604	regulation of epidermal cell differentiation	BP
2	3	3.73581349091	-	7.25e-03	GO:2000611	positive regulation of thyroid hormone generation	BP
2	3	3.73581349091	-	7.25e-03	GO:0045925	positive regulation of female receptivity	BP
2	3	3.73581349091	-	7.25e-03	GO:0070141	response to UV-A	BP
2	3	3.73581349091	-	7.25e-03	GO:0000432	positive regulation of transcription from RNA polymerase II promoter by glucose	BP
2	3	3.73581349091	-	7.25e-03	GO:0038163	thrombopoietin-mediated signaling pathway	BP
2	3	3.73581349091	-	7.25e-03	GO:0032692	negative regulation of interleukin-1 production	BP
2	3	3.73581349091	-	7.25e-03	GO:0019218	regulation of steroid metabolic process	BP
2	3	3.73581349091	-	7.25e-03	GO:0003340	negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
2	3	3.73581349091	-	7.25e-03	GO:0061614	pri-miRNA transcription from RNA polymerase II promoter	BP
2	3	3.73581349091	-	7.25e-03	GO:0000189	MAPK import into nucleus	BP
2	3	3.73581349091	-	7.25e-03	GO:1903025	regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
2	3	3.73581349091	-	7.25e-03	GO:0035054	embryonic heart tube anterior/posterior pattern specification	BP
2	3	3.73581349091	-	7.25e-03	GO:0035880	embryonic nail plate morphogenesis	BP
2	3	3.73581349091	-	7.25e-03	GO:0002265	astrocyte activation involved in immune response	BP
2	3	3.73581349091	-	7.25e-03	GO:2000111	positive regulation of macrophage apoptotic process	BP
2	3	3.73581349091	-	7.25e-03	GO:2000630	positive regulation of miRNA metabolic process	BP
2	3	3.73581349091	-	7.25e-03	GO:0046886	positive regulation of hormone biosynthetic process	BP
2	3	3.73581349091	-	7.25e-03	GO:0019065	receptor-mediated endocytosis of virus by host cell	BP
2	3	3.73581349091	-	7.25e-03	GO:0002520	immune system development	BP
2	3	3.73581349091	-	7.25e-03	GO:0071871	response to epinephrine	BP
2	3	3.73581349091	-	7.25e-03	GO:0071409	cellular response to cycloheximide	BP
2	3	3.73581349091	-	7.25e-03	GO:0021697	cerebellar cortex formation	BP
2	3	3.73581349091	-	7.25e-03	GO:0034370	triglyceride-rich lipoprotein particle remodeling	BP
2	3	3.73581349091	-	7.25e-03	GO:1900222	negative regulation of amyloid-beta clearance	BP
2	3	3.73581349091	-	7.25e-03	GO:0061577	calcium ion transmembrane transport via high voltage-gated calcium channel	BP
8	12	3.73581349091	-	1.56e-08	GO:0042974	retinoic acid receptor binding	MF
4	6	3.73581349091	-	8.60e-05	GO:0001221	transcription cofactor binding	MF
2	3	3.73581349091	-	2.50e-03	GO:0050473	arachidonate 15-lipoxygenase activity	MF
2	3	3.73581349091	-	7.25e-03	GO:0001093	TFIIB-class transcription factor binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0070644	vitamin D response element binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0019826	oxygen sensor activity	MF
2	3	3.73581349091	-	7.25e-03	GO:0001161	intronic transcription regulatory region sequence-specific DNA binding	MF
2	3	3.73581349091	-	7.25e-03	GO:0004882	androgen receptor activity	MF
2	3	3.73581349091	-	7.25e-03	GO:0043398	HLH domain binding	MF
10	16	3.64270408652	-	7.71e-11	GO:0048384	retinoic acid receptor signaling pathway	BP
5	8	3.64270408652	-	5.97e-06	GO:0035357	peroxisome proliferator activated receptor signaling pathway	BP
13	21	3.62889828699	-	4.35e-11	GO:0016922	ligand-dependent nuclear receptor binding	MF
8	13	3.62033627349	-	3.89e-08	GO:0035259	glucocorticoid receptor binding	MF
3	5	3.58381039747	-	4.80e-04	GO:0045347	negative regulation of MHC class II biosynthetic process	BP
3	5	3.58381039747	-	4.80e-04	GO:0003417	growth plate cartilage development	BP
3	5	3.58381039747	-	1.16e-03	GO:0042158	lipoprotein biosynthetic process	BP
3	5	3.58381039747	-	1.16e-03	GO:0071599	otic vesicle development	BP
3	5	3.58381039747	-	1.16e-03	GO:0050847	progesterone receptor signaling pathway	BP
3	5	3.58381039747	-	1.16e-03	GO:0072584	caveolin-mediated endocytosis	BP
3	5	3.58381039747	-	1.16e-03	GO:0071376	cellular response to corticotropin-releasing hormone stimulus	BP
3	5	3.58381039747	-	1.16e-03	GO:0010828	positive regulation of glucose transport	BP
3	5	3.58381039747	-	1.16e-03	GO:0042501	serine phosphorylation of STAT protein	BP
6	10	3.58381039747	-	2.71e-06	GO:0042975	peroxisome proliferator activated receptor binding	MF
3	5	3.58381039747	-	1.16e-03	GO:0030284	estrogen receptor activity	MF
3	5	3.58381039747	-	1.16e-03	GO:0051525	NFAT protein binding	MF
3	5	3.58381039747	-	1.16e-03	GO:0030235	nitric-oxide synthase regulator activity	MF
13	22	3.56178409114	-	9.14e-11	GO:0035257	nuclear hormone receptor binding	MF
15	26	3.5272268691	-	6.28e-11	GO:0035035	histone acetyltransferase binding	MF
4	7	3.51342106957	-	8.60e-05	GO:0034372	very-low-density lipoprotein particle remodeling	BP
4	7	3.51342106957	-	1.93e-04	GO:2000641	regulation of early endosome to late endosome transport	BP
4	7	3.51342106957	-	1.93e-04	GO:0071499	cellular response to laminar fluid shear stress	BP
4	7	3.51342106957	-	1.93e-04	GO:0010870	positive regulation of receptor biosynthetic process	BP
5	9	3.47277908508	-	5.97e-06	GO:0003143	embryonic heart tube morphogenesis	BP
10	18	3.47277908508	-	5.62e-10	GO:0001190	transcriptional activator activity, RNA polymerase II transcription factor binding	MF
6	11	3.44630687372	-	1.13e-06	GO:2000188	regulation of cholesterol homeostasis	BP
7	13	3.42769119555	-	4.84e-07	GO:0010745	negative regulation of macrophage derived foam cell differentiation	BP
7	13	3.42769119555	-	4.84e-07	GO:0004535	poly(A)-specific ribonuclease activity	MF
6	12	3.32077599163	-	5.72e-06	GO:0071498	cellular response to fluid shear stress	BP
5	10	3.32077599163	-	3.29e-05	GO:0034378	chylomicron assembly	BP
5	10	3.32077599163	-	6.31e-05	GO:0033148	positive regulation of intracellular estrogen receptor signaling pathway	BP
5	10	3.32077599163	-	6.31e-05	GO:0051247	positive regulation of protein metabolic process	BP
4	8	3.32077599163	-	8.60e-05	GO:0051152	positive regulation of smooth muscle cell differentiation	BP
3	6	3.32077599163	-	1.25e-04	GO:0016098	monoterpenoid metabolic process	BP
4	8	3.32077599163	-	1.93e-04	GO:0034382	chylomicron remnant clearance	BP
4	8	3.32077599163	-	1.93e-04	GO:0001542	ovulation from ovarian follicle	BP
4	8	3.32077599163	-	3.70e-04	GO:0002467	germinal center formation	BP
4	8	3.32077599163	-	3.70e-04	GO:0042753	positive regulation of circadian rhythm	BP
4	8	3.32077599163	-	3.70e-04	GO:2000020	positive regulation of male gonad development	BP
3	6	3.32077599163	-	4.80e-04	GO:0010694	positive regulation of alkaline phosphatase activity	BP
3	6	3.32077599163	-	4.80e-04	GO:0009913	epidermal cell differentiation	BP
3	6	3.32077599163	-	1.16e-03	GO:0034447	very-low-density lipoprotein particle clearance	BP
3	6	3.32077599163	-	1.16e-03	GO:0038092	nodal signaling pathway	BP
3	6	3.32077599163	-	1.16e-03	GO:0061469	regulation of type B pancreatic cell proliferation	BP
3	6	3.32077599163	-	1.16e-03	GO:0003406	retinal pigment epithelium development	BP
3	6	3.32077599163	-	2.23e-03	GO:0043619	regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
3	6	3.32077599163	-	2.23e-03	GO:1904798	positive regulation of core promoter binding	BP
3	6	3.32077599163	-	2.23e-03	GO:0060789	hair follicle placode formation	BP
3	6	3.32077599163	-	2.23e-03	GO:1903799	negative regulation of production of miRNAs involved in gene silencing by miRNA	BP
3	6	3.32077599163	-	2.23e-03	GO:0060536	cartilage morphogenesis	BP
3	6	3.32077599163	-	2.23e-03	GO:0061312	BMP signaling pathway involved in heart development	BP
2	4	3.32077599163	-	2.50e-03	GO:0090403	oxidative stress-induced premature senescence	BP
2	4	3.32077599163	-	2.50e-03	GO:0042481	regulation of odontogenesis	BP
2	4	3.32077599163	-	7.25e-03	GO:0070384	Harderian gland development	BP
2	4	3.32077599163	-	7.25e-03	GO:0060742	epithelial cell differentiation involved in prostate gland development	BP
2	4	3.32077599163	-	7.25e-03	GO:0070858	negative regulation of bile acid biosynthetic process	BP
2	4	3.32077599163	-	7.25e-03	GO:0070857	regulation of bile acid biosynthetic process	BP
2	4	3.32077599163	-	7.25e-03	GO:0007290	spermatid nucleus elongation	BP
2	4	3.32077599163	-	7.25e-03	GO:2000757	negative regulation of peptidyl-lysine acetylation	BP
2	4	3.32077599163	-	7.25e-03	GO:0035886	vascular smooth muscle cell differentiation	BP
2	4	3.32077599163	-	7.25e-03	GO:0060571	morphogenesis of an epithelial fold	BP
2	4	3.32077599163	-	7.25e-03	GO:2001141	regulation of RNA biosynthetic process	BP
2	4	3.32077599163	-	7.25e-03	GO:0003257	positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation	BP
2	4	3.32077599163	-	1.40e-02	GO:1902219	negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress	BP
2	4	3.32077599163	-	1.40e-02	GO:0046545	development of primary female sexual characteristics	BP
2	4	3.32077599163	-	1.40e-02	GO:0032369	negative regulation of lipid transport	BP
2	4	3.32077599163	-	1.40e-02	GO:1901203	positive regulation of extracellular matrix assembly	BP
2	4	3.32077599163	-	1.40e-02	GO:0014044	Schwann cell development	BP
2	4	3.32077599163	-	1.40e-02	GO:0032079	positive regulation of endodeoxyribonuclease activity	BP
2	4	3.32077599163	-	1.40e-02	GO:0045415	negative regulation of interleukin-8 biosynthetic process	BP
2	4	3.32077599163	-	1.40e-02	GO:0032376	positive regulation of cholesterol transport	BP
2	4	3.32077599163	-	1.40e-02	GO:0060033	anatomical structure regression	BP
2	4	3.32077599163	-	1.40e-02	GO:0018393	internal peptidyl-lysine acetylation	BP
2	4	3.32077599163	-	1.40e-02	GO:0018394	peptidyl-lysine acetylation	BP
2	4	3.32077599163	-	1.40e-02	GO:0098815	modulation of excitatory postsynaptic potential	BP
2	4	3.32077599163	-	1.40e-02	GO:0070849	response to epidermal growth factor	BP
2	4	3.32077599163	-	1.40e-02	GO:0048679	regulation of axon regeneration	BP
2	4	3.32077599163	-	1.40e-02	GO:0048386	positive regulation of retinoic acid receptor signaling pathway	BP
2	4	3.32077599163	-	1.40e-02	GO:0003266	regulation of secondary heart field cardioblast proliferation	BP
2	4	3.32077599163	-	1.40e-02	GO:0006642	triglyceride mobilization	BP
2	4	3.32077599163	-	1.40e-02	GO:0006344	maintenance of chromatin silencing	BP
2	4	3.32077599163	-	1.40e-02	GO:0060430	lung saccule development	BP
2	4	3.32077599163	-	1.40e-02	GO:0010822	positive regulation of mitochondrion organization	BP
2	4	3.32077599163	-	1.40e-02	GO:0033600	negative regulation of mammary gland epithelial cell proliferation	BP
2	4	3.32077599163	-	1.40e-02	GO:0051098	regulation of binding	BP
2	4	3.32077599163	-	1.40e-02	GO:0070836	caveola assembly	BP
2	4	3.32077599163	-	1.40e-02	GO:0003219	cardiac right ventricle formation	BP
2	4	3.32077599163	-	1.40e-02	GO:0033158	regulation of protein import into nucleus, translocation	BP
2	4	3.32077599163	-	1.40e-02	GO:0072289	metanephric nephron tubule formation	BP
2	4	3.32077599163	-	1.40e-02	GO:0060018	astrocyte fate commitment	BP
2	4	3.32077599163	-	1.40e-02	GO:2000189	positive regulation of cholesterol homeostasis	BP
2	4	3.32077599163	-	1.40e-02	GO:0060750	epithelial cell proliferation involved in mammary gland duct elongation	BP
2	4	3.32077599163	-	1.40e-02	GO:0060528	secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development	BP
2	4	3.32077599163	-	1.40e-02	GO:0032909	regulation of transforming growth factor beta2 production	BP
1	2	3.32077599163	-	5.00e-02	GO:0072079	nephron tubule formation	BP
1	2	3.32077599163	-	5.00e-02	GO:0045720	negative regulation of integrin biosynthetic process	BP
1	2	3.32077599163	-	5.00e-02	GO:0030505	inorganic diphosphate transport	BP
1	2	3.32077599163	-	5.00e-02	GO:0033594	response to hydroxyisoflavone	BP
1	2	3.32077599163	-	5.00e-02	GO:1903860	negative regulation of dendrite extension	BP
1	2	3.32077599163	-	5.00e-02	GO:1901857	positive regulation of cellular respiration	BP
1	2	3.32077599163	-	5.00e-02	GO:0003415	chondrocyte hypertrophy	BP
1	2	3.32077599163	-	5.00e-02	GO:0007423	sensory organ development	BP
1	2	3.32077599163	-	5.00e-02	GO:0086029	Purkinje myocyte to ventricular cardiac muscle cell signaling	BP
1	2	3.32077599163	-	5.00e-02	GO:0072190	ureter urothelium development	BP
1	2	3.32077599163	-	5.00e-02	GO:0060460	left lung morphogenesis	BP
1	2	3.32077599163	-	5.00e-02	GO:0060738	epithelial-mesenchymal signaling involved in prostate gland development	BP
1	2	3.32077599163	-	5.00e-02	GO:0090362	positive regulation of platelet-derived growth factor production	BP
1	2	3.32077599163	-	5.00e-02	GO:1902995	positive regulation of phospholipid efflux	BP
1	2	3.32077599163	-	5.00e-02	GO:0045976	negative regulation of mitotic cell cycle, embryonic	BP
1	2	3.32077599163	-	5.00e-02	GO:1900111	positive regulation of histone H3-K9 dimethylation	BP
1	2	3.32077599163	-	5.00e-02	GO:1904639	cellular response to resveratrol	BP
1	2	3.32077599163	-	5.00e-02	GO:0035358	regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	2	3.32077599163	-	5.00e-02	GO:0021557	oculomotor nerve development	BP
1	2	3.32077599163	-	5.00e-02	GO:0021558	trochlear nerve development	BP
1	2	3.32077599163	-	5.00e-02	GO:0009115	xanthine catabolic process	BP
1	2	3.32077599163	-	5.00e-02	GO:0042595	behavioral response to starvation	BP
1	2	3.32077599163	-	5.00e-02	GO:0090187	positive regulation of pancreatic juice secretion	BP
1	2	3.32077599163	-	5.00e-02	GO:1903979	negative regulation of microglial cell activation	BP
1	2	3.32077599163	-	5.00e-02	GO:1900224	positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry	BP
1	2	3.32077599163	-	5.00e-02	GO:0072560	type B pancreatic cell maturation	BP
1	2	3.32077599163	-	5.00e-02	GO:2000143	negative regulation of DNA-templated transcription, initiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0045659	negative regulation of neutrophil differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0071109	superior temporal gyrus development	BP
1	2	3.32077599163	-	9.76e-02	GO:0003207	cardiac chamber formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0090402	oncogene-induced cell senescence	BP
1	2	3.32077599163	-	9.76e-02	GO:0061325	cell proliferation involved in outflow tract morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0017055	negative regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0001776	leukocyte homeostasis	BP
1	2	3.32077599163	-	9.76e-02	GO:0010652	positive regulation of cell communication by chemical coupling	BP
1	2	3.32077599163	-	9.76e-02	GO:0060302	negative regulation of cytokine activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0021855	hypothalamus cell migration	BP
1	2	3.32077599163	-	9.76e-02	GO:0098907	regulation of SA node cell action potential	BP
1	2	3.32077599163	-	9.76e-02	GO:0001869	negative regulation of complement activation, lectin pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0071650	negative regulation of chemokine (C-C motif) ligand 5 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0071417	cellular response to organonitrogen compound	BP
1	2	3.32077599163	-	9.76e-02	GO:0006742	NADP catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:1905665	positive regulation of calcium ion import across plasma membrane	BP
1	2	3.32077599163	-	9.76e-02	GO:0071929	alpha-tubulin acetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0021681	cerebellar granular layer development	BP
1	2	3.32077599163	-	9.76e-02	GO:0060599	lateral sprouting involved in mammary gland duct morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0060621	negative regulation of cholesterol import	BP
1	2	3.32077599163	-	9.76e-02	GO:0043370	regulation of CD4-positive, alpha-beta T cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0014041	regulation of neuron maturation	BP
1	2	3.32077599163	-	9.76e-02	GO:0014040	positive regulation of Schwann cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0032071	regulation of endodeoxyribonuclease activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0060025	regulation of synaptic activity	BP
1	2	3.32077599163	-	9.76e-02	GO:2000077	negative regulation of type B pancreatic cell development	BP
1	2	3.32077599163	-	9.76e-02	GO:0060557	positive regulation of vitamin D biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:1905167	positive regulation of lysosomal protein catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0055092	sterol homeostasis	BP
1	2	3.32077599163	-	9.76e-02	GO:0048210	Golgi vesicle fusion to target membrane	BP
1	2	3.32077599163	-	9.76e-02	GO:0090169	regulation of spindle assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0046619	optic placode formation involved in camera-type eye formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0036294	cellular response to decreased oxygen levels	BP
1	2	3.32077599163	-	9.76e-02	GO:2000824	negative regulation of androgen receptor activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0035585	calcium-mediated signaling using extracellular calcium source	BP
1	2	3.32077599163	-	9.76e-02	GO:0034971	histone H3-R17 methylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0021571	rhombomere 5 development	BP
1	2	3.32077599163	-	9.76e-02	GO:0072160	nephron tubule epithelial cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0071306	cellular response to vitamin E	BP
1	2	3.32077599163	-	9.76e-02	GO:0051650	establishment of vesicle localization	BP
1	2	3.32077599163	-	9.76e-02	GO:0032915	positive regulation of transforming growth factor beta2 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0031393	negative regulation of prostaglandin biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0003188	heart valve formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0034391	regulation of smooth muscle cell apoptotic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0034395	regulation of transcription from RNA polymerase II promoter in response to iron	BP
1	2	3.32077599163	-	9.76e-02	GO:1905908	positive regulation of amyloid fibril formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0045645	positive regulation of eosinophil differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0010934	macrophage cytokine production	BP
1	2	3.32077599163	-	9.76e-02	GO:0048069	eye pigmentation	BP
1	2	3.32077599163	-	9.76e-02	GO:0072054	renal outer medulla development	BP
1	2	3.32077599163	-	9.76e-02	GO:0071624	positive regulation of granulocyte chemotaxis	BP
1	2	3.32077599163	-	9.76e-02	GO:0045023	G0 to G1 transition	BP
1	2	3.32077599163	-	9.76e-02	GO:0010874	regulation of cholesterol efflux	BP
1	2	3.32077599163	-	9.76e-02	GO:0003220	left ventricular cardiac muscle tissue morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0045355	negative regulation of interferon-alpha biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0000430	regulation of transcription from RNA polymerase II promoter by glucose	BP
1	2	3.32077599163	-	9.76e-02	GO:0045684	positive regulation of epidermis development	BP
1	2	3.32077599163	-	9.76e-02	GO:0030821	negative regulation of cAMP catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0019046	release from viral latency	BP
1	2	3.32077599163	-	9.76e-02	GO:0019049	evasion or tolerance of host defenses by virus	BP
1	2	3.32077599163	-	9.76e-02	GO:1900078	positive regulation of cellular response to insulin stimulus	BP
1	2	3.32077599163	-	9.76e-02	GO:1903038	negative regulation of leukocyte cell-cell adhesion	BP
1	2	3.32077599163	-	9.76e-02	GO:0048822	enucleate erythrocyte development	BP
1	2	3.32077599163	-	9.76e-02	GO:0044334	canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition	BP
1	2	3.32077599163	-	9.76e-02	GO:0051284	positive regulation of sequestering of calcium ion	BP
1	2	3.32077599163	-	9.76e-02	GO:0070101	positive regulation of chemokine-mediated signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0072197	ureter morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0044869	negative regulation by host of viral exo-alpha-sialidase activity	BP
1	2	3.32077599163	-	9.76e-02	GO:0044860	protein localization to plasma membrane raft	BP
1	2	3.32077599163	-	9.76e-02	GO:2000594	positive regulation of metanephric DCT cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0030997	regulation of centriole-centriole cohesion	BP
1	2	3.32077599163	-	9.76e-02	GO:0006542	glutamine biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:1903894	regulation of IRE1-mediated unfolded protein response	BP
1	2	3.32077599163	-	9.76e-02	GO:0072305	negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0003062	regulation of heart rate by chemical signal	BP
1	2	3.32077599163	-	9.76e-02	GO:0032701	negative regulation of interleukin-18 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0072738	cellular response to diamide	BP
1	2	3.32077599163	-	9.76e-02	GO:0033032	regulation of myeloid cell apoptotic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0060502	epithelial cell proliferation involved in lung morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0022037	metencephalon development	BP
1	2	3.32077599163	-	9.76e-02	GO:0014806	smooth muscle hyperplasia	BP
1	2	3.32077599163	-	9.76e-02	GO:0071506	cellular response to mycophenolic acid	BP
1	2	3.32077599163	-	9.76e-02	GO:0032615	interleukin-12 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0006601	creatine biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0045054	constitutive secretory pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0055025	positive regulation of cardiac muscle tissue development	BP
1	2	3.32077599163	-	9.76e-02	GO:0001927	exocyst assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0001712	ectodermal cell fate commitment	BP
1	2	3.32077599163	-	9.76e-02	GO:0010902	positive regulation of very-low-density lipoprotein particle remodeling	BP
1	2	3.32077599163	-	9.76e-02	GO:1903305	regulation of regulated secretory pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:2001178	positive regulation of mediator complex assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0052314	phytoalexin metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0090288	negative regulation of cellular response to growth factor stimulus	BP
1	2	3.32077599163	-	9.76e-02	GO:0003193	pulmonary valve formation	BP
1	2	3.32077599163	-	9.76e-02	GO:2001038	regulation of cellular response to drug	BP
1	2	3.32077599163	-	9.76e-02	GO:0071379	cellular response to prostaglandin stimulus	BP
1	2	3.32077599163	-	9.76e-02	GO:2000663	negative regulation of interleukin-5 secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:2000666	negative regulation of interleukin-13 secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:0090241	negative regulation of histone H4 acetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0072053	renal inner medulla development	BP
1	2	3.32077599163	-	9.76e-02	GO:0014889	muscle atrophy	BP
1	2	3.32077599163	-	9.76e-02	GO:0061153	trachea gland development	BP
1	2	3.32077599163	-	9.76e-02	GO:0035408	histone H3-T6 phosphorylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0021873	forebrain neuroblast division	BP
1	2	3.32077599163	-	9.76e-02	GO:0003156	regulation of animal organ formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0044091	membrane biogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0090035	positive regulation of chaperone-mediated protein complex assembly	BP
1	2	3.32077599163	-	9.76e-02	GO:0090209	negative regulation of triglyceride metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0044324	regulation of transcription involved in anterior/posterior axis specification	BP
1	2	3.32077599163	-	9.76e-02	GO:2000978	negative regulation of forebrain neuron differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:2000707	positive regulation of dense core granule biogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0035802	adrenal cortex formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0060086	circadian temperature homeostasis	BP
1	2	3.32077599163	-	9.76e-02	GO:0044871	negative regulation by host of viral glycoprotein metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0032805	positive regulation of low-density lipoprotein particle receptor catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0021986	habenula development	BP
1	2	3.32077599163	-	9.76e-02	GO:0051124	synaptic growth at neuromuscular junction	BP
1	2	3.32077599163	-	9.76e-02	GO:1904057	negative regulation of sensory perception of pain	BP
1	2	3.32077599163	-	9.76e-02	GO:0045872	positive regulation of rhodopsin gene expression	BP
1	2	3.32077599163	-	9.76e-02	GO:1900215	negative regulation of apoptotic process involved in metanephric collecting duct development	BP
1	2	3.32077599163	-	9.76e-02	GO:1900218	negative regulation of apoptotic process involved in metanephric nephron tubule development	BP
1	2	3.32077599163	-	9.76e-02	GO:0048669	collateral sprouting in absence of injury	BP
1	2	3.32077599163	-	9.76e-02	GO:0007521	muscle cell fate determination	BP
1	2	3.32077599163	-	9.76e-02	GO:0071900	regulation of protein serine/threonine kinase activity	BP
1	2	3.32077599163	-	9.76e-02	GO:2000016	negative regulation of determination of dorsal identity	BP
1	2	3.32077599163	-	9.76e-02	GO:0035051	cardiocyte differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0045161	neuronal ion channel clustering	BP
1	2	3.32077599163	-	9.76e-02	GO:0019100	male germ-line sex determination	BP
1	2	3.32077599163	-	9.76e-02	GO:0021599	abducens nerve formation	BP
1	2	3.32077599163	-	9.76e-02	GO:1902722	positive regulation of prolactin secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:0090149	mitochondrial membrane fission	BP
1	2	3.32077599163	-	9.76e-02	GO:0044154	histone H3-K14 acetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0007070	negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle	BP
1	2	3.32077599163	-	9.76e-02	GO:0035922	foramen ovale closure	BP
1	2	3.32077599163	-	9.76e-02	GO:0043313	regulation of neutrophil degranulation	BP
1	2	3.32077599163	-	9.76e-02	GO:0003430	growth plate cartilage chondrocyte growth	BP
1	2	3.32077599163	-	9.76e-02	GO:0032227	negative regulation of synaptic transmission, dopaminergic	BP
1	2	3.32077599163	-	9.76e-02	GO:0045624	positive regulation of T-helper cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:1904674	positive regulation of somatic stem cell population maintenance	BP
1	2	3.32077599163	-	9.76e-02	GO:0000720	pyrimidine dimer repair by nucleotide-excision repair	BP
1	2	3.32077599163	-	9.76e-02	GO:2000342	negative regulation of chemokine (C-X-C motif) ligand 2 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0035397	helper T cell enhancement of adaptive immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:0061647	histone H3-K9 modification	BP
1	2	3.32077599163	-	9.76e-02	GO:0021514	ventral spinal cord interneuron differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0003218	cardiac left ventricle formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0046068	cGMP metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:2000309	positive regulation of tumor necrosis factor (ligand) superfamily member 11 production	BP
1	2	3.32077599163	-	9.76e-02	GO:0002302	CD8-positive, alpha-beta T cell differentiation involved in immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:2000845	positive regulation of testosterone secretion	BP
1	2	3.32077599163	-	9.76e-02	GO:0043970	histone H3-K9 acetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:1903016	negative regulation of exo-alpha-sialidase activity	BP
1	2	3.32077599163	-	9.76e-02	GO:1903019	negative regulation of glycoprotein metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0033484	nitric oxide homeostasis	BP
1	2	3.32077599163	-	9.76e-02	GO:1990619	histone H3-K9 deacetylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0031943	regulation of glucocorticoid metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0043006	activation of phospholipase A2 activity by calcium-mediated signaling	BP
1	2	3.32077599163	-	9.76e-02	GO:0072368	regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter	BP
1	2	3.32077599163	-	9.76e-02	GO:0072369	regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter	BP
1	2	3.32077599163	-	9.76e-02	GO:0032834	positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response	BP
1	2	3.32077599163	-	9.76e-02	GO:0006711	estrogen catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0003290	atrial septum secundum morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0061290	canonical Wnt signaling pathway involved in metanephric kidney development	BP
1	2	3.32077599163	-	9.76e-02	GO:0045082	positive regulation of interleukin-10 biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0032764	negative regulation of mast cell cytokine production	BP
1	2	3.32077599163	-	9.76e-02	GO:0071874	cellular response to norepinephrine stimulus	BP
1	2	3.32077599163	-	9.76e-02	GO:2000779	regulation of double-strand break repair	BP
1	2	3.32077599163	-	9.76e-02	GO:0039003	pronephric field specification	BP
1	2	3.32077599163	-	9.76e-02	GO:0006285	base-excision repair, AP site formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0048638	regulation of developmental growth	BP
1	2	3.32077599163	-	9.76e-02	GO:0052651	monoacylglycerol catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0006568	tryptophan metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0035026	leading edge cell differentiation	BP
1	2	3.32077599163	-	9.76e-02	GO:0044027	hypermethylation of CpG island	BP
1	2	3.32077599163	-	9.76e-02	GO:1900221	regulation of amyloid-beta clearance	BP
1	2	3.32077599163	-	9.76e-02	GO:0035511	oxidative DNA demethylation	BP
1	2	3.32077599163	-	9.76e-02	GO:0050725	positive regulation of interleukin-1 beta biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0070375	ERK5 cascade	BP
1	2	3.32077599163	-	9.76e-02	GO:0097050	type B pancreatic cell apoptotic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0010899	regulation of phosphatidylcholine catabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0019858	cytosine metabolic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0046331	lateral inhibition	BP
1	2	3.32077599163	-	9.76e-02	GO:2000182	regulation of progesterone biosynthetic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0072179	nephric duct formation	BP
1	2	3.32077599163	-	9.76e-02	GO:0071888	macrophage apoptotic process	BP
1	2	3.32077599163	-	9.76e-02	GO:0033561	regulation of water loss via skin	BP
1	2	3.32077599163	-	9.76e-02	GO:0060713	labyrinthine layer morphogenesis	BP
1	2	3.32077599163	-	9.76e-02	GO:0060717	chorion development	BP
1	2	3.32077599163	-	9.76e-02	GO:0038194	thyroid-stimulating hormone signaling pathway	BP
1	2	3.32077599163	-	9.76e-02	GO:0045994	positive regulation of translational initiation by iron	BP
1	2	3.32077599163	-	9.76e-02	GO:0072033	renal vesicle formation	BP
14	28	3.32077599163	-	1.13e-11	GO:0046966	thyroid hormone receptor binding	MF
5	10	3.32077599163	-	6.31e-05	GO:0033558	protein deacetylase activity	MF
2	4	3.32077599163	-	7.25e-03	GO:0030229	very-low-density lipoprotein particle receptor activity	MF
2	4	3.32077599163	-	1.40e-02	GO:0016361	activin receptor activity, type I	MF
2	4	3.32077599163	-	1.40e-02	GO:0001012	RNA polymerase II regulatory region DNA binding	MF
2	4	3.32077599163	-	1.40e-02	GO:0070851	growth factor receptor binding	MF
2	4	3.32077599163	-	1.40e-02	GO:0034186	apolipoprotein A-I binding	MF
2	4	3.32077599163	-	1.40e-02	GO:0034191	apolipoprotein A-I receptor binding	MF
2	4	3.32077599163	-	1.40e-02	GO:0071535	RING-like zinc finger domain binding	MF
2	4	3.32077599163	-	1.40e-02	GO:0004176	ATP-dependent peptidase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0017050	D-erythro-sphingosine kinase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0018675	(S)-limonene 6-monooxygenase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0034188	apolipoprotein A-I receptor activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0030549	acetylcholine receptor activator activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0016903	oxidoreductase activity, acting on the aldehyde or oxo group of donors	MF
1	2	3.32077599163	-	5.00e-02	GO:0034437	glycoprotein transporter activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0008481	sphinganine kinase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0052741	(R)-limonene 6-monooxygenase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0016811	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides	MF
1	2	3.32077599163	-	5.00e-02	GO:0030343	vitamin D3 25-hydroxylase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:1903763	gap junction channel activity involved in cell communication by electrical coupling	MF
1	2	3.32077599163	-	5.00e-02	GO:0018676	(S)-limonene 7-monooxygenase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0090556	phosphatidylserine-translocating ATPase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0038181	bile acid receptor activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0004031	aldehyde oxidase activity	MF
1	2	3.32077599163	-	5.00e-02	GO:0001567	cholesterol 25-hydroxylase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004996	thyroid-stimulating hormone receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0033142	progesterone receptor binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0001632	leukotriene B4 receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0061733	peptide-lysine-N-acetyltransferase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0015432	bile acid-exporting ATPase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0016165	linoleate 13S-lipoxygenase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0035034	histone acetyltransferase regulator activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0061629	RNA polymerase II sequence-specific DNA binding transcription factor binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0008534	oxidized purine nucleobase lesion DNA N-glycosylase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0034189	very-low-density lipoprotein particle binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0070576	vitamin D 24-hydroxylase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0008263	pyrimidine-specific mismatch base pair DNA N-glycosylase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004906	interferon-gamma receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0015235	cobalamin transporter activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0033549	MAP kinase phosphatase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0005128	erythropoietin receptor binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0016641	oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor	MF
1	2	3.32077599163	-	9.76e-02	GO:0001134	transcription factor activity, transcription factor recruiting	MF
1	2	3.32077599163	-	9.76e-02	GO:0010736	serum response element binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0004874	aryl hydrocarbon receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0086075	gap junction channel activity involved in cardiac conduction electrical coupling	MF
1	2	3.32077599163	-	9.76e-02	GO:0035403	histone kinase activity (H3-T6 specific)	MF
1	2	3.32077599163	-	9.76e-02	GO:0016890	site-specific endodeoxyribonuclease activity, specific for altered base	MF
1	2	3.32077599163	-	9.76e-02	GO:0034988	Fc-gamma receptor I complex binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0001071	nucleic acid binding transcription factor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0005006	epidermal growth factor-activated receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0035014	phosphatidylinositol 3-kinase regulator activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004105	choline-phosphate cytidylyltransferase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0004356	glutamate-ammonia ligase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0018479	benzaldehyde dehydrogenase (NAD+) activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0046969	NAD-dependent histone deacetylase activity (H3-K9 specific)	MF
1	2	3.32077599163	-	9.76e-02	GO:0017002	activin-activated receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0017129	triglyceride binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0000171	ribonuclease MRP activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0001640	adenylate cyclase inhibiting G-protein coupled glutamate receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0001025	RNA polymerase III transcription factor binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0015114	phosphate ion transmembrane transporter activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0038025	reelin receptor activity	MF
1	2	3.32077599163	-	9.76e-02	GO:1990763	arrestin family protein binding	MF
1	2	3.32077599163	-	9.76e-02	GO:0008124	4-alpha-hydroxytetrahydrobiopterin dehydratase activity	MF
1	2	3.32077599163	-	9.76e-02	GO:0016427	tRNA (cytosine) methyltransferase activity	MF
14	30	3.22124031808	-	2.09e-11	GO:0001205	transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding	MF
7	15	3.22124031808	-	1.92e-06	GO:0035326	enhancer binding	MF
7	15	3.22124031808	-	1.92e-06	GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	MF
6	13	3.20529877421	-	1.10e-05	GO:2000273	positive regulation of receptor activity	BP
6	13	3.20529877421	-	1.95e-05	GO:0060334	regulation of interferon-gamma-mediated signaling pathway	BP
5	11	3.18327246788	-	6.31e-05	GO:1990440	positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
5	11	3.18327246788	-	6.31e-05	GO:0006473	protein acetylation	BP
5	11	3.18327246788	-	1.11e-04	GO:0004707	MAP kinase activity	MF
9	20	3.16877289819	-	1.91e-07	GO:1902895	positive regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
4	9	3.15085099019	-	8.60e-05	GO:0048617	embryonic foregut morphogenesis	BP
4	9	3.15085099019	-	1.93e-04	GO:0034371	chylomicron remodeling	BP
4	9	3.15085099019	-	6.40e-04	GO:0034405	response to fluid shear stress	BP
4	9	3.15085099019	-	6.40e-04	GO:0032183	SUMO binding	MF
4	9	3.15085099019	-	6.40e-04	GO:0017162	aryl hydrocarbon receptor binding	MF
18	41	3.13314898846	-	1.67e-11	GO:0030331	estrogen receptor binding	MF
7	16	3.12813091369	-	5.86e-06	GO:0030518	intracellular steroid hormone receptor signaling pathway	BP
65	150	3.11432511416	-	3.90e-11	GO:0006367	transcription initiation from RNA polymerase II promoter	BP
6	14	3.0983835703	-	5.72e-06	GO:0010875	positive regulation of cholesterol efflux	BP
6	14	3.0983835703	-	1.95e-05	GO:0033147	negative regulation of intracellular estrogen receptor signaling pathway	BP
6	14	3.0983835703	-	3.27e-05	GO:0060644	mammary gland epithelial cell differentiation	BP
3	7	3.0983835703	-	1.16e-03	GO:0060740	prostate gland epithelium morphogenesis	BP
3	7	3.0983835703	-	2.23e-03	GO:0071455	cellular response to hyperoxia	BP
3	7	3.0983835703	-	2.23e-03	GO:0045722	positive regulation of gluconeogenesis	BP
3	7	3.0983835703	-	3.75e-03	GO:0042921	glucocorticoid receptor signaling pathway	BP
3	7	3.0983835703	-	3.75e-03	GO:0035360	positive regulation of peroxisome proliferator activated receptor signaling pathway	BP
3	7	3.0983835703	-	3.75e-03	GO:0060290	transdifferentiation	BP
3	7	3.0983835703	-	3.75e-03	GO:0010742	macrophage derived foam cell differentiation	BP
3	7	3.0983835703	-	3.75e-03	GO:0043983	histone H4-K12 acetylation	BP
3	7	3.0983835703	-	3.75e-03	GO:2000144	positive regulation of DNA-templated transcription, initiation	BP
6	14	3.0983835703	-	1.10e-05	GO:0000982	transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
6	14	3.0983835703	-	3.27e-05	GO:0000983	transcription factor activity, RNA polymerase II core promoter sequence-specific	MF
20	47	3.08811523484	-	1.88e-11	GO:0001046	core promoter sequence-specific DNA binding	MF
8	19	3.07284847819	-	1.74e-06	GO:0051568	histone H3-K4 methylation	BP
5	12	3.0577415858	-	3.29e-05	GO:0033700	phospholipid efflux	BP
5	12	3.0577415858	-	1.82e-04	GO:0033160	positive regulation of protein import into nucleus, translocation	BP
19	46	3.04514154902	-	1.23e-11	GO:0030521	androgen receptor signaling pathway	BP
7	17	3.04066807244	-	3.45e-06	GO:0043691	reverse cholesterol transport	BP
7	17	3.04066807244	-	3.45e-06	GO:0021542	dentate gyrus development	BP
7	17	3.04066807244	-	3.45e-06	GO:0000987	core promoter proximal region sequence-specific DNA binding	MF
7	17	3.04066807244	-	5.86e-06	GO:0001223	transcription coactivator binding	MF
6	15	2.99884789674	-	5.21e-05	GO:0042809	vitamin D receptor binding	MF
4	10	2.99884789674	-	6.40e-04	GO:1902894	negative regulation of pri-miRNA transcription from RNA polymerase II promoter	BP
4	10	2.99884789674	-	6.40e-04	GO:0010954	positive regulation of protein processing	BP
4	10	2.99884789674	-	1.02e-03	GO:0051775	response to redox state	BP
2	5	2.99884789674	-	7.25e-03	GO:2001016	positive regulation of skeletal muscle cell differentiation	BP
2	5	2.99884789674	-	1.40e-02	GO:1904179	positive regulation of adipose tissue development	BP
2	5	2.99884789674	-	1.40e-02	GO:0071557	histone H3-K27 demethylation	BP
2	5	2.99884789674	-	1.40e-02	GO:0048311	mitochondrion distribution	BP
2	5	2.99884789674	-	1.40e-02	GO:0019217	regulation of fatty acid metabolic process	BP
2	5	2.99884789674	-	1.40e-02	GO:2000987	positive regulation of behavioral fear response	BP
2	5	2.99884789674	-	1.40e-02	GO:0051122	hepoxilin biosynthetic process	BP
2	5	2.99884789674	-	1.40e-02	GO:0002155	regulation of thyroid hormone mediated signaling pathway	BP
2	5	2.99884789674	-	1.40e-02	GO:1901727	positive regulation of histone deacetylase activity	BP
2	5	2.99884789674	-	1.40e-02	GO:0045542	positive regulation of cholesterol biosynthetic process	BP
2	5	2.99884789674	-	2.26e-02	GO:0042541	hemoglobin biosynthetic process	BP
2	5	2.99884789674	-	2.26e-02	GO:0072655	establishment of protein localization to mitochondrion	BP
2	5	2.99884789674	-	2.26e-02	GO:0042634	regulation of hair cycle	BP
2	5	2.99884789674	-	2.26e-02	GO:0003289	atrial septum primum morphogenesis	BP
2	5	2.99884789674	-	2.26e-02	GO:0036091	positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress	BP
2	5	2.99884789674	-	2.26e-02	GO:0060744	mammary gland branching involved in thelarche	BP
2	5	2.99884789674	-	2.26e-02	GO:1902749	regulation of cell cycle G2/M phase transition	BP
2	5	2.99884789674	-	2.26e-02	GO:1902262	apoptotic process involved in blood vessel morphogenesis	BP
2	5	2.99884789674	-	2.26e-02	GO:0002634	regulation of germinal center formation	BP
2	5	2.99884789674	-	2.26e-02	GO:0016202	regulation of striated muscle tissue development	BP
2	5	2.99884789674	-	2.26e-02	GO:0071504	cellular response to heparin	BP
2	5	2.99884789674	-	2.26e-02	GO:0034197	triglyceride transport	BP
2	5	2.99884789674	-	2.26e-02	GO:1903307	positive regulation of regulated secretory pathway	BP
2	5	2.99884789674	-	2.26e-02	GO:0071864	positive regulation of cell proliferation in bone marrow	BP
2	5	2.99884789674	-	2.26e-02	GO:0038033	positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	BP
2	5	2.99884789674	-	2.26e-02	GO:0032269	negative regulation of cellular protein metabolic process	BP
2	5	2.99884789674	-	2.26e-02	GO:0051546	keratinocyte migration	BP
2	5	2.99884789674	-	2.26e-02	GO:0060761	negative regulation of response to cytokine stimulus	BP
2	5	2.99884789674	-	2.26e-02	GO:0032489	regulation of Cdc42 protein signal transduction	BP
2	5	2.99884789674	-	2.26e-02	GO:2000535	regulation of entry of bacterium into host cell	BP
2	5	2.99884789674	-	2.26e-02	GO:0021861	forebrain radial glial cell differentiation	BP
2	5	2.99884789674	-	2.26e-02	GO:0043550	regulation of lipid kinase activity	BP
2	5	2.99884789674	-	2.26e-02	GO:0051534	negative regulation of NFAT protein import into nucleus	BP
2	5	2.99884789674	-	2.26e-02	GO:0010891	negative regulation of sequestering of triglyceride	BP
2	5	2.99884789674	-	1.40e-02	GO:0101020	estrogen 16-alpha-hydroxylase activity	MF
2	5	2.99884789674	-	1.40e-02	GO:0071558	histone demethylase activity (H3-K27 specific)	MF
2	5	2.99884789674	-	1.40e-02	GO:0004920	interleukin-10 receptor activity	MF
2	5	2.99884789674	-	2.26e-02	GO:0044388	small protein activating enzyme binding	MF
2	5	2.99884789674	-	2.26e-02	GO:0000975	regulatory region DNA binding	MF
2	5	2.99884789674	-	2.26e-02	GO:0004532	exoribonuclease activity	MF
2	5	2.99884789674	-	2.26e-02	GO:0008142	oxysterol binding	MF
2	5	2.99884789674	-	2.26e-02	GO:0030618	transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity	MF
17	43	2.98197407818	-	9.73e-11	GO:0050681	androgen receptor binding	MF
13	33	2.97682159041	-	1.59e-09	GO:0001104	RNA polymerase II transcription cofactor activity	MF
11	28	2.97285268821	-	2.84e-08	GO:0033613	activating transcription factor binding	MF
5	13	2.94226436838	-	6.31e-05	GO:0034380	high-density lipoprotein particle assembly	BP
5	13	2.94226436838	-	1.11e-04	GO:0061029	eyelid development in camera-type eye	BP
5	13	2.94226436838	-	2.84e-04	GO:0001829	trophectodermal cell differentiation	BP
3	8	2.90573849235	-	3.75e-03	GO:0003139	secondary heart field specification	BP
3	8	2.90573849235	-	3.75e-03	GO:0060020	Bergmann glial cell differentiation	BP
3	8	2.90573849235	-	3.75e-03	GO:0071316	cellular response to nicotine	BP
3	8	2.90573849235	-	5.78e-03	GO:0045348	positive regulation of MHC class II biosynthetic process	BP
3	8	2.90573849235	-	5.78e-03	GO:0048143	astrocyte activation	BP
3	8	2.90573849235	-	5.78e-03	GO:0035457	cellular response to interferon-alpha	BP
3	8	2.90573849235	-	5.78e-03	GO:0021795	cerebral cortex cell migration	BP
3	8	2.90573849235	-	5.78e-03	GO:0032872	regulation of stress-activated MAPK cascade	BP
18	48	2.90573849235	-	9.73e-11	GO:0000976	transcription regulatory region sequence-specific DNA binding	MF
3	8	2.90573849235	-	1.16e-03	GO:0019213	deacetylase activity	MF
3	8	2.90573849235	-	5.78e-03	GO:0070878	primary miRNA binding	MF
18	49	2.87599114896	-	2.85e-11	GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	MF
8	22	2.86134437299	-	2.78e-06	GO:0030520	intracellular estrogen receptor signaling pathway	BP
4	11	2.86134437299	-	6.40e-04	GO:0010867	positive regulation of triglyceride biosynthetic process	BP
4	11	2.86134437299	-	1.02e-03	GO:2000036	regulation of stem cell population maintenance	BP
4	11	2.86134437299	-	1.02e-03	GO:0006476	protein deacetylation	BP
4	11	2.86134437299	-	1.02e-03	GO:0030850	prostate gland development	BP
4	11	2.86134437299	-	1.02e-03	GO:0060213	positive regulation of nuclear-transcribed mRNA poly(A) tail shortening	BP
4	11	2.86134437299	-	1.55e-03	GO:0010884	positive regulation of lipid storage	BP
4	11	2.86134437299	-	1.55e-03	GO:0031065	positive regulation of histone deacetylation	BP
4	11	2.86134437299	-	1.55e-03	GO:1901653	cellular response to peptide	BP
24	66	2.86134437299	-	6.21e-11	GO:0003705	transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
4	11	2.86134437299	-	1.02e-03	GO:0016407	acetyltransferase activity	MF
4	11	2.86134437299	-	1.55e-03	GO:0032041	NAD-dependent histone deacetylase activity (H3-K14 specific)	MF
4	11	2.86134437299	-	1.55e-03	GO:0070410	co-SMAD binding	MF
5	14	2.83534916446	-	1.82e-04	GO:0060065	uterus development	BP
5	14	2.83534916446	-	1.82e-04	GO:0031641	regulation of myelination	BP
10	28	2.83534916446	-	1.97e-08	GO:0005496	steroid binding	MF
6	17	2.8182756511	-	5.21e-05	GO:0034375	high-density lipoprotein particle remodeling	BP
6	17	2.8182756511	-	7.99e-05	GO:0033189	response to vitamin A	BP
6	17	2.8182756511	-	1.18e-04	GO:0035994	response to muscle stretch	BP
6	17	2.8182756511	-	1.18e-04	GO:0042800	histone methyltransferase activity (H3-K4 specific)	MF
17	49	2.79352898877	-	1.88e-11	GO:0001085	RNA polymerase II transcription factor binding	MF
20	59	2.76006103716	-	5.53e-11	GO:0031490	chromatin DNA binding	MF
10	30	2.73581349091	-	5.33e-07	GO:0000289	nuclear-transcribed mRNA poly(A) tail shortening	BP
8	24	2.73581349091	-	1.06e-06	GO:0030878	thyroid gland development	BP
4	12	2.73581349091	-	8.60e-05	GO:0042738	exogenous drug catabolic process	BP
5	15	2.73581349091	-	2.84e-04	GO:0007548	sex differentiation	BP
4	12	2.73581349091	-	3.70e-04	GO:0045723	positive regulation of fatty acid biosynthetic process	BP
5	15	2.73581349091	-	4.24e-04	GO:0030330	DNA damage response, signal transduction by p53 class mediator	BP
5	15	2.73581349091	-	6.10e-04	GO:0043923	positive regulation by host of viral transcription	BP
5	15	2.73581349091	-	6.10e-04	GO:0043982	histone H4-K8 acetylation	BP
5	15	2.73581349091	-	6.10e-04	GO:0043981	histone H4-K5 acetylation	BP
4	12	2.73581349091	-	1.55e-03	GO:0060766	negative regulation of androgen receptor signaling pathway	BP
4	12	2.73581349091	-	1.55e-03	GO:0003215	cardiac right ventricle morphogenesis	BP
4	12	2.73581349091	-	2.23e-03	GO:0043149	stress fiber assembly	BP
4	12	2.73581349091	-	2.23e-03	GO:0036499	PERK-mediated unfolded protein response	BP
2	6	2.73581349091	-	7.25e-03	GO:0042737	drug catabolic process	BP
2	6	2.73581349091	-	7.25e-03	GO:0046483	heterocycle metabolic process	BP
2	6	2.73581349091	-	1.40e-02	GO:2001054	negative regulation of mesenchymal cell apoptotic process	BP
2	6	2.73581349091	-	1.40e-02	GO:0030856	regulation of epithelial cell differentiation	BP
2	6	2.73581349091	-	1.40e-02	GO:0045743	positive regulation of fibroblast growth factor receptor signaling pathway	BP
2	6	2.73581349091	-	1.40e-02	GO:0002933	lipid hydroxylation	BP
2	6	2.73581349091	-	2.26e-02	GO:0042536	negative regulation of tumor necrosis factor biosynthetic process	BP
2	6	2.73581349091	-	2.26e-02	GO:0002320	lymphoid progenitor cell differentiation	BP
2	6	2.73581349091	-	2.26e-02	GO:0048525	negative regulation of viral process	BP
2	6	2.73581349091	-	2.26e-02	GO:0032792	negative regulation of CREB transcription factor activity	BP
2	6	2.73581349091	-	2.26e-02	GO:0035315	hair cell differentiation	BP
2	6	2.73581349091	-	2.26e-02	GO:0051150	regulation of smooth muscle cell differentiation	BP
2	6	2.73581349091	-	3.28e-02	GO:0042092	type 2 immune response	BP
2	6	2.73581349091	-	3.28e-02	GO:0090647	modulation of age-related behavioral decline	BP
2	6	2.73581349091	-	3.28e-02	GO:1902533	positive regulation of intracellular signal transduction	BP
2	6	2.73581349091	-	3.28e-02	GO:0002740	negative regulation of cytokine secretion involved in immune response	BP
2	6	2.73581349091	-	3.28e-02	GO:2000288	positive regulation of myoblast proliferation	BP
2	6	2.73581349091	-	3.28e-02	GO:0036465	synaptic vesicle recycling	BP
2	6	2.73581349091	-	3.28e-02	GO:2000323	negative regulation of glucocorticoid receptor signaling pathway	BP
2	6	2.73581349091	-	3.28e-02	GO:0010835	regulation of protein ADP-ribosylation	BP
2	6	2.73581349091	-	3.28e-02	GO:0051902	negative regulation of mitochondrial depolarization	BP
2	6	2.73581349091	-	3.28e-02	GO:0044794	positive regulation by host of viral process	BP
2	6	2.73581349091	-	3.28e-02	GO:0003158	endothelium development	BP
2	6	2.73581349091	-	3.28e-02	GO:1903026	negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding	BP
2	6	2.73581349091	-	3.28e-02	GO:0003180	aortic valve morphogenesis	BP
2	6	2.73581349091	-	3.28e-02	GO:0048667	cell morphogenesis involved in neuron differentiation	BP
2	6	2.73581349091	-	3.28e-02	GO:0045661	regulation of myoblast differentiation	BP
2	6	2.73581349091	-	3.28e-02	GO:0007182	common-partner SMAD protein phosphorylation	BP
2	6	2.73581349091	-	3.28e-02	GO:0045084	positive regulation of interleukin-12 biosynthetic process	BP
2	6	2.73581349091	-	3.28e-02	GO:0031087	deadenylation-independent decapping of nuclear-transcribed mRNA	BP
1	3	2.73581349091	-	5.00e-02	GO:2000721	positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation	BP
1	3	2.73581349091	-	5.00e-02	GO:0006670	sphingosine metabolic process	BP
1	3	2.73581349091	-	5.00e-02	GO:0030858	positive regulation of epithelial cell differentiation	BP
1	3	2.73581349091	-	5.00e-02	GO:0036378	calcitriol biosynthetic process from calciol	BP
1	3	2.73581349091	-	5.00e-02	GO:0060005	vestibular reflex	BP
1	3	2.73581349091	-	5.00e-02	GO:0015917	aminophospholipid transport	BP
1	3	2.73581349091	-	5.00e-02	GO:0030886	negative regulation of myeloid dendritic cell activation	BP
1	3	2.73581349091	-	5.00e-02	GO:0006082	organic acid metabolic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0021524	visceral motor neuron differentiation	BP
1	3	2.73581349091	-	9.76e-02	GO:0070561	vitamin D receptor signaling pathway	BP
1	3	2.73581349091	-	9.76e-02	GO:1990418	response to insulin-like growth factor stimulus	BP
1	3	2.73581349091	-	9.76e-02	GO:1900625	positive regulation of monocyte aggregation	BP
1	3	2.73581349091	-	9.76e-02	GO:0071224	cellular response to peptidoglycan	BP
1	3	2.73581349091	-	9.76e-02	GO:0060066	oviduct development	BP
1	3	2.73581349091	-	9.76e-02	GO:0045726	positive regulation of integrin biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0072278	metanephric comma-shaped body morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0032732	positive regulation of interleukin-1 production	BP
1	3	2.73581349091	-	9.76e-02	GO:0072102	glomerulus morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0001781	neutrophil apoptotic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0061031	endodermal digestive tract morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:2000078	positive regulation of type B pancreatic cell development	BP
1	3	2.73581349091	-	9.76e-02	GO:0034436	glycoprotein transport	BP
1	3	2.73581349091	-	9.76e-02	GO:0046167	glycerol-3-phosphate biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0070859	positive regulation of bile acid biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0060916	mesenchymal cell proliferation involved in lung development	BP
1	3	2.73581349091	-	9.76e-02	GO:0072050	S-shaped body morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0009822	alkaloid catabolic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0044336	canonical Wnt signaling pathway involved in negative regulation of apoptotic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0032787	monocarboxylic acid metabolic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0010573	vascular endothelial growth factor production	BP
1	3	2.73581349091	-	9.76e-02	GO:0051490	negative regulation of filopodium assembly	BP
1	3	2.73581349091	-	9.76e-02	GO:0033076	isoquinoline alkaloid metabolic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0010909	positive regulation of heparan sulfate proteoglycan biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0021502	neural fold elevation formation	BP
1	3	2.73581349091	-	9.76e-02	GO:0035873	lactate transmembrane transport	BP
1	3	2.73581349091	-	9.76e-02	GO:0032696	negative regulation of interleukin-13 production	BP
1	3	2.73581349091	-	9.76e-02	GO:0060947	cardiac vascular smooth muscle cell differentiation	BP
1	3	2.73581349091	-	9.76e-02	GO:0010980	positive regulation of vitamin D 24-hydroxylase activity	BP
1	3	2.73581349091	-	9.76e-02	GO:1902990	mitotic telomere maintenance via semi-conservative replication	BP
1	3	2.73581349091	-	9.76e-02	GO:0061113	pancreas morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:1900114	positive regulation of histone H3-K9 trimethylation	BP
1	3	2.73581349091	-	9.76e-02	GO:0003350	pulmonary myocardium development	BP
1	3	2.73581349091	-	9.76e-02	GO:0010956	negative regulation of calcidiol 1-monooxygenase activity	BP
1	3	2.73581349091	-	9.76e-02	GO:0046340	diacylglycerol catabolic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0046885	regulation of hormone biosynthetic process	BP
1	3	2.73581349091	-	9.76e-02	GO:0090271	positive regulation of fibroblast growth factor production	BP
1	3	2.73581349091	-	9.76e-02	GO:0072049	comma-shaped body morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:0035411	catenin import into nucleus	BP
1	3	2.73581349091	-	9.76e-02	GO:0036023	embryonic skeletal limb joint morphogenesis	BP
1	3	2.73581349091	-	9.76e-02	GO:1902617	response to fluoride	BP
1	3	2.73581349091	-	9.76e-02	GO:0042668	auditory receptor cell fate determination	BP
1	3	2.73581349091	-	9.76e-02	GO:2000381	negative regulation of mesoderm development	BP
1	3	2.73581349091	-	9.76e-02	GO:1901536	negative regulation of DNA demethylation	BP
1	3	2.73581349091	-	9.76e-02	GO:0071393	cellular response to progesterone stimulus	BP
1	3	2.73581349091	-	9.76e-02	GO:0072136	metanephric mesenchymal cell proliferation involved in metanephros development	BP
1	3	2.73581349091	-	9.76e-02	GO:1904339	negative regulation of dopaminergic neuron differentiation	BP
1	3	2.73581349091	-	9.76e-02	GO:0061009	common bile duct development	BP
1	3	2.73581349091	-	9.76e-02	GO:0050893	sensory processing	BP
1	3	2.73581349091	-	9.76e-02	GO:0072718	response to cisplatin	BP
1	3	2.73581349091	-	9.76e-02	GO:0050954	sensory perception of mechanical stimulus	BP
1	3	2.73581349091	-	9.76e-02	GO:0060523	prostate epithelial cord elongation	BP
1	3	2.73581349091	-	9.76e-02	GO:0042427	serotonin biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0034770	histone H4-K20 methylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0034381	plasma lipoprotein particle clearance	BP
1	3	2.73581349091	-	1.43e-01	GO:1902661	positive regulation of glucose mediated signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:1903984	positive regulation of TRAIL-activated apoptotic signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0035993	deltoid tuberosity development	BP
1	3	2.73581349091	-	1.43e-01	GO:0043415	positive regulation of skeletal muscle tissue regeneration	BP
1	3	2.73581349091	-	1.43e-01	GO:0043418	homocysteine catabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:1902255	positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator	BP
1	3	2.73581349091	-	1.43e-01	GO:0060923	cardiac muscle cell fate commitment	BP
1	3	2.73581349091	-	1.43e-01	GO:0006499	N-terminal protein myristoylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060492	lung induction	BP
1	3	2.73581349091	-	1.43e-01	GO:0060491	regulation of cell projection assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0060143	positive regulation of syncytium formation by plasma membrane fusion	BP
1	3	2.73581349091	-	1.43e-01	GO:2001015	negative regulation of skeletal muscle cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0090261	positive regulation of inclusion body assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0008218	bioluminescence	BP
1	3	2.73581349091	-	1.43e-01	GO:0033144	negative regulation of intracellular steroid hormone receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0031937	positive regulation of chromatin silencing	BP
1	3	2.73581349091	-	1.43e-01	GO:0007113	endomitotic cell cycle	BP
1	3	2.73581349091	-	1.43e-01	GO:0098904	regulation of AV node cell action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0098908	regulation of neuronal action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0046985	positive regulation of hemoglobin biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0061138	morphogenesis of a branching epithelium	BP
1	3	2.73581349091	-	1.43e-01	GO:0031587	positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity	BP
1	3	2.73581349091	-	1.43e-01	GO:1903208	negative regulation of hydrogen peroxide-induced neuron death	BP
1	3	2.73581349091	-	1.43e-01	GO:0014005	microglia development	BP
1	3	2.73581349091	-	1.43e-01	GO:0072331	signal transduction by p53 class mediator	BP
1	3	2.73581349091	-	1.43e-01	GO:0007500	mesodermal cell fate determination	BP
1	3	2.73581349091	-	1.43e-01	GO:0071386	cellular response to corticosterone stimulus	BP
1	3	2.73581349091	-	1.43e-01	GO:0060559	positive regulation of calcidiol 1-monooxygenase activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0070602	regulation of centromeric sister chromatid cohesion	BP
1	3	2.73581349091	-	1.43e-01	GO:0060743	epithelial cell maturation involved in prostate gland development	BP
1	3	2.73581349091	-	1.43e-01	GO:0060741	prostate gland stromal morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0022028	tangential migration from the subventricular zone to the olfactory bulb	BP
1	3	2.73581349091	-	1.43e-01	GO:0018158	protein oxidation	BP
1	3	2.73581349091	-	1.43e-01	GO:0021885	forebrain cell migration	BP
1	3	2.73581349091	-	1.43e-01	GO:0010766	negative regulation of sodium ion transport	BP
1	3	2.73581349091	-	1.43e-01	GO:0071899	negative regulation of estrogen receptor binding	BP
1	3	2.73581349091	-	1.43e-01	GO:0071895	odontoblast differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:1990737	response to manganese-induced endoplasmic reticulum stress	BP
1	3	2.73581349091	-	1.43e-01	GO:0045608	negative regulation of auditory receptor cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0051795	positive regulation of timing of catagen	BP
1	3	2.73581349091	-	1.43e-01	GO:2000619	negative regulation of histone H4-K16 acetylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0003274	endocardial cushion fusion	BP
1	3	2.73581349091	-	1.43e-01	GO:0014854	response to inactivity	BP
1	3	2.73581349091	-	1.43e-01	GO:0022898	regulation of transmembrane transporter activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0045061	thymic T cell selection	BP
1	3	2.73581349091	-	1.43e-01	GO:2000138	positive regulation of cell proliferation involved in heart morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0050803	regulation of synapse structure or activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0007352	zygotic specification of dorsal/ventral axis	BP
1	3	2.73581349091	-	1.43e-01	GO:0048294	negative regulation of isotype switching to IgE isotypes	BP
1	3	2.73581349091	-	1.43e-01	GO:0035986	senescence-associated heterochromatin focus assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0035984	cellular response to trichostatin A	BP
1	3	2.73581349091	-	1.43e-01	GO:0042816	vitamin B6 metabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:2001258	negative regulation of cation channel activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0090043	regulation of tubulin deacetylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0038162	erythropoietin-mediated signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0060374	mast cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0051365	cellular response to potassium ion starvation	BP
1	3	2.73581349091	-	1.43e-01	GO:0046890	regulation of lipid biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0072193	ureter smooth muscle cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0098910	regulation of atrial cardiac muscle cell action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0098912	membrane depolarization during atrial cardiac muscle cell action potential	BP
1	3	2.73581349091	-	1.43e-01	GO:0034435	cholesterol esterification	BP
1	3	2.73581349091	-	1.43e-01	GO:0006549	isoleucine metabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0000255	allantoin metabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0060675	ureteric bud morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0031630	regulation of synaptic vesicle fusion to presynaptic active zone membrane	BP
1	3	2.73581349091	-	1.43e-01	GO:1903421	regulation of synaptic vesicle recycling	BP
1	3	2.73581349091	-	1.43e-01	GO:0070966	nuclear-transcribed mRNA catabolic process, no-go decay	BP
1	3	2.73581349091	-	1.43e-01	GO:0090245	axis elongation involved in somitogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0010641	positive regulation of platelet-derived growth factor receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0030917	midbrain-hindbrain boundary development	BP
1	3	2.73581349091	-	1.43e-01	GO:0015966	diadenosine tetraphosphate biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:2000286	receptor internalization involved in canonical Wnt signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0060800	regulation of cell differentiation involved in embryonic placenta development	BP
1	3	2.73581349091	-	1.43e-01	GO:0045408	regulation of interleukin-6 biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:1902952	positive regulation of dendritic spine maintenance	BP
1	3	2.73581349091	-	1.43e-01	GO:0032613	interleukin-10 production	BP
1	3	2.73581349091	-	1.43e-01	GO:0023021	termination of signal transduction	BP
1	3	2.73581349091	-	1.43e-01	GO:0001922	B-1 B cell homeostasis	BP
1	3	2.73581349091	-	1.43e-01	GO:0090204	protein localization to nuclear pore	BP
1	3	2.73581349091	-	1.43e-01	GO:2000291	regulation of myoblast proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:0010903	negative regulation of very-low-density lipoprotein particle remodeling	BP
1	3	2.73581349091	-	1.43e-01	GO:0048388	endosomal lumen acidification	BP
1	3	2.73581349091	-	1.43e-01	GO:0002904	positive regulation of B cell apoptotic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0035166	post-embryonic hemopoiesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0072014	proximal tubule development	BP
1	3	2.73581349091	-	1.43e-01	GO:0032651	regulation of interleukin-1 beta production	BP
1	3	2.73581349091	-	1.43e-01	GO:0018125	peptidyl-cysteine methylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0035633	maintenance of permeability of blood-brain barrier	BP
1	3	2.73581349091	-	1.43e-01	GO:0003199	endocardial cushion to mesenchymal transition involved in heart valve formation	BP
1	3	2.73581349091	-	1.43e-01	GO:1990785	response to water-immersion restraint stress	BP
1	3	2.73581349091	-	1.43e-01	GO:0060126	somatotropin secreting cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0002317	plasma cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0035284	brain segmentation	BP
1	3	2.73581349091	-	1.43e-01	GO:2000504	positive regulation of blood vessel remodeling	BP
1	3	2.73581349091	-	1.43e-01	GO:1903721	positive regulation of I-kappaB phosphorylation	BP
1	3	2.73581349091	-	1.43e-01	GO:0061309	cardiac neural crest cell development involved in outflow tract morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:1902037	negative regulation of hematopoietic stem cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:1902991	regulation of amyloid precursor protein catabolic process	BP
1	3	2.73581349091	-	1.43e-01	GO:2000544	regulation of endothelial cell chemotaxis to fibroblast growth factor	BP
1	3	2.73581349091	-	1.43e-01	GO:0034465	response to carbon monoxide	BP
1	3	2.73581349091	-	1.43e-01	GO:2000974	negative regulation of pro-B cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:1903598	positive regulation of gap junction assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0033363	secretory granule organization	BP
1	3	2.73581349091	-	1.43e-01	GO:0032800	receptor biosynthetic process	BP
1	3	2.73581349091	-	1.43e-01	GO:0048625	myoblast fate commitment	BP
1	3	2.73581349091	-	1.43e-01	GO:0060297	regulation of sarcomere organization	BP
1	3	2.73581349091	-	1.43e-01	GO:0007176	regulation of epidermal growth factor-activated receptor activity	BP
1	3	2.73581349091	-	1.43e-01	GO:1900212	negative regulation of mesenchymal cell apoptotic process involved in metanephros development	BP
1	3	2.73581349091	-	1.43e-01	GO:0048858	cell projection morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:2000466	negative regulation of glycogen (starch) synthase activity	BP
1	3	2.73581349091	-	1.43e-01	GO:1905144	response to acetylcholine	BP
1	3	2.73581349091	-	1.43e-01	GO:0072125	negative regulation of glomerular mesangial cell proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:0043504	mitochondrial DNA repair	BP
1	3	2.73581349091	-	1.43e-01	GO:2000195	negative regulation of female gonad development	BP
1	3	2.73581349091	-	1.43e-01	GO:0001555	oocyte growth	BP
1	3	2.73581349091	-	1.43e-01	GO:0034201	response to oleic acid	BP
1	3	2.73581349091	-	1.43e-01	GO:0070168	negative regulation of biomineral tissue development	BP
1	3	2.73581349091	-	1.43e-01	GO:0045682	regulation of epidermis development	BP
1	3	2.73581349091	-	1.43e-01	GO:0035359	negative regulation of peroxisome proliferator activated receptor signaling pathway	BP
1	3	2.73581349091	-	1.43e-01	GO:0030888	regulation of B cell proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:0033687	osteoblast proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060729	intestinal epithelial structure maintenance	BP
1	3	2.73581349091	-	1.43e-01	GO:0009451	RNA modification	BP
1	3	2.73581349091	-	1.43e-01	GO:0090258	negative regulation of mitochondrial fission	BP
1	3	2.73581349091	-	1.43e-01	GO:0090259	regulation of retinal ganglion cell axon guidance	BP
1	3	2.73581349091	-	1.43e-01	GO:1905232	cellular response to L-glutamate	BP
1	3	2.73581349091	-	1.43e-01	GO:0032608	interferon-beta production	BP
1	3	2.73581349091	-	1.43e-01	GO:2000345	regulation of hepatocyte proliferation	BP
1	3	2.73581349091	-	1.43e-01	GO:0009648	photoperiodism	BP
1	3	2.73581349091	-	1.43e-01	GO:0002118	aggressive behavior	BP
1	3	2.73581349091	-	1.43e-01	GO:2001180	negative regulation of interleukin-10 secretion	BP
1	3	2.73581349091	-	1.43e-01	GO:0048541	Peyer's patch development	BP
1	3	2.73581349091	-	1.43e-01	GO:0045007	depurination	BP
1	3	2.73581349091	-	1.43e-01	GO:0019060	intracellular transport of viral protein in host cell	BP
1	3	2.73581349091	-	1.43e-01	GO:0051154	negative regulation of striated muscle cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0090234	regulation of kinetochore assembly	BP
1	3	2.73581349091	-	1.43e-01	GO:0032765	positive regulation of mast cell cytokine production	BP
1	3	2.73581349091	-	1.43e-01	GO:0051306	mitotic sister chromatid separation	BP
1	3	2.73581349091	-	1.43e-01	GO:0060058	positive regulation of apoptotic process involved in mammary gland involution	BP
1	3	2.73581349091	-	1.43e-01	GO:0031281	positive regulation of cyclase activity	BP
1	3	2.73581349091	-	1.43e-01	GO:0001560	regulation of cell growth by extracellular stimulus	BP
1	3	2.73581349091	-	1.43e-01	GO:0072282	metanephric nephron tubule morphogenesis	BP
1	3	2.73581349091	-	1.43e-01	GO:0072717	cellular response to actinomycin D	BP
1	3	2.73581349091	-	1.43e-01	GO:0016553	base conversion or substitution editing	BP
1	3	2.73581349091	-	1.43e-01	GO:1904645	response to amyloid-beta	BP
1	3	2.73581349091	-	1.43e-01	GO:1904640	response to methionine	BP
1	3	2.73581349091	-	1.43e-01	GO:0060221	retinal rod cell differentiation	BP
1	3	2.73581349091	-	1.43e-01	GO:0072034	renal vesicle induction	BP
1	3	2.73581349091	-	1.43e-01	GO:0090118	receptor-mediated endocytosis involved in cholesterol transport	BP
13	39	2.73581349091	-	1.29e-08	GO:0001102	RNA polymerase II activating transcription factor binding	MF
8	24	2.73581349091	-	1.36e-05	GO:0043425	bHLH transcription factor binding	MF
2	6	2.73581349091	-	1.40e-02	GO:0016651	oxidoreductase activity, acting on NAD(P)H	MF
2	6	2.73581349091	-	2.26e-02	GO:0004468	lysine N-acetyltransferase activity, acting on acetyl phosphate as donor	MF
2	6	2.73581349091	-	2.26e-02	GO:0060228	phosphatidylcholine-sterol O-acyltransferase activator activity	MF
2	6	2.73581349091	-	2.26e-02	GO:0042500	aspartic endopeptidase activity, intramembrane cleaving	MF
2	6	2.73581349091	-	3.28e-02	GO:0055102	lipase inhibitor activity	MF
2	6	2.73581349091	-	3.28e-02	GO:0071253	connexin binding	MF
1	3	2.73581349091	-	5.00e-02	GO:0047844	deoxycytidine deaminase activity	MF
1	3	2.73581349091	-	5.00e-02	GO:0033218	amide binding	MF
1	3	2.73581349091	-	9.76e-02	GO:0035651	AP-3 adaptor complex binding	MF
1	3	2.73581349091	-	9.76e-02	GO:0102490	8-oxo-dGTP phosphohydrolase activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0004370	glycerol kinase activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0008427	calcium-dependent protein kinase inhibitor activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0051120	hepoxilin A3 synthase activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0004809	tRNA (guanine-N2-)-methyltransferase activity	MF
1	3	2.73581349091	-	9.76e-02	GO:0016807	cysteine-type carboxypeptidase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0050816	phosphothreonine residue binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0086056	voltage-gated calcium channel activity involved in AV node cell action potential	MF
1	3	2.73581349091	-	1.43e-01	GO:0019959	interleukin-8 binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0004505	phenylalanine 4-monooxygenase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0060230	lipoprotein lipase activator activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0010484	H3 histone acetyltransferase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0019166	trans-2-enoyl-CoA reductase (NADPH) activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0031531	thyrotropin-releasing hormone receptor binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0044729	hemi-methylated DNA-binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0055106	ubiquitin-protein transferase regulator activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0043812	phosphatidylinositol-4-phosphate phosphatase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0050508	glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004948	calcitonin receptor activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0034190	apolipoprotein receptor binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0030348	syntaxin-3 binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0045322	unmethylated CpG binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0070095	fructose-6-phosphate binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0004060	arylamine N-acetyltransferase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0004351	glutamate decarboxylase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0070051	fibrinogen binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0043120	tumor necrosis factor binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0004699	calcium-independent protein kinase C activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0042978	ornithine decarboxylase activator activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0070653	high-density lipoprotein particle receptor binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0004517	nitric-oxide synthase activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0015093	ferrous iron transmembrane transporter activity	MF
1	3	2.73581349091	-	1.43e-01	GO:0070905	serine binding	MF
1	3	2.73581349091	-	1.43e-01	GO:0043139	5'-3' DNA helicase activity	MF
6	18	2.73581349091	-	5.21e-05	GO:0060324	face development	BP
6	18	2.73581349091	-	7.99e-05	GO:0042789	mRNA transcription from RNA polymerase II promoter	BP
6	18	2.73581349091	-	1.18e-04	GO:0001892	embryonic placenta development	BP
3	9	2.73581349091	-	2.23e-03	GO:0055091	phospholipid homeostasis	BP
3	9	2.73581349091	-	2.23e-03	GO:0070989	oxidative demethylation	BP
3	9	2.73581349091	-	3.75e-03	GO:0030903	notochord development	BP
3	9	2.73581349091	-	3.75e-03	GO:0071374	cellular response to parathyroid hormone stimulus	BP
3	9	2.73581349091	-	5.78e-03	GO:1990403	embryonic brain development	BP
3	9	2.73581349091	-	5.78e-03	GO:0003197	endocardial cushion development	BP
3	9	2.73581349091	-	5.78e-03	GO:0051974	negative regulation of telomerase activity	BP
3	9	2.73581349091	-	8.35e-03	GO:0034384	high-density lipoprotein particle clearance	BP
3	9	2.73581349091	-	8.35e-03	GO:0007196	adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway	BP
3	9	2.73581349091	-	8.35e-03	GO:0050807	regulation of synapse organization	BP
3	9	2.73581349091	-	8.35e-03	GO:0033762	response to glucagon	BP
6	18	2.73581349091	-	5.21e-05	GO:0005319	lipid transporter activity	MF
3	9	2.73581349091	-	8.35e-03	GO:0043995	histone acetyltransferase activity (H4-K5 specific)	MF
3	9	2.73581349091	-	8.35e-03	GO:0043996	histone acetyltransferase activity (H4-K8 specific)	MF
3	9	2.73581349091	-	8.35e-03	GO:0003680	AT DNA binding	MF
3	9	2.73581349091	-	8.35e-03	GO:0046972	histone acetyltransferase activity (H4-K16 specific)	MF
10	31	2.68850777613	-	7.77e-07	GO:0071276	cellular response to cadmium ion	BP
23	72	2.67441294625	-	8.43e-11	GO:0000980	RNA polymerase II distal enhancer sequence-specific DNA binding	MF
91	286	2.66869929505	-	7.45e-11	GO:0008134	transcription factor binding	MF
5	16	2.64270408652	-	8.51e-04	GO:0006978	DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	BP
4	13	2.62033627349	-	6.40e-04	GO:0010839	negative regulation of keratinocyte proliferation	BP
4	13	2.62033627349	-	6.40e-04	GO:0034374	low-density lipoprotein particle remodeling	BP
4	13	2.62033627349	-	1.02e-03	GO:0031076	embryonic camera-type eye development	BP
4	13	2.62033627349	-	1.55e-03	GO:0051145	smooth muscle cell differentiation	BP
4	13	2.62033627349	-	1.55e-03	GO:0071391	cellular response to estrogen stimulus	BP
4	13	2.62033627349	-	3.09e-03	GO:0086064	cell communication by electrical coupling involved in cardiac conduction	BP
4	13	2.62033627349	-	3.09e-03	GO:1902176	negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
4	13	2.62033627349	-	3.09e-03	GO:0035729	cellular response to hepatocyte growth factor stimulus	BP
6	20	2.58381039747	-	3.26e-04	GO:0070932	histone H3 deacetylation	BP
3	10	2.58381039747	-	1.16e-03	GO:0048387	negative regulation of retinoic acid receptor signaling pathway	BP
3	10	2.58381039747	-	2.23e-03	GO:0005513	detection of calcium ion	BP
3	10	2.58381039747	-	3.75e-03	GO:0045598	regulation of fat cell differentiation	BP
3	10	2.58381039747	-	3.75e-03	GO:0090009	primitive streak formation	BP
3	10	2.58381039747	-	3.75e-03	GO:0051006	positive regulation of lipoprotein lipase activity	BP
3	10	2.58381039747	-	3.75e-03	GO:0015909	long-chain fatty acid transport	BP
3	10	2.58381039747	-	8.35e-03	GO:0000288	nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
3	10	2.58381039747	-	8.35e-03	GO:0060674	placenta blood vessel development	BP
3	10	2.58381039747	-	8.35e-03	GO:0006307	DNA dealkylation involved in DNA repair	BP
3	10	2.58381039747	-	8.35e-03	GO:0034115	negative regulation of heterotypic cell-cell adhesion	BP
3	10	2.58381039747	-	1.15e-02	GO:0051272	positive regulation of cellular component movement	BP
3	10	2.58381039747	-	1.15e-02	GO:0050678	regulation of epithelial cell proliferation	BP
3	10	2.58381039747	-	1.15e-02	GO:1902237	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BP
3	10	2.58381039747	-	1.15e-02	GO:1901522	positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	BP
3	10	2.58381039747	-	1.15e-02	GO:0031000	response to caffeine	BP
3	10	2.58381039747	-	8.35e-03	GO:0001222	transcription corepressor binding	MF
3	10	2.58381039747	-	8.35e-03	GO:0016504	peptidase activator activity	MF
5	17	2.55524124527	-	1.16e-03	GO:0071837	HMG box domain binding	MF
7	24	2.54316841297	-	3.33e-05	GO:0055088	lipid homeostasis	BP
7	24	2.54316841297	-	1.25e-04	GO:0051403	stress-activated MAPK cascade	BP
16	55	2.53941627811	-	4.62e-09	GO:0032922	circadian regulation of gene expression	BP
9	31	2.53650468269	-	5.46e-06	GO:0034614	cellular response to reactive oxygen species	BP
6	21	2.51342106957	-	1.70e-04	GO:0046697	decidualization	BP
6	21	2.51342106957	-	4.37e-04	GO:0043393	regulation of protein binding	BP
4	14	2.51342106957	-	6.40e-04	GO:0021854	hypothalamus development	BP
4	14	2.51342106957	-	1.55e-03	GO:0061045	negative regulation of wound healing	BP
4	14	2.51342106957	-	2.23e-03	GO:1900153	positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay	BP
4	14	2.51342106957	-	3.09e-03	GO:0001678	cellular glucose homeostasis	BP
4	14	2.51342106957	-	3.09e-03	GO:0040029	regulation of gene expression, epigenetic	BP
4	14	2.51342106957	-	3.09e-03	GO:1903351	cellular response to dopamine	BP
4	14	2.51342106957	-	3.09e-03	GO:0060441	epithelial tube branching involved in lung morphogenesis	BP
2	7	2.51342106957	-	1.40e-02	GO:0035356	cellular triglyceride homeostasis	BP
2	7	2.51342106957	-	2.26e-02	GO:0048646	anatomical structure formation involved in morphogenesis	BP
2	7	2.51342106957	-	2.26e-02	GO:1904948	midbrain dopaminergic neuron differentiation	BP
2	7	2.51342106957	-	2.26e-02	GO:0007530	sex determination	BP
2	7	2.51342106957	-	3.28e-02	GO:1902430	negative regulation of amyloid-beta formation	BP
2	7	2.51342106957	-	3.28e-02	GO:2000049	positive regulation of cell-cell adhesion mediated by cadherin	BP
2	7	2.51342106957	-	3.28e-02	GO:0061154	endothelial tube morphogenesis	BP
2	7	2.51342106957	-	3.28e-02	GO:2001028	positive regulation of endothelial cell chemotaxis	BP
2	7	2.51342106957	-	3.28e-02	GO:1902004	positive regulation of amyloid-beta formation	BP
2	7	2.51342106957	-	3.28e-02	GO:0043620	regulation of DNA-templated transcription in response to stress	BP
2	7	2.51342106957	-	3.28e-02	GO:0051574	positive regulation of histone H3-K9 methylation	BP
2	7	2.51342106957	-	4.44e-02	GO:0055009	atrial cardiac muscle tissue morphogenesis	BP
2	7	2.51342106957	-	4.44e-02	GO:0090050	positive regulation of cell migration involved in sprouting angiogenesis	BP
2	7	2.51342106957	-	4.44e-02	GO:0099565	chemical synaptic transmission, postsynaptic	BP
2	7	2.51342106957	-	4.44e-02	GO:1902808	positive regulation of cell cycle G1/S phase transition	BP
2	7	2.51342106957	-	4.44e-02	GO:0030948	negative regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	7	2.51342106957	-	4.44e-02	GO:1903071	positive regulation of ER-associated ubiquitin-dependent protein catabolic process	BP
2	7	2.51342106957	-	4.44e-02	GO:0034351	negative regulation of glial cell apoptotic process	BP
2	7	2.51342106957	-	4.44e-02	GO:0031340	positive regulation of vesicle fusion	BP
2	7	2.51342106957	-	4.44e-02	GO:0010941	regulation of cell death	BP
2	7	2.51342106957	-	4.44e-02	GO:0071636	positive regulation of transforming growth factor beta production	BP
2	7	2.51342106957	-	4.44e-02	GO:0044321	response to leptin	BP
2	7	2.51342106957	-	4.44e-02	GO:1903599	positive regulation of autophagy of mitochondrion	BP
2	7	2.51342106957	-	4.44e-02	GO:0034616	response to laminar fluid shear stress	BP
2	7	2.51342106957	-	4.44e-02	GO:0031642	negative regulation of myelination	BP
2	7	2.51342106957	-	4.44e-02	GO:0060008	Sertoli cell differentiation	BP
2	7	2.51342106957	-	4.44e-02	GO:0060687	regulation of branching involved in prostate gland morphogenesis	BP
2	7	2.51342106957	-	4.44e-02	GO:0071447	cellular response to hydroperoxide	BP
2	7	2.51342106957	-	4.44e-02	GO:0030050	vesicle transport along actin filament	BP
2	7	2.51342106957	-	4.44e-02	GO:0031659	positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle	BP
2	7	2.51342106957	-	4.44e-02	GO:0035065	regulation of histone acetylation	BP
2	7	2.51342106957	-	3.28e-02	GO:0008430	selenium binding	MF
2	7	2.51342106957	-	3.28e-02	GO:0070324	thyroid hormone binding	MF
2	7	2.51342106957	-	4.44e-02	GO:0004675	transmembrane receptor protein serine/threonine kinase activity	MF
2	7	2.51342106957	-	4.44e-02	GO:0004691	cAMP-dependent protein kinase activity	MF
76	272	2.48124066383	-	4.08e-11	GO:0001077	transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
12	43	2.47947373765	-	8.21e-07	GO:1904837	beta-catenin-TCF complex assembly	BP
5	18	2.47277908508	-	6.10e-04	GO:0032331	negative regulation of chondrocyte differentiation	BP
5	18	2.47277908508	-	6.10e-04	GO:0030301	cholesterol transport	BP
5	18	2.47277908508	-	1.16e-03	GO:0030225	macrophage differentiation	BP
5	18	2.47277908508	-	1.54e-03	GO:0006337	nucleosome disassembly	BP
5	18	2.47277908508	-	4.24e-04	GO:0017127	cholesterol transporter activity	MF
8	29	2.4627949965	-	1.36e-05	GO:0001569	branching involved in blood vessel morphogenesis	BP
6	22	2.44630687372	-	3.26e-04	GO:0043536	positive regulation of blood vessel endothelial cell migration	BP
3	11	2.44630687372	-	2.23e-03	GO:0070166	enamel mineralization	BP
3	11	2.44630687372	-	5.78e-03	GO:0030857	negative regulation of epithelial cell differentiation	BP
3	11	2.44630687372	-	8.35e-03	GO:0030278	regulation of ossification	BP
3	11	2.44630687372	-	8.35e-03	GO:0032703	negative regulation of interleukin-2 production	BP
3	11	2.44630687372	-	8.35e-03	GO:0001893	maternal placenta development	BP
3	11	2.44630687372	-	8.35e-03	GO:0019371	cyclooxygenase pathway	BP
3	11	2.44630687372	-	1.15e-02	GO:0045899	positive regulation of RNA polymerase II transcriptional preinitiation complex assembly	BP
3	11	2.44630687372	-	1.15e-02	GO:0033234	negative regulation of protein sumoylation	BP
3	11	2.44630687372	-	1.15e-02	GO:0098911	regulation of ventricular cardiac muscle cell action potential	BP
3	11	2.44630687372	-	1.15e-02	GO:0042445	hormone metabolic process	BP
3	11	2.44630687372	-	1.52e-02	GO:0071383	cellular response to steroid hormone stimulus	BP
3	11	2.44630687372	-	1.52e-02	GO:0006983	ER overload response	BP
3	11	2.44630687372	-	1.52e-02	GO:0003279	cardiac septum development	BP
3	11	2.44630687372	-	1.52e-02	GO:0000302	response to reactive oxygen species	BP
3	11	2.44630687372	-	1.52e-02	GO:0060444	branching involved in mammary gland duct morphogenesis	BP
6	22	2.44630687372	-	1.18e-04	GO:0001158	enhancer sequence-specific DNA binding	MF
3	11	2.44630687372	-	1.15e-02	GO:0004526	ribonuclease P activity	MF
3	11	2.44630687372	-	1.52e-02	GO:0008066	glutamate receptor activity	MF
20	74	2.43325072089	-	6.21e-11	GO:0007623	circadian rhythm	BP
18	67	2.42461180262	-	1.69e-09	GO:0001047	core promoter binding	MF
8	30	2.41388539602	-	1.91e-05	GO:0001707	mesoderm formation	BP
4	15	2.41388539602	-	2.23e-03	GO:0045618	positive regulation of keratinocyte differentiation	BP
4	15	2.41388539602	-	3.09e-03	GO:0034356	NAD biosynthesis via nicotinamide riboside salvage pathway	BP
4	15	2.41388539602	-	4.16e-03	GO:0097067	cellular response to thyroid hormone stimulus	BP
4	15	2.41388539602	-	4.16e-03	GO:0060397	JAK-STAT cascade involved in growth hormone signaling pathway	BP
4	15	2.41388539602	-	5.45e-03	GO:0004697	protein kinase C activity	MF
65	245	2.40650586566	-	4.65e-11	GO:0003713	transcription coactivator activity	MF
28	106	2.40021045913	-	2.76e-11	GO:0042826	histone deacetylase binding	MF
5	19	2.39477657308	-	1.11e-04	GO:0023019	signal transduction involved in regulation of gene expression	BP
5	19	2.39477657308	-	2.00e-03	GO:0043011	myeloid dendritic cell differentiation	BP
10	38	2.39477657308	-	7.17e-06	GO:0001105	RNA polymerase II transcription coactivator activity	MF
6	23	2.3821765363	-	5.75e-04	GO:0070412	R-SMAD binding	MF
9	35	2.36141797613	-	1.85e-05	GO:0006641	triglyceride metabolic process	BP
9	35	2.36141797613	-	1.85e-05	GO:0045787	positive regulation of cell cycle	BP
54	210	2.36141797613	-	6.23e-11	GO:0044212	transcription regulatory region DNA binding	MF
9	35	2.36141797613	-	4.08e-05	GO:0070491	repressing transcription factor binding	MF
11	43	2.35394285557	-	1.58e-06	GO:0048538	thymus development	BP
12	47	2.35114964068	-	4.63e-07	GO:0051591	response to cAMP	BP
15	59	2.34502353788	-	3.71e-08	GO:0000979	RNA polymerase II core promoter sequence-specific DNA binding	MF
10	40	2.32077599163	-	2.18e-06	GO:0032526	response to retinoic acid	BP
9	36	2.32077599163	-	2.44e-05	GO:0071392	cellular response to estradiol stimulus	BP
7	28	2.32077599163	-	9.24e-05	GO:0035116	embryonic hindlimb morphogenesis	BP
7	28	2.32077599163	-	2.17e-04	GO:0051090	regulation of sequence-specific DNA binding transcription factor activity	BP
6	24	2.32077599163	-	4.37e-04	GO:0033344	cholesterol efflux	BP
4	16	2.32077599163	-	2.23e-03	GO:0032924	activin receptor signaling pathway	BP
4	16	2.32077599163	-	5.45e-03	GO:0060749	mammary gland alveolus development	BP
4	16	2.32077599163	-	5.45e-03	GO:0010608	posttranscriptional regulation of gene expression	BP
3	12	2.32077599163	-	5.78e-03	GO:0046889	positive regulation of lipid biosynthetic process	BP
4	16	2.32077599163	-	6.98e-03	GO:0032270	positive regulation of cellular protein metabolic process	BP
4	16	2.32077599163	-	6.98e-03	GO:0030224	monocyte differentiation	BP
3	12	2.32077599163	-	8.35e-03	GO:0060402	calcium ion transport into cytosol	BP
3	12	2.32077599163	-	1.15e-02	GO:0043616	keratinocyte proliferation	BP
3	12	2.32077599163	-	1.15e-02	GO:0042592	homeostatic process	BP
3	12	2.32077599163	-	1.52e-02	GO:0060425	lung morphogenesis	BP
3	12	2.32077599163	-	1.52e-02	GO:0001682	tRNA 5'-leader removal	BP
3	12	2.32077599163	-	1.96e-02	GO:0021819	layer formation in cerebral cortex	BP
3	12	2.32077599163	-	1.96e-02	GO:0007252	I-kappaB phosphorylation	BP
3	12	2.32077599163	-	1.96e-02	GO:0051457	maintenance of protein location in nucleus	BP
3	12	2.32077599163	-	1.96e-02	GO:0035635	entry of bacterium into host cell	BP
3	12	2.32077599163	-	1.96e-02	GO:0016578	histone deubiquitination	BP
3	12	2.32077599163	-	1.96e-02	GO:0061014	positive regulation of mRNA catabolic process	BP
3	12	2.32077599163	-	1.96e-02	GO:0048821	erythrocyte development	BP
3	12	2.32077599163	-	1.96e-02	GO:0045820	negative regulation of glycolytic process	BP
2	8	2.32077599163	-	3.28e-02	GO:0060346	bone trabecula formation	BP
2	8	2.32077599163	-	3.28e-02	GO:0030828	positive regulation of cGMP biosynthetic process	BP
2	8	2.32077599163	-	3.28e-02	GO:0006029	proteoglycan metabolic process	BP
2	8	2.32077599163	-	3.28e-02	GO:0042987	amyloid precursor protein catabolic process	BP
2	8	2.32077599163	-	3.28e-02	GO:0060736	prostate gland growth	BP
2	8	2.32077599163	-	3.28e-02	GO:0043129	surfactant homeostasis	BP
2	8	2.32077599163	-	3.28e-02	GO:0071313	cellular response to caffeine	BP
2	8	2.32077599163	-	4.44e-02	GO:0000012	single strand break repair	BP
2	8	2.32077599163	-	4.44e-02	GO:0009629	response to gravity	BP
2	8	2.32077599163	-	4.44e-02	GO:0032330	regulation of chondrocyte differentiation	BP
2	8	2.32077599163	-	4.44e-02	GO:0007183	SMAD protein complex assembly	BP
2	8	2.32077599163	-	4.44e-02	GO:0015908	fatty acid transport	BP
1	4	2.32077599163	-	5.00e-02	GO:1900239	regulation of phenotypic switching	BP
1	4	2.32077599163	-	5.00e-02	GO:1903609	negative regulation of inward rectifier potassium channel activity	BP
2	8	2.32077599163	-	5.73e-02	GO:0033598	mammary gland epithelial cell proliferation	BP
2	8	2.32077599163	-	5.73e-02	GO:0051569	regulation of histone H3-K4 methylation	BP
2	8	2.32077599163	-	5.73e-02	GO:2000177	regulation of neural precursor cell proliferation	BP
2	8	2.32077599163	-	5.73e-02	GO:0045647	negative regulation of erythrocyte differentiation	BP
2	8	2.32077599163	-	5.73e-02	GO:0002674	negative regulation of acute inflammatory response	BP
2	8	2.32077599163	-	5.73e-02	GO:0051593	response to folic acid	BP
2	8	2.32077599163	-	5.73e-02	GO:0030851	granulocyte differentiation	BP
2	8	2.32077599163	-	5.73e-02	GO:0035093	spermatogenesis, exchange of chromosomal proteins	BP
2	8	2.32077599163	-	5.73e-02	GO:0010544	negative regulation of platelet activation	BP
2	8	2.32077599163	-	5.73e-02	GO:1900119	positive regulation of execution phase of apoptosis	BP
2	8	2.32077599163	-	5.73e-02	GO:1903800	positive regulation of production of miRNAs involved in gene silencing by miRNA	BP
2	8	2.32077599163	-	5.73e-02	GO:1901838	positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter	BP
2	8	2.32077599163	-	5.73e-02	GO:0007184	SMAD protein import into nucleus	BP
2	8	2.32077599163	-	5.73e-02	GO:0045008	depyrimidination	BP
2	8	2.32077599163	-	5.73e-02	GO:2000774	positive regulation of cellular senescence	BP
1	4	2.32077599163	-	9.76e-02	GO:1904954	canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	BP
1	4	2.32077599163	-	9.76e-02	GO:2000724	positive regulation of cardiac vascular smooth muscle cell differentiation	BP
1	4	2.32077599163	-	9.76e-02	GO:0021575	hindbrain morphogenesis	BP
1	4	2.32077599163	-	9.76e-02	GO:0046684	response to pyrethroid	BP
1	4	2.32077599163	-	9.76e-02	GO:0043587	tongue morphogenesis	BP
1	4	2.32077599163	-	9.76e-02	GO:0060214	endocardium formation	BP
1	4	2.32077599163	-	9.76e-02	GO:0021555	midbrain-hindbrain boundary morphogenesis	BP
1	4	2.32077599163	-	9.76e-02	GO:0021759	globus pallidus development	BP
1	4	2.32077599163	-	9.76e-02	GO:0030311	poly-N-acetyllactosamine biosynthetic process	BP
1	4	2.32077599163	-	9.76e-02	GO:0050994	regulation of lipid catabolic process	BP
1	4	2.32077599163	-	1.43e-01	GO:0035616	histone H2B conserved C-terminal lysine deubiquitination	BP
1	4	2.32077599163	-	1.43e-01	GO:0060965	negative regulation of gene silencing by miRNA	BP
1	4	2.32077599163	-	1.43e-01	GO:0031936	negative regulation of chromatin silencing	BP
1	4	2.32077599163	-	1.43e-01	GO:1903243	negative regulation of cardiac muscle hypertrophy in response to stress	BP
1	4	2.32077599163	-	1.43e-01	GO:0009987	cellular process	BP
1	4	2.32077599163	-	1.43e-01	GO:0048368	lateral mesoderm development	BP
1	4	2.32077599163	-	1.43e-01	GO:0003338	metanephros morphogenesis	BP
1	4	2.32077599163	-	1.43e-01	GO:0061030	epithelial cell differentiation involved in mammary gland alveolus development	BP
1	4	2.32077599163	-	1.43e-01	GO:0072676	lymphocyte migration	BP
1	4	2.32077599163	-	1.43e-01	GO:0003272	endocardial cushion formation	BP
1	4	2.32077599163	-	1.43e-01	GO:1902261	positive regulation of delayed rectifier potassium channel activity	BP
1	4	2.32077599163	-	1.43e-01	GO:0003231	cardiac ventricle development	BP
1	4	2.32077599163	-	1.43e-01	GO:0072221	metanephric distal convoluted tubule development	BP
1	4	2.32077599163	-	1.43e-01	GO:0048808	male genitalia morphogenesis	BP
1	4	2.32077599163	-	1.43e-01	GO:0015842	aminergic neurotransmitter loading into synaptic vesicle	BP
1	4	2.32077599163	-	1.43e-01	GO:0010644	cell communication by electrical coupling	BP
1	4	2.32077599163	-	1.43e-01	GO:1900127	positive regulation of hyaluronan biosynthetic process	BP
1	4	2.32077599163	-	1.43e-01	GO:0048713	regulation of oligodendrocyte differentiation	BP
1	4	2.32077599163	-	1.43e-01	GO:0021782	glial cell development	BP
1	4	2.32077599163	-	1.43e-01	GO:0070741	response to interleukin-6	BP
1	4	2.32077599163	-	1.43e-01	GO:1902074	response to salt	BP
1	4	2.32077599163	-	1.43e-01	GO:1902177	positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway	BP
1	4	2.32077599163	-	1.43e-01	GO:0002768	immune response-regulating cell surface receptor signaling pathway	BP
1	4	2.32077599163	-	1.43e-01	GO:0035112	genitalia morphogenesis	BP
1	4	2.32077599163	-	1.43e-01	GO:1901165	positive regulation of trophoblast cell migration	BP
1	4	2.32077599163	-	1.43e-01	GO:0090184	positive regulation of kidney development	BP
1	4	2.32077599163	-	1.43e-01	GO:0060971	embryonic heart tube left/right pattern formation	BP
1	4	2.32077599163	-	1.43e-01	GO:0071442	positive regulation of histone H3-K14 acetylation	BP
1	4	2.32077599163	-	1.43e-01	GO:0045759	negative regulation of action potential	BP
1	4	2.32077599163	-	1.86e-01	GO:0002455	humoral immune response mediated by circulating immunoglobulin	BP
1	4	2.32077599163	-	1.86e-01	GO:0071359	cellular response to dsRNA	BP
1	4	2.32077599163	-	1.86e-01	GO:0090400	stress-induced premature senescence	BP
1	4	2.32077599163	-	1.86e-01	GO:0071801	regulation of podosome assembly	BP
1	4	2.32077599163	-	1.86e-01	GO:2001013	epithelial cell proliferation involved in renal tubule morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0043201	response to leucine	BP
1	4	2.32077599163	-	1.86e-01	GO:0097411	hypoxia-inducible factor-1alpha signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0010523	negative regulation of calcium ion transport into cytosol	BP
1	4	2.32077599163	-	1.86e-01	GO:0035799	ureter maturation	BP
1	4	2.32077599163	-	1.86e-01	GO:0003170	heart valve development	BP
1	4	2.32077599163	-	1.86e-01	GO:0035655	interleukin-18-mediated signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:1901509	regulation of endothelial tube morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0016199	axon midline choice point recognition	BP
1	4	2.32077599163	-	1.86e-01	GO:0002070	epithelial cell maturation	BP
1	4	2.32077599163	-	1.86e-01	GO:0002074	extraocular skeletal muscle development	BP
1	4	2.32077599163	-	1.86e-01	GO:0050689	negative regulation of defense response to virus by host	BP
1	4	2.32077599163	-	1.86e-01	GO:0072107	positive regulation of ureteric bud formation	BP
1	4	2.32077599163	-	1.86e-01	GO:0072108	positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0031296	B cell costimulation	BP
1	4	2.32077599163	-	1.86e-01	GO:0033625	positive regulation of integrin activation	BP
1	4	2.32077599163	-	1.86e-01	GO:0042345	regulation of NF-kappaB import into nucleus	BP
1	4	2.32077599163	-	1.86e-01	GO:0032507	maintenance of protein location in cell	BP
1	4	2.32077599163	-	1.86e-01	GO:0065002	intracellular protein transmembrane transport	BP
1	4	2.32077599163	-	1.86e-01	GO:0010883	regulation of lipid storage	BP
1	4	2.32077599163	-	1.86e-01	GO:0002248	connective tissue replacement involved in inflammatory response wound healing	BP
1	4	2.32077599163	-	1.86e-01	GO:0098779	positive regulation of mitophagy in response to mitochondrial depolarization	BP
1	4	2.32077599163	-	1.86e-01	GO:0090312	positive regulation of protein deacetylation	BP
1	4	2.32077599163	-	1.86e-01	GO:0016080	synaptic vesicle targeting	BP
1	4	2.32077599163	-	1.86e-01	GO:0003413	chondrocyte differentiation involved in endochondral bone morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0060708	spongiotrophoblast differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:1903377	negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0061428	negative regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
1	4	2.32077599163	-	1.86e-01	GO:0015722	canalicular bile acid transport	BP
1	4	2.32077599163	-	1.86e-01	GO:0031394	positive regulation of prostaglandin biosynthetic process	BP
1	4	2.32077599163	-	1.86e-01	GO:1905907	negative regulation of amyloid fibril formation	BP
1	4	2.32077599163	-	1.86e-01	GO:0019086	late viral transcription	BP
1	4	2.32077599163	-	1.86e-01	GO:0038127	ERBB signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0061333	renal tubule morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0051712	positive regulation of killing of cells of other organism	BP
1	4	2.32077599163	-	1.86e-01	GO:0048318	axial mesoderm development	BP
1	4	2.32077599163	-	1.86e-01	GO:0007296	vitellogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0042063	gliogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0003104	positive regulation of glomerular filtration	BP
1	4	2.32077599163	-	1.86e-01	GO:0060421	positive regulation of heart growth	BP
1	4	2.32077599163	-	1.86e-01	GO:2001044	regulation of integrin-mediated signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0070318	positive regulation of G0 to G1 transition	BP
1	4	2.32077599163	-	1.86e-01	GO:0060676	ureteric bud formation	BP
1	4	2.32077599163	-	1.86e-01	GO:0009750	response to fructose	BP
1	4	2.32077599163	-	1.86e-01	GO:1905867	epididymis development	BP
1	4	2.32077599163	-	1.86e-01	GO:2000491	positive regulation of hepatic stellate cell activation	BP
1	4	2.32077599163	-	1.86e-01	GO:0030910	olfactory placode formation	BP
1	4	2.32077599163	-	1.86e-01	GO:1990182	exosomal secretion	BP
1	4	2.32077599163	-	1.86e-01	GO:0006432	phenylalanyl-tRNA aminoacylation	BP
1	4	2.32077599163	-	1.86e-01	GO:1903347	negative regulation of bicellular tight junction assembly	BP
1	4	2.32077599163	-	1.86e-01	GO:1901841	regulation of high voltage-gated calcium channel activity	BP
1	4	2.32077599163	-	1.86e-01	GO:0045191	regulation of isotype switching	BP
1	4	2.32077599163	-	1.86e-01	GO:0007621	negative regulation of female receptivity	BP
1	4	2.32077599163	-	1.86e-01	GO:0051660	establishment of centrosome localization	BP
1	4	2.32077599163	-	1.86e-01	GO:0061419	positive regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
1	4	2.32077599163	-	1.86e-01	GO:0038026	reelin-mediated signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0072012	glomerulus vasculature development	BP
1	4	2.32077599163	-	1.86e-01	GO:0010735	positive regulation of transcription via serum response element binding	BP
1	4	2.32077599163	-	1.86e-01	GO:0032417	positive regulation of sodium:proton antiporter activity	BP
1	4	2.32077599163	-	1.86e-01	GO:2000664	positive regulation of interleukin-5 secretion	BP
1	4	2.32077599163	-	1.86e-01	GO:0046449	creatinine metabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0060161	positive regulation of dopamine receptor signaling pathway	BP
1	4	2.32077599163	-	1.86e-01	GO:0010988	regulation of low-density lipoprotein particle clearance	BP
1	4	2.32077599163	-	1.86e-01	GO:0048305	immunoglobulin secretion	BP
1	4	2.32077599163	-	1.86e-01	GO:0060364	frontal suture morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0051351	positive regulation of ligase activity	BP
1	4	2.32077599163	-	1.86e-01	GO:0006538	glutamate catabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0051169	nuclear transport	BP
1	4	2.32077599163	-	1.86e-01	GO:0010044	response to aluminum ion	BP
1	4	2.32077599163	-	1.86e-01	GO:0071866	negative regulation of apoptotic process in bone marrow	BP
1	4	2.32077599163	-	1.86e-01	GO:0016071	mRNA metabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0006573	valine metabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0031077	post-embryonic camera-type eye development	BP
1	4	2.32077599163	-	1.86e-01	GO:2000741	positive regulation of mesenchymal stem cell differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0045876	positive regulation of sister chromatid cohesion	BP
1	4	2.32077599163	-	1.86e-01	GO:0035522	monoubiquitinated histone H2A deubiquitination	BP
1	4	2.32077599163	-	1.86e-01	GO:0031999	negative regulation of fatty acid beta-oxidation	BP
1	4	2.32077599163	-	1.86e-01	GO:0043353	enucleate erythrocyte differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0045833	negative regulation of lipid metabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0010463	mesenchymal cell proliferation	BP
1	4	2.32077599163	-	1.86e-01	GO:0030223	neutrophil differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0034698	response to gonadotropin	BP
1	4	2.32077599163	-	1.86e-01	GO:0034205	amyloid-beta formation	BP
1	4	2.32077599163	-	1.86e-01	GO:0060574	intestinal epithelial cell maturation	BP
1	4	2.32077599163	-	1.86e-01	GO:0022009	central nervous system vasculogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:1904637	cellular response to ionomycin	BP
1	4	2.32077599163	-	1.86e-01	GO:0021943	formation of radial glial scaffolds	BP
1	4	2.32077599163	-	1.86e-01	GO:0045629	negative regulation of T-helper 2 cell differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0010957	negative regulation of vitamin D biosynthetic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0045986	negative regulation of smooth muscle contraction	BP
1	4	2.32077599163	-	1.86e-01	GO:1902949	positive regulation of tau-protein kinase activity	BP
1	4	2.32077599163	-	1.86e-01	GO:0014878	response to electrical stimulus involved in regulation of muscle adaptation	BP
1	4	2.32077599163	-	1.86e-01	GO:0003253	cardiac neural crest cell migration involved in outflow tract morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0010748	negative regulation of plasma membrane long-chain fatty acid transport	BP
1	4	2.32077599163	-	1.86e-01	GO:0042089	cytokine biosynthetic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0010916	negative regulation of very-low-density lipoprotein particle clearance	BP
1	4	2.32077599163	-	1.86e-01	GO:0048549	positive regulation of pinocytosis	BP
1	4	2.32077599163	-	1.86e-01	GO:0032640	tumor necrosis factor production	BP
1	4	2.32077599163	-	1.86e-01	GO:0060485	mesenchyme development	BP
1	4	2.32077599163	-	1.86e-01	GO:0008088	axo-dendritic transport	BP
1	4	2.32077599163	-	1.86e-01	GO:0002159	desmosome assembly	BP
1	4	2.32077599163	-	1.86e-01	GO:0006924	activation-induced cell death of T cells	BP
1	4	2.32077599163	-	1.86e-01	GO:2000676	positive regulation of type B pancreatic cell apoptotic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0060192	negative regulation of lipase activity	BP
1	4	2.32077599163	-	1.86e-01	GO:2000736	regulation of stem cell differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:1903936	cellular response to sodium arsenite	BP
1	4	2.32077599163	-	1.86e-01	GO:0010992	ubiquitin recycling	BP
1	4	2.32077599163	-	1.86e-01	GO:1901984	negative regulation of protein acetylation	BP
1	4	2.32077599163	-	1.86e-01	GO:1901985	positive regulation of protein acetylation	BP
1	4	2.32077599163	-	1.86e-01	GO:0060355	positive regulation of cell adhesion molecule production	BP
1	4	2.32077599163	-	1.86e-01	GO:0051345	positive regulation of hydrolase activity	BP
1	4	2.32077599163	-	1.86e-01	GO:0097201	negative regulation of transcription from RNA polymerase II promoter in response to stress	BP
1	4	2.32077599163	-	1.86e-01	GO:1902714	negative regulation of interferon-gamma secretion	BP
1	4	2.32077599163	-	1.86e-01	GO:0032042	mitochondrial DNA metabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0038028	insulin receptor signaling pathway via phosphatidylinositol 3-kinase	BP
1	4	2.32077599163	-	1.86e-01	GO:0051385	response to mineralocorticoid	BP
1	4	2.32077599163	-	1.86e-01	GO:0006990	positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response	BP
1	4	2.32077599163	-	1.86e-01	GO:0035910	ascending aorta morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0000904	cell morphogenesis involved in differentiation	BP
1	4	2.32077599163	-	1.86e-01	GO:0021764	amygdala development	BP
1	4	2.32077599163	-	1.86e-01	GO:0010499	proteasomal ubiquitin-independent protein catabolic process	BP
1	4	2.32077599163	-	1.86e-01	GO:0097114	NMDA glutamate receptor clustering	BP
1	4	2.32077599163	-	1.86e-01	GO:0097113	AMPA glutamate receptor clustering	BP
1	4	2.32077599163	-	1.86e-01	GO:0048570	notochord morphogenesis	BP
1	4	2.32077599163	-	1.86e-01	GO:0043137	DNA replication, removal of RNA primer	BP
7	28	2.32077599163	-	3.59e-04	GO:0051059	NF-kappaB binding	MF
4	16	2.32077599163	-	4.16e-03	GO:0019789	SUMO transferase activity	MF
3	12	2.32077599163	-	1.15e-02	GO:0005548	phospholipid transporter activity	MF
2	8	2.32077599163	-	3.28e-02	GO:0032052	bile acid binding	MF
2	8	2.32077599163	-	5.73e-02	GO:0097157	pre-mRNA intronic binding	MF
2	8	2.32077599163	-	5.73e-02	GO:0008140	cAMP response element binding protein binding	MF
2	8	2.32077599163	-	5.73e-02	GO:0001135	transcription factor activity, RNA polymerase II transcription factor recruiting	MF
1	4	2.32077599163	-	9.76e-02	GO:0016614	oxidoreductase activity, acting on CH-OH group of donors	MF
1	4	2.32077599163	-	1.43e-01	GO:0008509	anion transmembrane transporter activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0005219	ryanodine-sensitive calcium-release channel activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0048763	calcium-induced calcium release activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0050833	pyruvate transmembrane transporter activity	MF
1	4	2.32077599163	-	1.43e-01	GO:0042287	MHC protein binding	MF
1	4	2.32077599163	-	1.43e-01	GO:0005176	ErbB-2 class receptor binding	MF
1	4	2.32077599163	-	1.43e-01	GO:0090554	phosphatidylcholine-translocating ATPase activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0050815	phosphoserine residue binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0005315	inorganic phosphate transmembrane transporter activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0043208	glycosphingolipid binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0097643	amylin receptor activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0009008	DNA-methyltransferase activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0031014	troponin T binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0005025	transforming growth factor beta receptor activity, type I	MF
1	4	2.32077599163	-	1.86e-01	GO:1904288	BAT3 complex binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0048408	epidermal growth factor binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0001129	RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly	MF
1	4	2.32077599163	-	1.86e-01	GO:0030546	receptor activator activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0004945	angiotensin type II receptor activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0036033	mediator complex binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0017136	NAD-dependent histone deacetylase activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0004974	leukotriene receptor activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0034617	tetrahydrobiopterin binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0070326	very-low-density lipoprotein particle receptor binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0003873	6-phosphofructo-2-kinase activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0051425	PTB domain binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0035312	5'-3' exodeoxyribonuclease activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0001882	nucleoside binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0005497	androgen binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0043125	ErbB-3 class receptor binding	MF
1	4	2.32077599163	-	1.86e-01	GO:0086007	voltage-gated calcium channel activity involved in cardiac muscle cell action potential	MF
1	4	2.32077599163	-	1.86e-01	GO:0004698	calcium-dependent protein kinase C activity	MF
1	4	2.32077599163	-	1.86e-01	GO:0031698	beta-2 adrenergic receptor binding	MF
11	45	2.28835451394	-	1.18e-06	GO:0035914	skeletal muscle cell differentiation	BP
15	62	2.27347027685	-	1.35e-07	GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	BP
15	62	2.27347027685	-	1.35e-07	GO:0043433	negative regulation of sequence-specific DNA binding transcription factor activity	BP
21	87	2.27014991856	-	1.72e-10	GO:0019216	regulation of lipid metabolic process	BP
6	25	2.26188230258	-	5.75e-04	GO:0045648	positive regulation of erythrocyte differentiation	BP
5	21	2.25038666374	-	8.51e-04	GO:0071542	dopaminergic neuron differentiation	BP
5	21	2.25038666374	-	1.54e-03	GO:0045672	positive regulation of osteoclast differentiation	BP
5	21	2.25038666374	-	1.54e-03	GO:0007492	endoderm development	BP
4	17	2.23331315038	-	3.09e-03	GO:0001708	cell fate specification	BP
4	17	2.23331315038	-	4.16e-03	GO:0061178	regulation of insulin secretion involved in cellular response to glucose stimulus	BP
4	17	2.23331315038	-	5.45e-03	GO:0071354	cellular response to interleukin-6	BP
4	17	2.23331315038	-	5.45e-03	GO:0071375	cellular response to peptide hormone stimulus	BP
4	17	2.23331315038	-	1.02e-03	GO:0008392	arachidonic acid epoxygenase activity	MF
4	17	2.23331315038	-	2.23e-03	GO:0051213	dioxygenase activity	MF
7	30	2.22124031808	-	3.59e-04	GO:0090503	RNA phosphodiester bond hydrolysis, exonucleolytic	BP
84	360	2.22124031808	-	8.91e-11	GO:0000978	RNA polymerase II core promoter proximal region sequence-specific DNA binding	MF
120	516	2.21643933182	-	1.34e-10	GO:0045893	positive regulation of transcription, DNA-templated	BP
13	56	2.21386078772	-	1.15e-06	GO:0003712	transcription cofactor activity	MF
6	26	2.20529877421	-	4.37e-04	GO:0070328	triglyceride homeostasis	BP
6	26	2.20529877421	-	5.75e-04	GO:0016573	histone acetylation	BP
6	26	2.20529877421	-	1.50e-03	GO:0043388	positive regulation of DNA binding	BP
3	13	2.20529877421	-	8.35e-03	GO:0001516	prostaglandin biosynthetic process	BP
3	13	2.20529877421	-	1.52e-02	GO:0090051	negative regulation of cell migration involved in sprouting angiogenesis	BP
3	13	2.20529877421	-	1.52e-02	GO:0006359	regulation of transcription from RNA polymerase III promoter	BP
3	13	2.20529877421	-	1.52e-02	GO:0050872	white fat cell differentiation	BP
3	13	2.20529877421	-	1.52e-02	GO:0046628	positive regulation of insulin receptor signaling pathway	BP
3	13	2.20529877421	-	1.52e-02	GO:0055089	fatty acid homeostasis	BP
3	13	2.20529877421	-	1.96e-02	GO:0010952	positive regulation of peptidase activity	BP
3	13	2.20529877421	-	1.96e-02	GO:0002526	acute inflammatory response	BP
3	13	2.20529877421	-	2.45e-02	GO:0006809	nitric oxide biosynthetic process	BP
3	13	2.20529877421	-	2.45e-02	GO:2000573	positive regulation of DNA biosynthetic process	BP
3	13	2.20529877421	-	2.45e-02	GO:0043984	histone H4-K16 acetylation	BP
3	13	2.20529877421	-	1.52e-02	GO:0001191	transcriptional repressor activity, RNA polymerase II transcription factor binding	MF
3	13	2.20529877421	-	2.45e-02	GO:0035497	cAMP response element binding	MF
5	22	2.18327246788	-	2.00e-03	GO:0042832	defense response to protozoan	BP
14	63	2.15085099019	-	2.11e-07	GO:0008203	cholesterol metabolic process	BP
6	27	2.15085099019	-	5.75e-04	GO:0010575	positive regulation of vascular endothelial growth factor production	BP
6	27	2.15085099019	-	1.84e-03	GO:0045931	positive regulation of mitotic cell cycle	BP
2	9	2.15085099019	-	7.25e-03	GO:1904753	negative regulation of vascular associated smooth muscle cell migration	BP
4	18	2.15085099019	-	8.78e-03	GO:0035066	positive regulation of histone acetylation	BP
2	9	2.15085099019	-	3.28e-02	GO:0097267	omega-hydroxylase P450 pathway	BP
2	9	2.15085099019	-	4.44e-02	GO:0061072	iris morphogenesis	BP
2	9	2.15085099019	-	4.44e-02	GO:0048643	positive regulation of skeletal muscle tissue development	BP
2	9	2.15085099019	-	4.44e-02	GO:0010873	positive regulation of cholesterol esterification	BP
2	9	2.15085099019	-	4.44e-02	GO:0060039	pericardium development	BP
2	9	2.15085099019	-	4.44e-02	GO:0010907	positive regulation of glucose metabolic process	BP
2	9	2.15085099019	-	4.44e-02	GO:0097011	cellular response to granulocyte macrophage colony-stimulating factor stimulus	BP
2	9	2.15085099019	-	5.73e-02	GO:0003208	cardiac ventricle morphogenesis	BP
2	9	2.15085099019	-	5.73e-02	GO:0019953	sexual reproduction	BP
2	9	2.15085099019	-	5.73e-02	GO:0042473	outer ear morphogenesis	BP
2	9	2.15085099019	-	5.73e-02	GO:0048660	regulation of smooth muscle cell proliferation	BP
2	9	2.15085099019	-	5.73e-02	GO:0007614	short-term memory	BP
2	9	2.15085099019	-	7.13e-02	GO:0060261	positive regulation of transcription initiation from RNA polymerase II promoter	BP
2	9	2.15085099019	-	7.13e-02	GO:0051146	striated muscle cell differentiation	BP
2	9	2.15085099019	-	7.13e-02	GO:0031053	primary miRNA processing	BP
2	9	2.15085099019	-	7.13e-02	GO:0050880	regulation of blood vessel size	BP
2	9	2.15085099019	-	7.13e-02	GO:0043068	positive regulation of programmed cell death	BP
2	9	2.15085099019	-	7.13e-02	GO:0060670	branching involved in labyrinthine layer morphogenesis	BP
2	9	2.15085099019	-	7.13e-02	GO:0043589	skin morphogenesis	BP
2	9	2.15085099019	-	7.13e-02	GO:0070933	histone H4 deacetylation	BP
2	9	2.15085099019	-	7.13e-02	GO:0035456	response to interferon-beta	BP
2	9	2.15085099019	-	7.13e-02	GO:0010944	negative regulation of transcription by competitive promoter binding	BP
2	9	2.15085099019	-	7.13e-02	GO:0045080	positive regulation of chemokine biosynthetic process	BP
2	9	2.15085099019	-	7.13e-02	GO:0022407	regulation of cell-cell adhesion	BP
2	9	2.15085099019	-	7.13e-02	GO:0021895	cerebral cortex neuron differentiation	BP
2	9	2.15085099019	-	7.13e-02	GO:0032000	positive regulation of fatty acid beta-oxidation	BP
32	144	2.15085099019	-	3.64e-11	GO:0001228	transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
2	9	2.15085099019	-	4.44e-02	GO:0071933	Arp2/3 complex binding	MF
2	9	2.15085099019	-	7.13e-02	GO:0044389	ubiquitin-like protein ligase binding	MF
2	9	2.15085099019	-	7.13e-02	GO:0017081	chloride channel regulator activity	MF
15	68	2.14020374599	-	1.72e-07	GO:0045444	fat cell differentiation	BP
9	41	2.13314898846	-	8.22e-05	GO:0007595	lactation	BP
9	41	2.13314898846	-	6.56e-05	GO:0004402	histone acetyltransferase activity	MF
7	32	2.12813091369	-	6.99e-04	GO:0051879	Hsp90 protein binding	MF
29	133	2.12347455126	-	6.16e-11	GO:0001078	transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding	MF
5	23	2.11914213046	-	2.00e-03	GO:0009954	proximal/distal pattern formation	BP
5	23	2.11914213046	-	2.56e-03	GO:0031018	endocrine pancreas development	BP
5	23	2.11914213046	-	2.56e-03	GO:0071398	cellular response to fatty acid	BP
46	214	2.10287096129	-	1.11e-10	GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	MF
15	70	2.0983835703	-	8.07e-07	GO:0002039	p53 binding	MF
6	28	2.0983835703	-	9.52e-04	GO:0048863	stem cell differentiation	BP
6	28	2.0983835703	-	1.84e-03	GO:0000060	protein import into nucleus, translocation	BP
3	14	2.0983835703	-	1.52e-02	GO:0003407	neural retina development	BP
3	14	2.0983835703	-	1.96e-02	GO:0042325	regulation of phosphorylation	BP
3	14	2.0983835703	-	1.96e-02	GO:2000678	negative regulation of transcription regulatory region DNA binding	BP
3	14	2.0983835703	-	2.45e-02	GO:0014912	negative regulation of smooth muscle cell migration	BP
3	14	2.0983835703	-	2.45e-02	GO:0071360	cellular response to exogenous dsRNA	BP
3	14	2.0983835703	-	3.00e-02	GO:0042953	lipoprotein transport	BP
3	14	2.0983835703	-	3.00e-02	GO:0042993	positive regulation of transcription factor import into nucleus	BP
3	14	2.0983835703	-	3.00e-02	GO:2001234	negative regulation of apoptotic signaling pathway	BP
6	28	2.0983835703	-	2.25e-03	GO:0097718	disordered domain specific binding	MF
3	14	2.0983835703	-	3.00e-02	GO:0034236	protein kinase A catalytic subunit binding	MF
4	19	2.07284847819	-	4.16e-03	GO:0002052	positive regulation of neuroblast proliferation	BP
4	19	2.07284847819	-	5.45e-03	GO:0001502	cartilage condensation	BP
4	19	2.07284847819	-	6.98e-03	GO:0030220	platelet formation	BP
4	19	2.07284847819	-	1.08e-02	GO:0010906	regulation of glucose metabolic process	BP
4	19	2.07284847819	-	1.08e-02	GO:0030099	myeloid cell differentiation	BP
13	62	2.06701939939	-	7.02e-07	GO:0042632	cholesterol homeostasis	BP
9	43	2.06443623837	-	3.17e-05	GO:0045599	negative regulation of fat cell differentiation	BP
9	43	2.06443623837	-	1.54e-04	GO:1901215	negative regulation of neuron death	BP
10	48	2.0577415858	-	5.98e-05	GO:0042752	regulation of circadian rhythm	BP
5	24	2.0577415858	-	8.51e-04	GO:0017144	drug metabolic process	BP
5	24	2.0577415858	-	4.90e-03	GO:0051966	regulation of synaptic transmission, glutamatergic	BP
22	106	2.05228715571	-	1.13e-09	GO:0051091	positive regulation of sequence-specific DNA binding transcription factor activity	BP
6	29	2.04775749723	-	7.45e-04	GO:0031047	gene silencing by RNA	BP
13	64	2.02121570977	-	1.82e-06	GO:0043627	response to estrogen	BP
12	60	1.99884789674	-	1.99e-05	GO:0070301	cellular response to hydrogen peroxide	BP
10	50	1.99884789674	-	5.98e-05	GO:0034097	response to cytokine	BP
5	25	1.99884789674	-	3.22e-03	GO:0046329	negative regulation of JNK cascade	BP
5	25	1.99884789674	-	4.90e-03	GO:0060612	adipose tissue development	BP
3	15	1.99884789674	-	1.15e-02	GO:0008209	androgen metabolic process	BP
3	15	1.99884789674	-	1.96e-02	GO:0010832	negative regulation of myotube differentiation	BP
3	15	1.99884789674	-	1.96e-02	GO:0035050	embryonic heart tube development	BP
3	15	1.99884789674	-	2.45e-02	GO:2000310	regulation of NMDA receptor activity	BP
3	15	1.99884789674	-	2.45e-02	GO:0044849	estrous cycle	BP
3	15	1.99884789674	-	3.00e-02	GO:0051412	response to corticosterone	BP
3	15	1.99884789674	-	3.00e-02	GO:1904646	cellular response to amyloid-beta	BP
3	15	1.99884789674	-	3.62e-02	GO:2000679	positive regulation of transcription regulatory region DNA binding	BP
3	15	1.99884789674	-	3.62e-02	GO:0051571	positive regulation of histone H3-K4 methylation	BP
3	15	1.99884789674	-	3.62e-02	GO:0004708	MAP kinase kinase activity	MF
8	40	1.99884789674	-	1.72e-04	GO:0032570	response to progesterone	BP
4	20	1.99884789674	-	6.98e-03	GO:0045987	positive regulation of smooth muscle contraction	BP
4	20	1.99884789674	-	6.98e-03	GO:0060716	labyrinthine layer blood vessel development	BP
2	10	1.99884789674	-	7.25e-03	GO:0002430	complement receptor mediated signaling pathway	BP
2	10	1.99884789674	-	2.26e-02	GO:0046470	phosphatidylcholine metabolic process	BP
2	10	1.99884789674	-	3.28e-02	GO:0060174	limb bud formation	BP
2	10	1.99884789674	-	3.28e-02	GO:0002021	response to dietary excess	BP
2	10	1.99884789674	-	5.73e-02	GO:0003300	cardiac muscle hypertrophy	BP
2	10	1.99884789674	-	5.73e-02	GO:0043267	negative regulation of potassium ion transport	BP
2	10	1.99884789674	-	5.73e-02	GO:0021904	dorsal/ventral neural tube patterning	BP
2	10	1.99884789674	-	5.73e-02	GO:0048048	embryonic eye morphogenesis	BP
2	10	1.99884789674	-	7.13e-02	GO:0006515	misfolded or incompletely synthesized protein catabolic process	BP
2	10	1.99884789674	-	7.13e-02	GO:0071548	response to dexamethasone	BP
2	10	1.99884789674	-	7.13e-02	GO:0048715	negative regulation of oligodendrocyte differentiation	BP
2	10	1.99884789674	-	7.13e-02	GO:2001022	positive regulation of response to DNA damage stimulus	BP
2	10	1.99884789674	-	8.62e-02	GO:2000178	negative regulation of neural precursor cell proliferation	BP
2	10	1.99884789674	-	8.62e-02	GO:0033235	positive regulation of protein sumoylation	BP
2	10	1.99884789674	-	8.62e-02	GO:0001759	organ induction	BP
2	10	1.99884789674	-	8.62e-02	GO:0033327	Leydig cell differentiation	BP
2	10	1.99884789674	-	8.62e-02	GO:0048304	positive regulation of isotype switching to IgG isotypes	BP
2	10	1.99884789674	-	8.62e-02	GO:0071985	multivesicular body sorting pathway	BP
2	10	1.99884789674	-	8.62e-02	GO:0042982	amyloid precursor protein metabolic process	BP
2	10	1.99884789674	-	8.62e-02	GO:0042416	dopamine biosynthetic process	BP
2	10	1.99884789674	-	8.62e-02	GO:0060487	lung epithelial cell differentiation	BP
2	10	1.99884789674	-	8.62e-02	GO:0000338	protein deneddylation	BP
1	5	1.99884789674	-	9.76e-02	GO:0006706	steroid catabolic process	BP
1	5	1.99884789674	-	9.76e-02	GO:0070309	lens fiber cell morphogenesis	BP
1	5	1.99884789674	-	9.76e-02	GO:1902807	negative regulation of cell cycle G1/S phase transition	BP
1	5	1.99884789674	-	9.76e-02	GO:0097070	ductus arteriosus closure	BP
1	5	1.99884789674	-	9.76e-02	GO:0042743	hydrogen peroxide metabolic process	BP
1	5	1.99884789674	-	1.43e-01	GO:0060414	aorta smooth muscle tissue morphogenesis	BP
1	5	1.99884789674	-	1.43e-01	GO:0048645	animal organ formation	BP
1	5	1.99884789674	-	1.43e-01	GO:0060335	positive regulation of interferon-gamma-mediated signaling pathway	BP
1	5	1.99884789674	-	1.43e-01	GO:0061743	motor learning	BP
1	5	1.99884789674	-	1.43e-01	GO:0046219	indolalkylamine biosynthetic process	BP
1	5	1.99884789674	-	1.43e-01	GO:0046618	drug export	BP
1	5	1.99884789674	-	1.43e-01	GO:0048513	animal organ development	BP
1	5	1.99884789674	-	1.43e-01	GO:0021879	forebrain neuron differentiation	BP
1	5	1.99884789674	-	1.43e-01	GO:0032714	negative regulation of interleukin-5 production	BP
1	5	1.99884789674	-	1.43e-01	GO:0003211	cardiac ventricle formation	BP
1	5	1.99884789674	-	1.86e-01	GO:0048730	epidermis morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:1905050	positive regulation of metallopeptidase activity	BP
1	5	1.99884789674	-	1.86e-01	GO:0007341	penetration of zona pellucida	BP
1	5	1.99884789674	-	1.86e-01	GO:0050851	antigen receptor-mediated signaling pathway	BP
1	5	1.99884789674	-	1.86e-01	GO:1900020	positive regulation of protein kinase C activity	BP
1	5	1.99884789674	-	1.86e-01	GO:0060666	dichotomous subdivision of terminal units involved in salivary gland branching	BP
1	5	1.99884789674	-	1.86e-01	GO:0050688	regulation of defense response to virus	BP
1	5	1.99884789674	-	1.86e-01	GO:0060591	chondroblast differentiation	BP
1	5	1.99884789674	-	1.86e-01	GO:1902514	regulation of calcium ion transmembrane transport via high voltage-gated calcium channel	BP
1	5	1.99884789674	-	1.86e-01	GO:0021960	anterior commissure morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:0072162	metanephric mesenchymal cell differentiation	BP
1	5	1.99884789674	-	1.86e-01	GO:0048562	embryonic organ morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:0072602	interleukin-4 secretion	BP
1	5	1.99884789674	-	1.86e-01	GO:1903232	melanosome assembly	BP
1	5	1.99884789674	-	1.86e-01	GO:0048752	semicircular canal morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:1901844	regulation of cell communication by electrical coupling involved in cardiac conduction	BP
1	5	1.99884789674	-	1.86e-01	GO:1901300	positive regulation of hydrogen peroxide-mediated programmed cell death	BP
1	5	1.99884789674	-	1.86e-01	GO:0017038	protein import	BP
1	5	1.99884789674	-	1.86e-01	GO:0030300	regulation of intestinal cholesterol absorption	BP
1	5	1.99884789674	-	1.86e-01	GO:0031914	negative regulation of synaptic plasticity	BP
1	5	1.99884789674	-	1.86e-01	GO:0019563	glycerol catabolic process	BP
1	5	1.99884789674	-	1.86e-01	GO:0010632	regulation of epithelial cell migration	BP
1	5	1.99884789674	-	1.86e-01	GO:0035881	amacrine cell differentiation	BP
1	5	1.99884789674	-	1.86e-01	GO:0016101	diterpenoid metabolic process	BP
1	5	1.99884789674	-	1.86e-01	GO:0009414	response to water deprivation	BP
1	5	1.99884789674	-	1.86e-01	GO:0032224	positive regulation of synaptic transmission, cholinergic	BP
1	5	1.99884789674	-	1.86e-01	GO:0021517	ventral spinal cord development	BP
1	5	1.99884789674	-	1.86e-01	GO:1904888	cranial skeletal system development	BP
1	5	1.99884789674	-	1.86e-01	GO:0086045	membrane depolarization during AV node cell action potential	BP
1	5	1.99884789674	-	1.86e-01	GO:0072207	metanephric epithelium development	BP
1	5	1.99884789674	-	1.86e-01	GO:0050996	positive regulation of lipid catabolic process	BP
1	5	1.99884789674	-	1.86e-01	GO:0009299	mRNA transcription	BP
1	5	1.99884789674	-	1.86e-01	GO:0043045	DNA methylation involved in embryo development	BP
1	5	1.99884789674	-	1.86e-01	GO:0043367	CD4-positive, alpha-beta T cell differentiation	BP
1	5	1.99884789674	-	1.86e-01	GO:0014050	negative regulation of glutamate secretion	BP
1	5	1.99884789674	-	1.86e-01	GO:1900223	positive regulation of amyloid-beta clearance	BP
1	5	1.99884789674	-	1.86e-01	GO:0072284	metanephric S-shaped body morphogenesis	BP
1	5	1.99884789674	-	1.86e-01	GO:0038027	apolipoprotein A-I-mediated signaling pathway	BP
1	5	1.99884789674	-	1.86e-01	GO:0006089	lactate metabolic process	BP
1	5	1.99884789674	-	1.86e-01	GO:0072178	nephric duct morphogenesis	BP
1	5	1.99884789674	-	2.26e-01	GO:0072656	maintenance of protein location in mitochondrion	BP
1	5	1.99884789674	-	2.26e-01	GO:0010715	regulation of extracellular matrix disassembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0051891	positive regulation of cardioblast differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0007262	STAT protein import into nucleus	BP
1	5	1.99884789674	-	2.26e-01	GO:0036016	cellular response to interleukin-3	BP
1	5	1.99884789674	-	2.26e-01	GO:0061737	leukotriene signaling pathway	BP
1	5	1.99884789674	-	2.26e-01	GO:0031622	positive regulation of fever generation	BP
1	5	1.99884789674	-	2.26e-01	GO:2000481	positive regulation of cAMP-dependent protein kinase activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0035509	negative regulation of myosin-light-chain-phosphatase activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0065004	protein-DNA complex assembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0010193	response to ozone	BP
1	5	1.99884789674	-	2.26e-01	GO:1905007	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	BP
1	5	1.99884789674	-	2.26e-01	GO:0098735	positive regulation of the force of heart contraction	BP
1	5	1.99884789674	-	2.26e-01	GO:0045063	T-helper 1 cell differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0031536	positive regulation of exit from mitosis	BP
1	5	1.99884789674	-	2.26e-01	GO:0019640	glucuronate catabolic process to xylulose 5-phosphate	BP
1	5	1.99884789674	-	2.26e-01	GO:0045646	regulation of erythrocyte differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0046602	regulation of mitotic centrosome separation	BP
1	5	1.99884789674	-	2.26e-01	GO:0060179	male mating behavior	BP
1	5	1.99884789674	-	2.26e-01	GO:0034316	negative regulation of Arp2/3 complex-mediated actin nucleation	BP
1	5	1.99884789674	-	2.26e-01	GO:0010830	regulation of myotube differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0001661	conditioned taste aversion	BP
1	5	1.99884789674	-	2.26e-01	GO:0032747	positive regulation of interleukin-23 production	BP
1	5	1.99884789674	-	2.26e-01	GO:0045843	negative regulation of striated muscle tissue development	BP
1	5	1.99884789674	-	2.26e-01	GO:0019530	taurine metabolic process	BP
1	5	1.99884789674	-	2.26e-01	GO:0038001	paracrine signaling	BP
1	5	1.99884789674	-	2.26e-01	GO:0044791	positive regulation by host of viral release from host cell	BP
1	5	1.99884789674	-	2.26e-01	GO:0018401	peptidyl-proline hydroxylation to 4-hydroxy-L-proline	BP
1	5	1.99884789674	-	2.26e-01	GO:0001504	neurotransmitter uptake	BP
1	5	1.99884789674	-	2.26e-01	GO:0030854	positive regulation of granulocyte differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0071332	cellular response to fructose stimulus	BP
1	5	1.99884789674	-	2.26e-01	GO:0070296	sarcoplasmic reticulum calcium ion transport	BP
1	5	1.99884789674	-	2.26e-01	GO:0090240	positive regulation of histone H4 acetylation	BP
1	5	1.99884789674	-	2.26e-01	GO:0036035	osteoclast development	BP
1	5	1.99884789674	-	2.26e-01	GO:1902035	positive regulation of hematopoietic stem cell proliferation	BP
1	5	1.99884789674	-	2.26e-01	GO:0048341	paraxial mesoderm formation	BP
1	5	1.99884789674	-	2.26e-01	GO:1990441	negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress	BP
1	5	1.99884789674	-	2.26e-01	GO:0002821	positive regulation of adaptive immune response	BP
1	5	1.99884789674	-	2.26e-01	GO:0032713	negative regulation of interleukin-4 production	BP
1	5	1.99884789674	-	2.26e-01	GO:0045838	positive regulation of membrane potential	BP
1	5	1.99884789674	-	2.26e-01	GO:0060762	regulation of branching involved in mammary gland duct morphogenesis	BP
1	5	1.99884789674	-	2.26e-01	GO:0036336	dendritic cell migration	BP
1	5	1.99884789674	-	2.26e-01	GO:0001887	selenium compound metabolic process	BP
1	5	1.99884789674	-	2.26e-01	GO:0090330	regulation of platelet aggregation	BP
1	5	1.99884789674	-	2.26e-01	GO:0090335	regulation of brown fat cell differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0007610	behavior	BP
1	5	1.99884789674	-	2.26e-01	GO:0002260	lymphocyte homeostasis	BP
1	5	1.99884789674	-	2.26e-01	GO:0070245	positive regulation of thymocyte apoptotic process	BP
1	5	1.99884789674	-	2.26e-01	GO:1904885	beta-catenin destruction complex assembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0033132	negative regulation of glucokinase activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0033133	positive regulation of glucokinase activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0060157	urinary bladder development	BP
1	5	1.99884789674	-	2.26e-01	GO:0034121	regulation of toll-like receptor signaling pathway	BP
1	5	1.99884789674	-	2.26e-01	GO:0090188	negative regulation of pancreatic juice secretion	BP
1	5	1.99884789674	-	2.26e-01	GO:0033153	T cell receptor V(D)J recombination	BP
1	5	1.99884789674	-	2.26e-01	GO:0045541	negative regulation of cholesterol biosynthetic process	BP
1	5	1.99884789674	-	2.26e-01	GO:0010991	negative regulation of SMAD protein complex assembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0060351	cartilage development involved in endochondral bone morphogenesis	BP
1	5	1.99884789674	-	2.26e-01	GO:0051344	negative regulation of cyclic-nucleotide phosphodiesterase activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0051302	regulation of cell division	BP
1	5	1.99884789674	-	2.26e-01	GO:0071681	cellular response to indole-3-methanol	BP
1	5	1.99884789674	-	2.26e-01	GO:0042976	activation of Janus kinase activity	BP
1	5	1.99884789674	-	2.26e-01	GO:0006003	fructose 2,6-bisphosphate metabolic process	BP
1	5	1.99884789674	-	2.26e-01	GO:0010626	negative regulation of Schwann cell proliferation	BP
1	5	1.99884789674	-	2.26e-01	GO:0010452	histone H3-K36 methylation	BP
1	5	1.99884789674	-	2.26e-01	GO:1904504	positive regulation of lipophagy	BP
1	5	1.99884789674	-	2.26e-01	GO:0032534	regulation of microvillus assembly	BP
1	5	1.99884789674	-	2.26e-01	GO:0030098	lymphocyte differentiation	BP
1	5	1.99884789674	-	2.26e-01	GO:0060385	axonogenesis involved in innervation	BP
1	5	1.99884789674	-	2.26e-01	GO:0042509	regulation of tyrosine phosphorylation of STAT protein	BP
1	5	1.99884789674	-	2.26e-01	GO:0021952	central nervous system projection neuron axonogenesis	BP
1	5	1.99884789674	-	2.26e-01	GO:1903361	protein localization to basolateral plasma membrane	BP
16	80	1.99884789674	-	5.76e-07	GO:0008013	beta-catenin binding	MF
2	10	1.99884789674	-	7.13e-02	GO:0019104	DNA N-glycosylase activity	MF
2	10	1.99884789674	-	8.62e-02	GO:0042805	actinin binding	MF
2	10	1.99884789674	-	8.62e-02	GO:0070016	armadillo repeat domain binding	MF
1	5	1.99884789674	-	1.43e-01	GO:0008532	N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity	MF
1	5	1.99884789674	-	1.43e-01	GO:0035529	NADH pyrophosphatase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0031545	peptidyl-proline 4-dioxygenase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0034979	NAD-dependent protein deacetylase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0061665	SUMO ligase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0071813	lipoprotein particle binding	MF
1	5	1.99884789674	-	1.86e-01	GO:0019871	sodium channel inhibitor activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0070290	N-acylphosphatidylethanolamine-specific phospholipase D activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0004028	3-chloroallyl aldehyde dehydrogenase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:1990254	keratin filament binding	MF
1	5	1.99884789674	-	1.86e-01	GO:0034596	phosphatidylinositol phosphate 4-phosphatase activity	MF
1	5	1.99884789674	-	1.86e-01	GO:0015129	lactate transmembrane transporter activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0010385	double-stranded methylated DNA binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0004331	fructose-2,6-bisphosphate 2-phosphatase activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0004826	phenylalanine-tRNA ligase activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0005324	long-chain fatty acid transporter activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0050544	arachidonic acid binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0015277	kainate selective glutamate receptor activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0032184	SUMO polymer binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0005134	interleukin-2 receptor binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0034711	inhibin binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0042799	histone methyltransferase activity (H4-K20 specific)	MF
1	5	1.99884789674	-	2.26e-01	GO:0044547	DNA topoisomerase binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0008379	thioredoxin peroxidase activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0042289	MHC class II protein binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0071532	ankyrin repeat binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0004844	uracil DNA N-glycosylase activity	MF
1	5	1.99884789674	-	2.26e-01	GO:0043426	MRF binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0019966	interleukin-1 binding	MF
1	5	1.99884789674	-	2.26e-01	GO:0000988	transcription factor activity, protein binding	MF
206	1041	1.98352216552	-	2.03e-10	GO:0045944	positive regulation of transcription from RNA polymerase II promoter	BP
11	56	1.97285268821	-	1.22e-05	GO:0009612	response to mechanical stimulus	BP
9	46	1.96713903702	-	8.22e-05	GO:0003151	outflow tract morphogenesis	BP
9	46	1.96713903702	-	1.54e-04	GO:0007611	learning or memory	BP
13	67	1.95512651932	-	1.93e-05	GO:0045652	regulation of megakaryocyte differentiation	BP
6	31	1.95154218197	-	9.52e-04	GO:0035115	embryonic forelimb morphogenesis	BP
6	31	1.95154218197	-	2.25e-03	GO:0048662	negative regulation of smooth muscle cell proliferation	BP
5	26	1.94226436838	-	5.94e-03	GO:0070371	ERK1 and ERK2 cascade	BP
38	199	1.93207888453	-	5.33e-11	GO:0003714	transcription corepressor activity	MF
8	42	1.92845856885	-	6.98e-04	GO:0030218	erythrocyte differentiation	BP
4	21	1.92845856885	-	3.09e-03	GO:0019373	epoxygenase P450 pathway	BP
4	21	1.92845856885	-	1.08e-02	GO:0035902	response to immobilization stress	BP
4	21	1.92845856885	-	1.32e-02	GO:0097150	neuronal stem cell population maintenance	BP
4	21	1.92845856885	-	1.59e-02	GO:0030879	mammary gland development	BP
4	21	1.92845856885	-	1.59e-02	GO:0003148	outflow tract septum morphogenesis	BP
4	21	1.92845856885	-	1.88e-02	GO:0045807	positive regulation of endocytosis	BP
7	37	1.91867754806	-	1.50e-03	GO:0048469	cell maturation	BP
71	376	1.91593425946	-	4.14e-11	GO:0043565	sequence-specific DNA binding	MF
10	53	1.91478363196	-	1.07e-04	GO:0048511	rhythmic process	BP
9	48	1.90573849235	-	5.41e-04	GO:0043525	positive regulation of neuron apoptotic process	BP
6	32	1.90573849235	-	3.25e-03	GO:0043967	histone H4 acetylation	BP
6	32	1.90573849235	-	4.56e-03	GO:0010803	regulation of tumor necrosis factor-mediated signaling pathway	BP
6	32	1.90573849235	-	4.56e-03	GO:1990090	cellular response to nerve growth factor stimulus	BP
3	16	1.90573849235	-	1.96e-02	GO:0019372	lipoxygenase pathway	BP
3	16	1.90573849235	-	2.45e-02	GO:0007220	Notch receptor processing	BP
3	16	1.90573849235	-	2.45e-02	GO:0048714	positive regulation of oligodendrocyte differentiation	BP
3	16	1.90573849235	-	2.45e-02	GO:0070509	calcium ion import	BP
3	16	1.90573849235	-	3.00e-02	GO:0031293	membrane protein intracellular domain proteolysis	BP
3	16	1.90573849235	-	3.00e-02	GO:0035855	megakaryocyte development	BP
3	16	1.90573849235	-	3.00e-02	GO:0070498	interleukin-1-mediated signaling pathway	BP
3	16	1.90573849235	-	3.62e-02	GO:2000179	positive regulation of neural precursor cell proliferation	BP
3	16	1.90573849235	-	3.62e-02	GO:0035162	embryonic hemopoiesis	BP
3	16	1.90573849235	-	3.62e-02	GO:0010744	positive regulation of macrophage derived foam cell differentiation	BP
3	16	1.90573849235	-	4.29e-02	GO:0003203	endocardial cushion morphogenesis	BP
3	16	1.90573849235	-	4.29e-02	GO:1900273	positive regulation of long-term synaptic potentiation	BP
3	16	1.90573849235	-	3.00e-02	GO:0017091	AU-rich element binding	MF
3	16	1.90573849235	-	4.29e-02	GO:0051393	alpha-actinin binding	MF
5	27	1.88781658436	-	8.47e-03	GO:0043392	negative regulation of DNA binding	BP
15	82	1.87011458262	-	7.19e-06	GO:0006338	chromatin remodeling	BP
14	77	1.86134437299	-	4.49e-06	GO:0009952	anterior/posterior pattern specification	BP
8	44	1.86134437299	-	2.67e-04	GO:0032870	cellular response to hormone stimulus	BP
6	33	1.86134437299	-	1.20e-03	GO:0001937	negative regulation of endothelial cell proliferation	BP
4	22	1.86134437299	-	8.78e-03	GO:0031016	pancreas development	BP
4	22	1.86134437299	-	1.08e-02	GO:0097755	positive regulation of blood vessel diameter	BP
4	22	1.86134437299	-	1.59e-02	GO:0035924	cellular response to vascular endothelial growth factor stimulus	BP
4	22	1.86134437299	-	1.88e-02	GO:0045453	bone resorption	BP
4	22	1.86134437299	-	1.88e-02	GO:0045662	negative regulation of myoblast differentiation	BP
2	11	1.86134437299	-	5.73e-02	GO:0006707	cholesterol catabolic process	BP
2	11	1.86134437299	-	5.73e-02	GO:0006346	methylation-dependent chromatin silencing	BP
2	11	1.86134437299	-	5.73e-02	GO:0043586	tongue development	BP
2	11	1.86134437299	-	7.13e-02	GO:0045670	regulation of osteoclast differentiation	BP
2	11	1.86134437299	-	7.13e-02	GO:0060055	angiogenesis involved in wound healing	BP
2	11	1.86134437299	-	8.62e-02	GO:1903204	negative regulation of oxidative stress-induced neuron death	BP
2	11	1.86134437299	-	8.62e-02	GO:0001823	mesonephros development	BP
2	11	1.86134437299	-	8.62e-02	GO:0060272	embryonic skeletal joint morphogenesis	BP
2	11	1.86134437299	-	8.62e-02	GO:0032930	positive regulation of superoxide anion generation	BP
2	11	1.86134437299	-	8.62e-02	GO:0050862	positive regulation of T cell receptor signaling pathway	BP
2	11	1.86134437299	-	8.62e-02	GO:0019068	virion assembly	BP
2	11	1.86134437299	-	8.62e-02	GO:0035413	positive regulation of catenin import into nucleus	BP
2	11	1.86134437299	-	8.62e-02	GO:0045945	positive regulation of transcription from RNA polymerase III promoter	BP
2	11	1.86134437299	-	1.02e-01	GO:0043249	erythrocyte maturation	BP
2	11	1.86134437299	-	1.02e-01	GO:0043276	anoikis	BP
2	11	1.86134437299	-	1.02e-01	GO:0030238	male sex determination	BP
2	11	1.86134437299	-	1.02e-01	GO:0045637	regulation of myeloid cell differentiation	BP
2	11	1.86134437299	-	1.02e-01	GO:0006600	creatine metabolic process	BP
2	11	1.86134437299	-	1.02e-01	GO:0045667	regulation of osteoblast differentiation	BP
2	11	1.86134437299	-	1.02e-01	GO:0034379	very-low-density lipoprotein particle assembly	BP
2	11	1.86134437299	-	5.73e-02	GO:0042301	phosphate ion binding	MF
2	11	1.86134437299	-	7.13e-02	GO:0001206	transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding	MF
2	11	1.86134437299	-	1.02e-01	GO:0043522	leucine zipper domain binding	MF
2	11	1.86134437299	-	1.02e-01	GO:0070411	I-SMAD binding	MF
9	50	1.8468448033	-	6.33e-04	GO:0001540	amyloid-beta binding	MF
5	28	1.83534916446	-	8.51e-04	GO:0015721	bile acid and bile salt transport	BP
5	28	1.83534916446	-	9.98e-03	GO:0051603	proteolysis involved in cellular protein catabolic process	BP
5	28	1.83534916446	-	1.17e-02	GO:0045739	positive regulation of DNA repair	BP
105	588	1.83534916446	-	1.45e-10	GO:0006366	transcription from RNA polymerase II promoter	BP
134	755	1.82653234788	-	1.19e-10	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	BP
6	34	1.8182756511	-	3.25e-03	GO:0002931	response to ischemia	BP
3	17	1.8182756511	-	2.45e-02	GO:0014850	response to muscle activity	BP
3	17	1.8182756511	-	2.45e-02	GO:0001953	negative regulation of cell-matrix adhesion	BP
3	17	1.8182756511	-	2.45e-02	GO:0045019	negative regulation of nitric oxide biosynthetic process	BP
3	17	1.8182756511	-	3.00e-02	GO:0043651	linoleic acid metabolic process	BP
3	17	1.8182756511	-	3.00e-02	GO:0030193	regulation of blood coagulation	BP
3	17	1.8182756511	-	3.00e-02	GO:0050767	regulation of neurogenesis	BP
3	17	1.8182756511	-	3.62e-02	GO:0001702	gastrulation with mouth forming second	BP
3	17	1.8182756511	-	3.62e-02	GO:0045926	negative regulation of growth	BP
3	17	1.8182756511	-	4.29e-02	GO:1904355	positive regulation of telomere capping	BP
3	17	1.8182756511	-	4.29e-02	GO:0048814	regulation of dendrite morphogenesis	BP
3	17	1.8182756511	-	5.02e-02	GO:0031668	cellular response to extracellular stimulus	BP
3	17	1.8182756511	-	5.02e-02	GO:0051123	RNA polymerase II transcriptional preinitiation complex assembly	BP
3	17	1.8182756511	-	3.62e-02	GO:0031489	myosin V binding	MF
19	108	1.81381600291	-	3.16e-07	GO:0009615	response to virus	BP
7	40	1.8062028188	-	2.11e-03	GO:0018024	histone-lysine N-methyltransferase activity	MF
12	69	1.79721403557	-	4.82e-05	GO:0001938	positive regulation of endothelial cell proliferation	BP
4	23	1.79721403557	-	5.45e-03	GO:0006694	steroid biosynthetic process	BP
4	23	1.79721403557	-	2.21e-02	GO:0090398	cellular senescence	BP
4	23	1.79721403557	-	2.21e-02	GO:0050999	regulation of nitric-oxide synthase activity	BP
4	23	1.79721403557	-	2.58e-02	GO:0045736	negative regulation of cyclin-dependent protein serine/threonine kinase activity	BP
8	46	1.79721403557	-	9.81e-04	GO:0046332	SMAD binding	MF
4	23	1.79721403557	-	2.58e-02	GO:0017025	TBP-class protein binding	MF
5	29	1.78472309139	-	1.35e-02	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
5	29	1.78472309139	-	1.35e-02	GO:0035666	TRIF-dependent toll-like receptor signaling pathway	BP
5	29	1.78472309139	-	8.47e-03	GO:0001103	RNA polymerase II repressing transcription factor binding	MF
6	35	1.77645547541	-	2.72e-03	GO:0048813	dendrite morphogenesis	BP
6	35	1.77645547541	-	5.34e-03	GO:0045786	negative regulation of cell cycle	BP
6	35	1.77645547541	-	1.18e-04	GO:0004497	monooxygenase activity	MF
7	41	1.77057890907	-	1.25e-03	GO:0009725	response to hormone	BP
7	41	1.77057890907	-	2.89e-03	GO:0043124	negative regulation of I-kappaB kinase/NF-kappaB signaling	BP
12	71	1.75599137285	-	1.64e-05	GO:0071300	cellular response to retinoic acid	BP
14	83	1.75309148234	-	2.06e-06	GO:0050728	negative regulation of inflammatory response	BP
5	30	1.73581349091	-	5.94e-03	GO:0030901	midbrain development	BP
5	30	1.73581349091	-	9.98e-03	GO:0007259	JAK-STAT cascade	BP
4	24	1.73581349091	-	2.21e-02	GO:0055007	cardiac muscle cell differentiation	BP
4	24	1.73581349091	-	2.97e-02	GO:0070423	nucleotide-binding oligomerization domain containing signaling pathway	BP
4	24	1.73581349091	-	2.97e-02	GO:1901216	positive regulation of neuron death	BP
2	12	1.73581349091	-	4.44e-02	GO:0032966	negative regulation of collagen biosynthetic process	BP
1	6	1.73581349091	-	5.00e-02	GO:1902110	positive regulation of mitochondrial membrane permeability involved in apoptotic process	BP
2	12	1.73581349091	-	5.73e-02	GO:2000727	positive regulation of cardiac muscle cell differentiation	BP
2	12	1.73581349091	-	8.62e-02	GO:0001706	endoderm formation	BP
2	12	1.73581349091	-	8.62e-02	GO:0019430	removal of superoxide radicals	BP
2	12	1.73581349091	-	8.62e-02	GO:0009888	tissue development	BP
2	12	1.73581349091	-	8.62e-02	GO:0050868	negative regulation of T cell activation	BP
2	12	1.73581349091	-	8.62e-02	GO:0008206	bile acid metabolic process	BP
1	6	1.73581349091	-	9.76e-02	GO:2000253	positive regulation of feeding behavior	BP
1	6	1.73581349091	-	9.76e-02	GO:0034755	iron ion transmembrane transport	BP
2	12	1.73581349091	-	1.02e-01	GO:0045651	positive regulation of macrophage differentiation	BP
2	12	1.73581349091	-	1.02e-01	GO:0060707	trophoblast giant cell differentiation	BP
2	12	1.73581349091	-	1.02e-01	GO:0043922	negative regulation by host of viral transcription	BP
2	12	1.73581349091	-	1.02e-01	GO:2000505	regulation of energy homeostasis	BP
2	12	1.73581349091	-	1.02e-01	GO:0014067	negative regulation of phosphatidylinositol 3-kinase signaling	BP
2	12	1.73581349091	-	1.02e-01	GO:0003016	respiratory system process	BP
2	12	1.73581349091	-	1.02e-01	GO:0060218	hematopoietic stem cell differentiation	BP
2	12	1.73581349091	-	1.02e-01	GO:0086004	regulation of cardiac muscle cell contraction	BP
2	12	1.73581349091	-	1.02e-01	GO:0000002	mitochondrial genome maintenance	BP
2	12	1.73581349091	-	1.02e-01	GO:0030212	hyaluronan metabolic process	BP
2	12	1.73581349091	-	1.18e-01	GO:0055093	response to hyperoxia	BP
2	12	1.73581349091	-	1.18e-01	GO:0003198	epithelial to mesenchymal transition involved in endocardial cushion formation	BP
2	12	1.73581349091	-	1.18e-01	GO:0032801	receptor catabolic process	BP
2	12	1.73581349091	-	1.18e-01	GO:0021954	central nervous system neuron development	BP
1	6	1.73581349091	-	1.43e-01	GO:1904996	positive regulation of leukocyte adhesion to vascular endothelial cell	BP
1	6	1.73581349091	-	1.43e-01	GO:0070383	DNA cytosine deamination	BP
1	6	1.73581349091	-	1.43e-01	GO:0007635	chemosensory behavior	BP
1	6	1.73581349091	-	1.43e-01	GO:0051552	flavone metabolic process	BP
1	6	1.73581349091	-	1.43e-01	GO:0032964	collagen biosynthetic process	BP
1	6	1.73581349091	-	1.43e-01	GO:0048512	circadian behavior	BP
1	6	1.73581349091	-	1.86e-01	GO:2000647	negative regulation of stem cell proliferation	BP
1	6	1.73581349091	-	1.86e-01	GO:0045345	positive regulation of MHC class I biosynthetic process	BP
1	6	1.73581349091	-	1.86e-01	GO:0032367	intracellular cholesterol transport	BP
1	6	1.73581349091	-	1.86e-01	GO:0018230	peptidyl-L-cysteine S-palmitoylation	BP
1	6	1.73581349091	-	1.86e-01	GO:0003100	regulation of systemic arterial blood pressure by endothelin	BP
1	6	1.73581349091	-	1.86e-01	GO:1990845	adaptive thermogenesis	BP
1	6	1.73581349091	-	1.86e-01	GO:0048793	pronephros development	BP
1	6	1.73581349091	-	1.86e-01	GO:0021930	cerebellar granule cell precursor proliferation	BP
1	6	1.73581349091	-	1.86e-01	GO:0070508	cholesterol import	BP
1	6	1.73581349091	-	1.86e-01	GO:2000507	positive regulation of energy homeostasis	BP
1	6	1.73581349091	-	1.86e-01	GO:1904468	negative regulation of tumor necrosis factor secretion	BP
1	6	1.73581349091	-	1.86e-01	GO:0060298	positive regulation of sarcomere organization	BP
1	6	1.73581349091	-	1.86e-01	GO:1900116	extracellular negative regulation of signal transduction	BP
1	6	1.73581349091	-	1.86e-01	GO:0018206	peptidyl-methionine modification	BP
1	6	1.73581349091	-	1.86e-01	GO:0061000	negative regulation of dendritic spine development	BP
1	6	1.73581349091	-	2.26e-01	GO:0030579	ubiquitin-dependent SMAD protein catabolic process	BP
1	6	1.73581349091	-	2.26e-01	GO:0003179	heart valve morphogenesis	BP
1	6	1.73581349091	-	2.26e-01	GO:0032364	oxygen homeostasis	BP
1	6	1.73581349091	-	2.26e-01	GO:1901621	negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning	BP
1	6	1.73581349091	-	2.26e-01	GO:0061037	negative regulation of cartilage development	BP
1	6	1.73581349091	-	2.26e-01	GO:0060136	embryonic process involved in female pregnancy	BP
1	6	1.73581349091	-	2.26e-01	GO:0060372	regulation of atrial cardiac muscle cell membrane repolarization	BP
1	6	1.73581349091	-	2.26e-01	GO:2000553	positive regulation of T-helper 2 cell cytokine production	BP
1	6	1.73581349091	-	2.26e-01	GO:0046533	negative regulation of photoreceptor cell differentiation	BP
1	6	1.73581349091	-	2.26e-01	GO:0061180	mammary gland epithelium development	BP
1	6	1.73581349091	-	2.26e-01	GO:0048845	venous blood vessel morphogenesis	BP
1	6	1.73581349091	-	2.26e-01	GO:0072540	T-helper 17 cell lineage commitment	BP
1	6	1.73581349091	-	2.26e-01	GO:0021707	cerebellar granule cell differentiation	BP
1	6	1.73581349091	-	2.26e-01	GO:0050667	homocysteine metabolic process	BP
1	6	1.73581349091	-	2.26e-01	GO:0032808	lacrimal gland development	BP
1	6	1.73581349091	-	2.26e-01	GO:0021984	adenohypophysis development	BP
1	6	1.73581349091	-	2.26e-01	GO:0060836	lymphatic endothelial cell differentiation	BP
1	6	1.73581349091	-	2.26e-01	GO:0010631	epithelial cell migration	BP
1	6	1.73581349091	-	2.26e-01	GO:0032717	negative regulation of interleukin-8 production	BP
1	6	1.73581349091	-	2.26e-01	GO:0051099	positive regulation of binding	BP
1	6	1.73581349091	-	2.26e-01	GO:0033211	adiponectin-activated signaling pathway	BP
1	6	1.73581349091	-	2.26e-01	GO:0042415	norepinephrine metabolic process	BP
1	6	1.73581349091	-	2.26e-01	GO:0021796	cerebral cortex regionalization	BP
1	6	1.73581349091	-	2.26e-01	GO:1904385	cellular response to angiotensin	BP
1	6	1.73581349091	-	2.26e-01	GO:0044806	G-quadruplex DNA unwinding	BP
1	6	1.73581349091	-	2.26e-01	GO:0045719	negative regulation of glycogen biosynthetic process	BP
1	6	1.73581349091	-	2.26e-01	GO:0060056	mammary gland involution	BP
1	6	1.73581349091	-	2.26e-01	GO:0010960	magnesium ion homeostasis	BP
1	6	1.73581349091	-	2.26e-01	GO:0042421	norepinephrine biosynthetic process	BP
1	6	1.73581349091	-	2.65e-01	GO:0051271	negative regulation of cellular component movement	BP
1	6	1.73581349091	-	2.65e-01	GO:0046632	alpha-beta T cell differentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:0098532	histone H3-K27 trimethylation	BP
1	6	1.73581349091	-	2.65e-01	GO:0097647	amylin receptor signaling pathway	BP
1	6	1.73581349091	-	2.65e-01	GO:0010564	regulation of cell cycle process	BP
1	6	1.73581349091	-	2.65e-01	GO:0051101	regulation of DNA binding	BP
1	6	1.73581349091	-	2.65e-01	GO:0051444	negative regulation of ubiquitin-protein transferase activity	BP
1	6	1.73581349091	-	2.65e-01	GO:0030240	skeletal muscle thin filament assembly	BP
1	6	1.73581349091	-	2.65e-01	GO:0097062	dendritic spine maintenance	BP
1	6	1.73581349091	-	2.65e-01	GO:0038202	TORC1 signaling	BP
1	6	1.73581349091	-	2.65e-01	GO:1900272	negative regulation of long-term synaptic potentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:0050671	positive regulation of lymphocyte proliferation	BP
1	6	1.73581349091	-	2.65e-01	GO:0018344	protein geranylgeranylation	BP
1	6	1.73581349091	-	2.65e-01	GO:1902065	response to L-glutamate	BP
1	6	1.73581349091	-	2.65e-01	GO:0072307	regulation of metanephric nephron tubule epithelial cell differentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:0034315	regulation of Arp2/3 complex-mediated actin nucleation	BP
1	6	1.73581349091	-	2.65e-01	GO:0014033	neural crest cell differentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:0034620	cellular response to unfolded protein	BP
1	6	1.73581349091	-	2.65e-01	GO:0030031	cell projection assembly	BP
1	6	1.73581349091	-	2.65e-01	GO:0003309	type B pancreatic cell differentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:1904417	positive regulation of xenophagy	BP
1	6	1.73581349091	-	2.65e-01	GO:0010216	maintenance of DNA methylation	BP
1	6	1.73581349091	-	2.65e-01	GO:1903140	regulation of establishment of endothelial barrier	BP
1	6	1.73581349091	-	2.65e-01	GO:0001711	endodermal cell fate commitment	BP
1	6	1.73581349091	-	2.65e-01	GO:0030853	negative regulation of granulocyte differentiation	BP
1	6	1.73581349091	-	2.65e-01	GO:0006101	citrate metabolic process	BP
1	6	1.73581349091	-	2.65e-01	GO:0014842	regulation of skeletal muscle satellite cell proliferation	BP
1	6	1.73581349091	-	2.65e-01	GO:0071371	cellular response to gonadotropin stimulus	BP
1	6	1.73581349091	-	2.65e-01	GO:2000667	positive regulation of interleukin-13 secretion	BP
1	6	1.73581349091	-	2.65e-01	GO:0071638	negative regulation of monocyte chemotactic protein-1 production	BP
1	6	1.73581349091	-	2.65e-01	GO:0097084	vascular smooth muscle cell development	BP
1	6	1.73581349091	-	2.65e-01	GO:0060363	cranial suture morphogenesis	BP
1	6	1.73581349091	-	2.65e-01	GO:0010042	response to manganese ion	BP
1	6	1.73581349091	-	2.65e-01	GO:0051932	synaptic transmission, GABAergic	BP
1	6	1.73581349091	-	2.65e-01	GO:1901016	regulation of potassium ion transmembrane transporter activity	BP
1	6	1.73581349091	-	2.65e-01	GO:1901222	regulation of NIK/NF-kappaB signaling	BP
1	6	1.73581349091	-	2.65e-01	GO:0032754	positive regulation of interleukin-5 production	BP
1	6	1.73581349091	-	2.65e-01	GO:1900113	negative regulation of histone H3-K9 trimethylation	BP
1	6	1.73581349091	-	2.65e-01	GO:0001553	luteinization	BP
1	6	1.73581349091	-	2.65e-01	GO:0033210	leptin-mediated signaling pathway	BP
1	6	1.73581349091	-	2.65e-01	GO:0070244	negative regulation of thymocyte apoptotic process	BP
1	6	1.73581349091	-	2.65e-01	GO:0071156	regulation of cell cycle arrest	BP
1	6	1.73581349091	-	2.65e-01	GO:0090279	regulation of calcium ion import	BP
1	6	1.73581349091	-	2.65e-01	GO:0097242	amyloid-beta clearance	BP
1	6	1.73581349091	-	2.65e-01	GO:0007100	mitotic centrosome separation	BP
1	6	1.73581349091	-	2.65e-01	GO:0051346	negative regulation of hydrolase activity	BP
1	6	1.73581349091	-	2.65e-01	GO:0033194	response to hydroperoxide	BP
1	6	1.73581349091	-	2.65e-01	GO:0071870	cellular response to catecholamine stimulus	BP
1	6	1.73581349091	-	2.65e-01	GO:0071218	cellular response to misfolded protein	BP
1	6	1.73581349091	-	2.65e-01	GO:0035897	proteolysis in other organism	BP
1	6	1.73581349091	-	2.65e-01	GO:0060561	apoptotic process involved in morphogenesis	BP
1	6	1.73581349091	-	2.65e-01	GO:0007435	salivary gland morphogenesis	BP
1	6	1.73581349091	-	2.65e-01	GO:0060527	prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis	BP
1	6	1.73581349091	-	2.65e-01	GO:0042423	catecholamine biosynthetic process	BP
4	24	1.73581349091	-	3.70e-04	GO:0008395	steroid hydroxylase activity	MF
2	12	1.73581349091	-	5.73e-02	GO:0042043	neurexin family protein binding	MF
2	12	1.73581349091	-	8.62e-02	GO:0008331	high voltage-gated calcium channel activity	MF
2	12	1.73581349091	-	1.02e-01	GO:0050321	tau-protein kinase activity	MF
2	12	1.73581349091	-	1.18e-01	GO:0004861	cyclin-dependent protein serine/threonine kinase inhibitor activity	MF
2	12	1.73581349091	-	1.18e-01	GO:0048185	activin binding	MF
2	12	1.73581349091	-	1.18e-01	GO:0043422	protein kinase B binding	MF
2	12	1.73581349091	-	1.18e-01	GO:0000989	transcription factor activity, transcription factor binding	MF
1	6	1.73581349091	-	1.43e-01	GO:0005381	iron ion transmembrane transporter activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0004630	phospholipase D activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0004983	neuropeptide Y receptor activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0016174	NAD(P)H oxidase activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0043546	molybdopterin cofactor binding	MF
1	6	1.73581349091	-	1.86e-01	GO:0004969	histamine receptor activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0004030	aldehyde dehydrogenase [NAD(P)+] activity	MF
1	6	1.73581349091	-	1.86e-01	GO:0048019	receptor antagonist activity	MF
1	6	1.73581349091	-	2.26e-01	GO:0036435	K48-linked polyubiquitin modification-dependent protein binding	MF
1	6	1.73581349091	-	2.26e-01	GO:0035473	lipase binding	MF
1	6	1.73581349091	-	2.26e-01	GO:0004430	1-phosphatidylinositol 4-kinase activity	MF
1	6	1.73581349091	-	2.26e-01	GO:0072341	modified amino acid binding	MF
1	6	1.73581349091	-	2.26e-01	GO:0030020	extracellular matrix structural constituent conferring tensile strength	MF
1	6	1.73581349091	-	2.65e-01	GO:0003958	NADPH-hemoprotein reductase activity	MF
1	6	1.73581349091	-	2.65e-01	GO:0004704	NF-kappaB-inducing kinase activity	MF
1	6	1.73581349091	-	2.65e-01	GO:1990239	steroid hormone binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0016004	phospholipase activator activity	MF
1	6	1.73581349091	-	2.65e-01	GO:0017108	5'-flap endonuclease activity	MF
1	6	1.73581349091	-	2.65e-01	GO:0030275	LRR domain binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0030911	TPR domain binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0046975	histone methyltransferase activity (H3-K36 specific)	MF
1	6	1.73581349091	-	2.65e-01	GO:0097371	MDM2/MDM4 family protein binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0048273	mitogen-activated protein kinase p38 binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0036402	proteasome-activating ATPase activity	MF
1	6	1.73581349091	-	2.65e-01	GO:0032357	oxidized purine DNA binding	MF
1	6	1.73581349091	-	2.65e-01	GO:0019239	deaminase activity	MF
9	54	1.73581349091	-	8.58e-04	GO:0071560	cellular response to transforming growth factor beta stimulus	BP
7	42	1.73581349091	-	3.87e-03	GO:0043966	histone H3 acetylation	BP
7	42	1.73581349091	-	3.87e-03	GO:0045429	positive regulation of nitric oxide biosynthetic process	BP
3	18	1.73581349091	-	3.62e-02	GO:0002076	osteoblast development	BP
3	18	1.73581349091	-	5.02e-02	GO:0030325	adrenal gland development	BP
3	18	1.73581349091	-	5.02e-02	GO:0001894	tissue homeostasis	BP
3	18	1.73581349091	-	5.02e-02	GO:0051000	positive regulation of nitric-oxide synthase activity	BP
3	18	1.73581349091	-	5.02e-02	GO:0048854	brain morphogenesis	BP
3	18	1.73581349091	-	5.02e-02	GO:0009416	response to light stimulus	BP
3	18	1.73581349091	-	5.81e-02	GO:0043523	regulation of neuron apoptotic process	BP
3	18	1.73581349091	-	8.35e-03	GO:0001972	retinoic acid binding	MF
3	18	1.73581349091	-	3.00e-02	GO:0016209	antioxidant activity	MF
14	86	1.70186615899	-	5.61e-07	GO:0006805	xenobiotic metabolic process	BP
7	43	1.70186615899	-	2.11e-03	GO:0007566	embryo implantation	BP
26	160	1.69928761489	-	2.88e-08	GO:0001666	response to hypoxia	BP
6	37	1.69628512672	-	9.47e-03	GO:0070888	E-box binding	MF
5	31	1.68850777613	-	5.94e-03	GO:0045907	positive regulation of vasoconstriction	BP
5	31	1.68850777613	-	9.98e-03	GO:0060412	ventricular septum morphogenesis	BP
5	31	1.68850777613	-	1.35e-02	GO:0006284	base-excision repair	BP
5	31	1.68850777613	-	1.17e-02	GO:1990841	promoter-specific chromatin binding	MF
77	479	1.68368068659	-	9.89e-11	GO:0045892	negative regulation of transcription, DNA-templated	BP
8	50	1.67691980186	-	3.28e-04	GO:0045600	positive regulation of fat cell differentiation	BP
4	25	1.67691980186	-	2.21e-02	GO:0021983	pituitary gland development	BP
4	25	1.67691980186	-	2.58e-02	GO:0002053	positive regulation of mesenchymal cell proliferation	BP
4	25	1.67691980186	-	2.58e-02	GO:0051602	response to electrical stimulus	BP
4	25	1.67691980186	-	3.40e-02	GO:0071353	cellular response to interleukin-4	BP
131	820	1.67471889366	-	1.02e-10	GO:0003700	transcription factor activity, sequence-specific DNA binding	MF
11	69	1.67168315349	-	2.99e-04	GO:0018107	peptidyl-threonine phosphorylation	BP
10	63	1.66542416302	-	5.44e-04	GO:0032091	negative regulation of protein binding	BP
9	57	1.65781097891	-	3.88e-04	GO:0001947	heart looping	BP
9	57	1.65781097891	-	1.31e-03	GO:0048661	positive regulation of smooth muscle cell proliferation	BP
6	38	1.65781097891	-	4.56e-03	GO:0045597	positive regulation of cell differentiation	BP
6	38	1.65781097891	-	8.28e-03	GO:0038128	ERBB2 signaling pathway	BP
3	19	1.65781097891	-	2.45e-02	GO:0010881	regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion	BP
3	19	1.65781097891	-	4.29e-02	GO:0032332	positive regulation of chondrocyte differentiation	BP
3	19	1.65781097891	-	5.02e-02	GO:0014911	positive regulation of smooth muscle cell migration	BP
3	19	1.65781097891	-	5.02e-02	GO:0010613	positive regulation of cardiac muscle hypertrophy	BP
3	19	1.65781097891	-	5.02e-02	GO:0051968	positive regulation of synaptic transmission, glutamatergic	BP
3	19	1.65781097891	-	5.81e-02	GO:0046827	positive regulation of protein export from nucleus	BP
3	19	1.65781097891	-	5.81e-02	GO:0043153	entrainment of circadian clock by photoperiod	BP
27	171	1.65781097891	-	8.08e-11	GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	MF
52	330	1.65489349553	-	5.55e-11	GO:0019899	enzyme binding	MF
11	70	1.65092459332	-	2.99e-04	GO:0001889	liver development	BP
5	32	1.64270408652	-	1.56e-02	GO:0070555	response to interleukin-1	BP
5	32	1.64270408652	-	1.56e-02	GO:0032008	positive regulation of TOR signaling	BP
12	78	1.62033627349	-	4.82e-05	GO:0030324	lung development	BP
2	13	1.62033627349	-	8.62e-02	GO:0007398	ectoderm development	BP
2	13	1.62033627349	-	8.62e-02	GO:2000773	negative regulation of cellular senescence	BP
2	13	1.62033627349	-	1.02e-01	GO:0050806	positive regulation of synaptic transmission	BP
2	13	1.62033627349	-	1.02e-01	GO:0008610	lipid biosynthetic process	BP
2	13	1.62033627349	-	1.02e-01	GO:0099133	ATP hydrolysis coupled anion transmembrane transport	BP
2	13	1.62033627349	-	1.02e-01	GO:0048546	digestive tract morphogenesis	BP
2	13	1.62033627349	-	1.02e-01	GO:2000737	negative regulation of stem cell differentiation	BP
2	13	1.62033627349	-	1.02e-01	GO:0051926	negative regulation of calcium ion transport	BP
2	13	1.62033627349	-	1.18e-01	GO:0060413	atrial septum morphogenesis	BP
2	13	1.62033627349	-	1.18e-01	GO:0019395	fatty acid oxidation	BP
2	13	1.62033627349	-	1.18e-01	GO:0042692	muscle cell differentiation	BP
2	13	1.62033627349	-	1.18e-01	GO:2000059	negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process	BP
2	13	1.62033627349	-	1.18e-01	GO:0045780	positive regulation of bone resorption	BP
2	13	1.62033627349	-	1.18e-01	GO:0071872	cellular response to epinephrine stimulus	BP
2	13	1.62033627349	-	1.18e-01	GO:1902166	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	BP
2	13	1.62033627349	-	1.36e-01	GO:0070306	lens fiber cell differentiation	BP
2	13	1.62033627349	-	1.36e-01	GO:0033630	positive regulation of cell adhesion mediated by integrin	BP
2	13	1.62033627349	-	1.36e-01	GO:0070986	left/right axis specification	BP
6	39	1.62033627349	-	2.72e-03	GO:0042626	ATPase activity, coupled to transmembrane movement of substances	MF
2	13	1.62033627349	-	1.02e-01	GO:0032454	histone demethylase activity (H3-K9 specific)	MF
2	13	1.62033627349	-	1.02e-01	GO:0003906	DNA-(apurinic or apyrimidinic site) lyase activity	MF
2	13	1.62033627349	-	1.36e-01	GO:1904264	ubiquitin protein ligase activity involved in ERAD pathway	MF
2	13	1.62033627349	-	1.36e-01	GO:0034450	ubiquitin-ubiquitin ligase activity	MF
7	46	1.60456895763	-	4.45e-03	GO:0007519	skeletal muscle tissue development	BP
10	66	1.59830996716	-	3.49e-04	GO:0060337	type I interferon signaling pathway	BP
5	33	1.59830996716	-	4.90e-03	GO:0042100	B cell proliferation	BP
6	40	1.58381039747	-	8.28e-03	GO:0071902	positive regulation of protein serine/threonine kinase activity	BP
6	40	1.58381039747	-	1.08e-02	GO:0031648	protein destabilization	BP
3	20	1.58381039747	-	4.29e-02	GO:0032753	positive regulation of interleukin-4 production	BP
3	20	1.58381039747	-	6.65e-02	GO:0045861	negative regulation of proteolysis	BP
13	87	1.57827221392	-	5.07e-05	GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding	MF
7	47	1.57354206201	-	5.80e-03	GO:0010595	positive regulation of endothelial cell migration	BP
7	47	1.57354206201	-	8.36e-03	GO:0034644	cellular response to UV	BP
7	47	1.57354206201	-	5.09e-03	GO:0005080	protein kinase C binding	MF
4	27	1.56588848947	-	2.58e-02	GO:0001958	endochondral ossification	BP
4	27	1.56588848947	-	4.37e-02	GO:0045070	positive regulation of viral genome replication	BP
4	27	1.56588848947	-	1.59e-02	GO:0017046	peptide hormone binding	MF
4	27	1.56588848947	-	4.37e-02	GO:0051721	protein phosphatase 2A binding	MF
5	34	1.55524124527	-	9.98e-03	GO:0030513	positive regulation of BMP signaling pathway	BP
5	34	1.55524124527	-	2.29e-02	GO:0051973	positive regulation of telomerase activity	BP
6	41	1.54818648773	-	9.47e-03	GO:0010718	positive regulation of epithelial to mesenchymal transition	BP
6	41	1.54818648773	-	1.22e-02	GO:0045740	positive regulation of DNA replication	BP
8	55	1.53941627811	-	2.10e-03	GO:0071277	cellular response to calcium ion	BP
15	104	1.5272268691	-	6.18e-05	GO:0071456	cellular response to hypoxia	BP
17	119	1.51342106957	-	3.12e-05	GO:0030308	negative regulation of cell growth	BP
5	35	1.51342106957	-	1.56e-02	GO:0050808	synapse organization	BP
5	35	1.51342106957	-	2.29e-02	GO:0048536	spleen development	BP
14	98	1.51342106957	-	6.62e-05	GO:0001764	neuron migration	BP
8	56	1.51342106957	-	2.10e-03	GO:0042475	odontogenesis of dentin-containing tooth	BP
7	49	1.51342106957	-	9.38e-03	GO:0032481	positive regulation of type I interferon production	BP
6	42	1.51342106957	-	1.08e-02	GO:0034198	cellular response to amino acid starvation	BP
4	28	1.51342106957	-	1.88e-02	GO:0001755	neural crest cell migration	BP
4	28	1.51342106957	-	2.58e-02	GO:0003281	ventricular septum development	BP
4	28	1.51342106957	-	2.97e-02	GO:0071158	positive regulation of cell cycle arrest	BP
2	14	1.51342106957	-	4.44e-02	GO:0061049	cell growth involved in cardiac muscle cell development	BP
1	7	1.51342106957	-	5.00e-02	GO:0006766	vitamin metabolic process	BP
3	21	1.51342106957	-	5.81e-02	GO:0048844	artery morphogenesis	BP
3	21	1.51342106957	-	7.55e-02	GO:0045921	positive regulation of exocytosis	BP
2	14	1.51342106957	-	1.18e-01	GO:2000810	regulation of bicellular tight junction assembly	BP
2	14	1.51342106957	-	1.18e-01	GO:0033169	histone H3-K9 demethylation	BP
2	14	1.51342106957	-	1.18e-01	GO:2001275	positive regulation of glucose import in response to insulin stimulus	BP
2	14	1.51342106957	-	1.36e-01	GO:0044130	negative regulation of growth of symbiont in host	BP
2	14	1.51342106957	-	1.36e-01	GO:0030818	negative regulation of cAMP biosynthetic process	BP
2	14	1.51342106957	-	1.36e-01	GO:0050892	intestinal absorption	BP
1	7	1.51342106957	-	1.43e-01	GO:0006776	vitamin A metabolic process	BP
1	7	1.51342106957	-	1.43e-01	GO:0000160	phosphorelay signal transduction system	BP
1	7	1.51342106957	-	1.43e-01	GO:2000272	negative regulation of receptor activity	BP
2	14	1.51342106957	-	1.53e-01	GO:0043069	negative regulation of programmed cell death	BP
2	14	1.51342106957	-	1.53e-01	GO:0008631	intrinsic apoptotic signaling pathway in response to oxidative stress	BP
2	14	1.51342106957	-	1.53e-01	GO:0007175	negative regulation of epidermal growth factor-activated receptor activity	BP
1	7	1.51342106957	-	1.86e-01	GO:0014807	regulation of somitogenesis	BP
1	7	1.51342106957	-	1.86e-01	GO:2000543	positive regulation of gastrulation	BP
1	7	1.51342106957	-	1.86e-01	GO:0095500	acetylcholine receptor signaling pathway	BP
1	7	1.51342106957	-	1.86e-01	GO:0021516	dorsal spinal cord development	BP
1	7	1.51342106957	-	2.26e-01	GO:0003416	endochondral bone growth	BP
1	7	1.51342106957	-	2.26e-01	GO:0072643	interferon-gamma secretion	BP
1	7	1.51342106957	-	2.26e-01	GO:0034144	negative regulation of toll-like receptor 4 signaling pathway	BP
1	7	1.51342106957	-	2.26e-01	GO:0033135	regulation of peptidyl-serine phosphorylation	BP
1	7	1.51342106957	-	2.26e-01	GO:0015844	monoamine transport	BP
1	7	1.51342106957	-	2.26e-01	GO:0070431	nucleotide-binding oligomerization domain containing 2 signaling pathway	BP
1	7	1.51342106957	-	2.26e-01	GO:2000252	negative regulation of feeding behavior	BP
1	7	1.51342106957	-	2.26e-01	GO:0031346	positive regulation of cell projection organization	BP
1	7	1.51342106957	-	2.26e-01	GO:0035878	nail development	BP
1	7	1.51342106957	-	2.26e-01	GO:0009950	dorsal/ventral axis specification	BP
1	7	1.51342106957	-	2.26e-01	GO:0003344	pericardium morphogenesis	BP
1	7	1.51342106957	-	2.26e-01	GO:0032927	positive regulation of activin receptor signaling pathway	BP
1	7	1.51342106957	-	2.26e-01	GO:0051045	negative regulation of membrane protein ectodomain proteolysis	BP
1	7	1.51342106957	-	2.26e-01	GO:0019227	neuronal action potential propagation	BP
1	7	1.51342106957	-	2.26e-01	GO:0042756	drinking behavior	BP
1	7	1.51342106957	-	2.26e-01	GO:0090336	positive regulation of brown fat cell differentiation	BP
1	7	1.51342106957	-	2.26e-01	GO:0006657	CDP-choline pathway	BP
1	7	1.51342106957	-	2.26e-01	GO:0010518	positive regulation of phospholipase activity	BP
1	7	1.51342106957	-	2.26e-01	GO:0045869	negative regulation of single stranded viral RNA replication via double stranded DNA intermediate	BP
1	7	1.51342106957	-	2.26e-01	GO:0070613	regulation of protein processing	BP
1	7	1.51342106957	-	2.26e-01	GO:0060710	chorio-allantoic fusion	BP
1	7	1.51342106957	-	2.65e-01	GO:0045654	positive regulation of megakaryocyte differentiation	BP
1	7	1.51342106957	-	2.65e-01	GO:0045656	negative regulation of monocyte differentiation	BP
1	7	1.51342106957	-	2.65e-01	GO:0048539	bone marrow development	BP
1	7	1.51342106957	-	2.65e-01	GO:1902018	negative regulation of cilium assembly	BP
1	7	1.51342106957	-	2.65e-01	GO:0032287	peripheral nervous system myelin maintenance	BP
1	7	1.51342106957	-	2.65e-01	GO:0060998	regulation of dendritic spine development	BP
1	7	1.51342106957	-	2.65e-01	GO:2000617	positive regulation of histone H3-K9 acetylation	BP
1	7	1.51342106957	-	2.65e-01	GO:2000650	negative regulation of sodium ion transmembrane transporter activity	BP
1	7	1.51342106957	-	2.65e-01	GO:0032466	negative regulation of cytokinesis	BP
1	7	1.51342106957	-	2.65e-01	GO:0019048	modulation by virus of host morphology or physiology	BP
1	7	1.51342106957	-	2.65e-01	GO:0010837	regulation of keratinocyte proliferation	BP
1	7	1.51342106957	-	2.65e-01	GO:0014037	Schwann cell differentiation	BP
1	7	1.51342106957	-	2.65e-01	GO:0022612	gland morphogenesis	BP
1	7	1.51342106957	-	2.65e-01	GO:0060075	regulation of resting membrane potential	BP
1	7	1.51342106957	-	2.65e-01	GO:0000578	embryonic axis specification	BP
1	7	1.51342106957	-	2.65e-01	GO:0043576	regulation of respiratory gaseous exchange	BP
1	7	1.51342106957	-	2.65e-01	GO:0006475	internal protein amino acid acetylation	BP
1	7	1.51342106957	-	2.65e-01	GO:0051001	negative regulation of nitric-oxide synthase activity	BP
1	7	1.51342106957	-	2.65e-01	GO:0031102	neuron projection regeneration	BP
1	7	1.51342106957	-	2.65e-01	GO:0032926	negative regulation of activin receptor signaling pathway	BP
1	7	1.51342106957	-	2.65e-01	GO:1900246	positive regulation of RIG-I signaling pathway	BP
1	7	1.51342106957	-	2.65e-01	GO:2000318	positive regulation of T-helper 17 type immune response	BP
1	7	1.51342106957	-	2.65e-01	GO:2000121	regulation of removal of superoxide radicals	BP
1	7	1.51342106957	-	2.65e-01	GO:0032411	positive regulation of transporter activity	BP
1	7	1.51342106957	-	2.65e-01	GO:0035095	behavioral response to nicotine	BP
1	7	1.51342106957	-	2.65e-01	GO:0034983	peptidyl-lysine deacetylation	BP
1	7	1.51342106957	-	2.65e-01	GO:0060042	retina morphogenesis in camera-type eye	BP
1	7	1.51342106957	-	2.65e-01	GO:0060576	intestinal epithelial cell development	BP
1	7	1.51342106957	-	2.65e-01	GO:0007617	mating behavior	BP
1	7	1.51342106957	-	2.65e-01	GO:0044539	long-chain fatty acid import	BP
1	7	1.51342106957	-	2.65e-01	GO:0007379	segment specification	BP
1	7	1.51342106957	-	2.65e-01	GO:0051057	positive regulation of small GTPase mediated signal transduction	BP
1	7	1.51342106957	-	2.65e-01	GO:0060972	left/right pattern formation	BP
1	7	1.51342106957	-	2.65e-01	GO:0061298	retina vasculature development in camera-type eye	BP
1	7	1.51342106957	-	2.65e-01	GO:0017121	phospholipid scrambling	BP
1	7	1.51342106957	-	2.65e-01	GO:0006527	arginine catabolic process	BP
1	7	1.51342106957	-	2.65e-01	GO:1903214	regulation of protein targeting to mitochondrion	BP
1	7	1.51342106957	-	2.65e-01	GO:0014902	myotube differentiation	BP
1	7	1.51342106957	-	2.65e-01	GO:0003084	positive regulation of systemic arterial blood pressure	BP
1	7	1.51342106957	-	2.65e-01	GO:0043551	regulation of phosphatidylinositol 3-kinase activity	BP
1	7	1.51342106957	-	2.65e-01	GO:0008366	axon ensheathment	BP
1	7	1.51342106957	-	2.65e-01	GO:0042297	vocal learning	BP
1	7	1.51342106957	-	2.65e-01	GO:0035726	common myeloid progenitor cell proliferation	BP
1	7	1.51342106957	-	2.65e-01	GO:0060017	parathyroid gland development	BP
1	7	1.51342106957	-	2.65e-01	GO:0042129	regulation of T cell proliferation	BP
1	7	1.51342106957	-	2.65e-01	GO:0045617	negative regulation of keratinocyte differentiation	BP
1	7	1.51342106957	-	3.02e-01	GO:0050810	regulation of steroid biosynthetic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0046826	negative regulation of protein export from nucleus	BP
1	7	1.51342106957	-	3.02e-01	GO:0019896	axonal transport of mitochondrion	BP
1	7	1.51342106957	-	3.02e-01	GO:0006516	glycoprotein catabolic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0034340	response to type I interferon	BP
1	7	1.51342106957	-	3.02e-01	GO:0032736	positive regulation of interleukin-13 production	BP
1	7	1.51342106957	-	3.02e-01	GO:0003337	mesenchymal to epithelial transition involved in metanephros morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0001783	B cell apoptotic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0070389	chaperone cofactor-dependent protein refolding	BP
1	7	1.51342106957	-	3.02e-01	GO:0010886	positive regulation of cholesterol storage	BP
1	7	1.51342106957	-	3.02e-01	GO:0010269	response to selenium ion	BP
1	7	1.51342106957	-	3.02e-01	GO:0031848	protection from non-homologous end joining at telomere	BP
1	7	1.51342106957	-	3.02e-01	GO:0002741	positive regulation of cytokine secretion involved in immune response	BP
1	7	1.51342106957	-	3.02e-01	GO:1902741	positive regulation of interferon-alpha secretion	BP
1	7	1.51342106957	-	3.02e-01	GO:0061626	pharyngeal arch artery morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:2000171	negative regulation of dendrite development	BP
1	7	1.51342106957	-	3.02e-01	GO:0060706	cell differentiation involved in embryonic placenta development	BP
1	7	1.51342106957	-	3.02e-01	GO:0003183	mitral valve morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0034141	positive regulation of toll-like receptor 3 signaling pathway	BP
1	7	1.51342106957	-	3.02e-01	GO:0043405	regulation of MAP kinase activity	BP
1	7	1.51342106957	-	3.02e-01	GO:1903715	regulation of aerobic respiration	BP
1	7	1.51342106957	-	3.02e-01	GO:0007253	cytoplasmic sequestering of NF-kappaB	BP
1	7	1.51342106957	-	3.02e-01	GO:0048102	autophagic cell death	BP
1	7	1.51342106957	-	3.02e-01	GO:0048261	negative regulation of receptor-mediated endocytosis	BP
1	7	1.51342106957	-	3.02e-01	GO:0006264	mitochondrial DNA replication	BP
1	7	1.51342106957	-	3.02e-01	GO:0030916	otic vesicle formation	BP
1	7	1.51342106957	-	3.02e-01	GO:0014808	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	BP
1	7	1.51342106957	-	3.02e-01	GO:2001171	positive regulation of ATP biosynthetic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0042035	regulation of cytokine biosynthetic process	BP
1	7	1.51342106957	-	3.02e-01	GO:2000394	positive regulation of lamellipodium morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0015813	L-glutamate transport	BP
1	7	1.51342106957	-	3.02e-01	GO:0071474	cellular hyperosmotic response	BP
1	7	1.51342106957	-	3.02e-01	GO:0033601	positive regulation of mammary gland epithelial cell proliferation	BP
1	7	1.51342106957	-	3.02e-01	GO:0035520	monoubiquitinated protein deubiquitination	BP
1	7	1.51342106957	-	3.02e-01	GO:0042178	xenobiotic catabolic process	BP
1	7	1.51342106957	-	3.02e-01	GO:0035194	posttranscriptional gene silencing by RNA	BP
1	7	1.51342106957	-	3.02e-01	GO:0032057	negative regulation of translational initiation in response to stress	BP
1	7	1.51342106957	-	3.02e-01	GO:0060575	intestinal epithelial cell differentiation	BP
1	7	1.51342106957	-	3.02e-01	GO:0010669	epithelial structure maintenance	BP
1	7	1.51342106957	-	3.02e-01	GO:2000347	positive regulation of hepatocyte proliferation	BP
1	7	1.51342106957	-	3.02e-01	GO:0048702	embryonic neurocranium morphogenesis	BP
1	7	1.51342106957	-	3.02e-01	GO:0010918	positive regulation of mitochondrial membrane potential	BP
1	7	1.51342106957	-	3.02e-01	GO:0032873	negative regulation of stress-activated MAPK cascade	BP
1	7	1.51342106957	-	3.02e-01	GO:0070417	cellular response to cold	BP
1	7	1.51342106957	-	3.02e-01	GO:0050764	regulation of phagocytosis	BP
3	21	1.51342106957	-	4.29e-02	GO:0031210	phosphatidylcholine binding	MF
2	14	1.51342106957	-	7.13e-02	GO:0070403	NAD+ binding	MF
3	21	1.51342106957	-	7.55e-02	GO:0000175	3'-5'-exoribonuclease activity	MF
3	21	1.51342106957	-	8.49e-02	GO:0050750	low-density lipoprotein particle receptor binding	MF
1	7	1.51342106957	-	9.76e-02	GO:0004875	complement receptor activity	MF
1	7	1.51342106957	-	1.43e-01	GO:0015645	fatty acid ligase activity	MF
1	7	1.51342106957	-	1.43e-01	GO:0004321	fatty-acyl-CoA synthase activity	MF
2	14	1.51342106957	-	1.53e-01	GO:1990381	ubiquitin-specific protease binding	MF
2	14	1.51342106957	-	1.53e-01	GO:0005041	low-density lipoprotein receptor activity	MF
2	14	1.51342106957	-	1.53e-01	GO:0005528	FK506 binding	MF
1	7	1.51342106957	-	2.65e-01	GO:0010485	H4 histone acetyltransferase activity	MF
1	7	1.51342106957	-	2.65e-01	GO:0046870	cadmium ion binding	MF
1	7	1.51342106957	-	2.65e-01	GO:0001848	complement binding	MF
1	7	1.51342106957	-	2.65e-01	GO:1901981	phosphatidylinositol phosphate binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0043140	ATP-dependent 3'-5' DNA helicase activity	MF
1	7	1.51342106957	-	3.02e-01	GO:0004970	ionotropic glutamate receptor activity	MF
1	7	1.51342106957	-	3.02e-01	GO:0034618	arginine binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0032050	clathrin heavy chain binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0051880	G-quadruplex DNA binding	MF
1	7	1.51342106957	-	3.02e-01	GO:0019784	NEDD8-specific protease activity	MF
17	120	1.50134823727	-	3.52e-05	GO:0071222	cellular response to lipopolysaccharide	BP
10	71	1.49295696701	-	1.20e-03	GO:0060333	interferon-gamma-mediated signaling pathway	BP
16	114	1.48788597747	-	3.43e-05	GO:0071356	cellular response to tumor necrosis factor	BP
8	57	1.48788597747	-	2.41e-03	GO:0045669	positive regulation of osteoblast differentiation	BP
7	50	1.48427472391	-	7.43e-03	GO:0071407	cellular response to organic cyclic compound	BP
18	129	1.47947373765	-	9.19e-07	GO:0009653	anatomical structure morphogenesis	BP
6	43	1.47947373765	-	6.22e-03	GO:0015485	cholesterol binding	MF
11	79	1.47642686209	-	5.84e-04	GO:0007005	mitochondrion organization	BP
10	72	1.47277908508	-	2.41e-03	GO:0032436	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
5	36	1.47277908508	-	1.56e-02	GO:0001568	blood vessel development	BP
5	36	1.47277908508	-	2.58e-02	GO:0007223	Wnt signaling pathway, calcium modulating pathway	BP
5	36	1.47277908508	-	2.58e-02	GO:0001837	epithelial to mesenchymal transition	BP
9	65	1.46833318005	-	1.71e-03	GO:0031647	regulation of protein stability	BP
13	94	1.4666268581	-	2.91e-04	GO:0008584	male gonad development	BP
4	29	1.4627949965	-	2.97e-02	GO:0050873	brown fat cell differentiation	BP
4	29	1.4627949965	-	4.37e-02	GO:0045765	regulation of angiogenesis	BP
6	44	1.44630687372	-	1.22e-02	GO:0071363	cellular response to growth factor stimulus	BP
3	22	1.44630687372	-	3.62e-02	GO:0017158	regulation of calcium ion-dependent exocytosis	BP
3	22	1.44630687372	-	7.55e-02	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP
3	22	1.44630687372	-	7.55e-02	GO:1904886	beta-catenin destruction complex disassembly	BP
3	22	1.44630687372	-	9.48e-02	GO:0006306	DNA methylation	BP
50	368	1.44107022535	-	5.08e-11	GO:0003682	chromatin binding	MF
11	81	1.44035760738	-	5.84e-04	GO:0060070	canonical Wnt signaling pathway	BP
56	413	1.43813294227	-	1.16e-10	GO:0006357	regulation of transcription from RNA polymerase II promoter	BP
10	74	1.43325072089	-	2.98e-03	GO:0061418	regulation of transcription from RNA polymerase II promoter in response to hypoxia	BP
5	37	1.43325072089	-	9.98e-03	GO:0008202	steroid metabolic process	BP
5	37	1.43325072089	-	1.35e-02	GO:0001942	hair follicle development	BP
5	37	1.43325072089	-	3.23e-02	GO:2001237	negative regulation of extrinsic apoptotic signaling pathway	BP
12	89	1.43000506139	-	9.23e-04	GO:0034599	cellular response to oxidative stress	BP
14	104	1.42769119555	-	5.97e-04	GO:0047485	protein N-terminus binding	MF
4	30	1.41388539602	-	3.40e-02	GO:0031667	response to nutrient levels	BP
4	30	1.41388539602	-	3.40e-02	GO:0048167	regulation of synaptic plasticity	BP
4	30	1.41388539602	-	3.40e-02	GO:0002027	regulation of heart rate	BP
4	30	1.41388539602	-	6.07e-02	GO:0070059	intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	BP
4	30	1.41388539602	-	6.07e-02	GO:0009314	response to radiation	BP
2	15	1.41388539602	-	7.13e-02	GO:0010831	positive regulation of myotube differentiation	BP
2	15	1.41388539602	-	8.62e-02	GO:0051604	protein maturation	BP
2	15	1.41388539602	-	1.18e-01	GO:0010759	positive regulation of macrophage chemotaxis	BP
2	15	1.41388539602	-	1.18e-01	GO:0048665	neuron fate specification	BP
2	15	1.41388539602	-	1.18e-01	GO:0034968	histone lysine methylation	BP
2	15	1.41388539602	-	1.36e-01	GO:0002042	cell migration involved in sprouting angiogenesis	BP
2	15	1.41388539602	-	1.36e-01	GO:0032793	positive regulation of CREB transcription factor activity	BP
2	15	1.41388539602	-	1.53e-01	GO:0006622	protein targeting to lysosome	BP
2	15	1.41388539602	-	1.53e-01	GO:0080182	histone H3-K4 trimethylation	BP
2	15	1.41388539602	-	1.53e-01	GO:0033146	regulation of intracellular estrogen receptor signaling pathway	BP
2	15	1.41388539602	-	1.53e-01	GO:0014898	cardiac muscle hypertrophy in response to stress	BP
2	15	1.41388539602	-	1.53e-01	GO:0032469	endoplasmic reticulum calcium ion homeostasis	BP
2	15	1.41388539602	-	1.53e-01	GO:0043277	apoptotic cell clearance	BP
2	15	1.41388539602	-	1.53e-01	GO:0051044	positive regulation of membrane protein ectodomain proteolysis	BP
2	15	1.41388539602	-	1.53e-01	GO:0000729	DNA double-strand break processing	BP
2	15	1.41388539602	-	1.53e-01	GO:0035458	cellular response to interferon-beta	BP
2	15	1.41388539602	-	1.71e-01	GO:0030949	positive regulation of vascular endothelial growth factor receptor signaling pathway	BP
2	15	1.41388539602	-	1.71e-01	GO:0031929	TOR signaling	BP
2	15	1.41388539602	-	1.71e-01	GO:1902230	negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	BP
2	15	1.41388539602	-	3.28e-02	GO:0008188	neuropeptide receptor activity	MF
2	15	1.41388539602	-	1.36e-01	GO:0005504	fatty acid binding	MF
2	15	1.41388539602	-	1.53e-01	GO:0004702	signal transducer, downstream of receptor, with serine/threonine kinase activity	MF
2	15	1.41388539602	-	1.71e-01	GO:0034185	apolipoprotein binding	MF
2	15	1.41388539602	-	1.71e-01	GO:0070742	C2H2 zinc finger domain binding	MF
6	45	1.41388539602	-	1.22e-02	GO:0034605	cellular response to heat	BP
6	45	1.41388539602	-	2.14e-02	GO:0031492	nucleosomal DNA binding	MF
15	113	1.40748762483	-	7.92e-05	GO:0007219	Notch signaling pathway	BP
9	68	1.40323815182	-	2.79e-03	GO:0009749	response to glucose	BP
12	91	1.39794385215	-	9.23e-04	GO:0007179	transforming growth factor beta receptor signaling pathway	BP
5	38	1.39477657308	-	2.89e-02	GO:0010634	positive regulation of epithelial cell migration	BP
13	99	1.39185908969	-	5.14e-04	GO:0051726	regulation of cell cycle	BP
8	61	1.39003865407	-	8.75e-03	GO:0007249	I-kappaB kinase/NF-kappaB signaling	BP
6	46	1.3821765363	-	2.14e-02	GO:0031100	animal organ regeneration	BP
3	23	1.3821765363	-	8.49e-02	GO:0048870	cell motility	BP
3	23	1.3821765363	-	8.49e-02	GO:0071345	cellular response to cytokine stimulus	BP
3	23	1.3821765363	-	9.48e-02	GO:0005978	glycogen biosynthetic process	BP
3	23	1.3821765363	-	1.05e-01	GO:0043044	ATP-dependent chromatin remodeling	BP
3	23	1.3821765363	-	1.05e-01	GO:0000715	nucleotide-excision repair, DNA damage recognition	BP
3	23	1.3821765363	-	8.35e-03	GO:0070330	aromatase activity	MF
11	85	1.37081667413	-	1.66e-03	GO:0019900	kinase binding	MF
4	31	1.36657968124	-	6.71e-02	GO:0031663	lipopolysaccharide-mediated signaling pathway	BP
23	179	1.36052217042	-	2.30e-05	GO:0008022	protein C-terminus binding	MF
5	39	1.35730186766	-	1.78e-02	GO:0030326	embryonic limb morphogenesis	BP
7	55	1.34677120016	-	6.58e-03	GO:0000902	cell morphogenesis	BP
15	118	1.34502353788	-	7.92e-05	GO:0045766	positive regulation of angiogenesis	BP
8	63	1.34349606813	-	7.90e-03	GO:0051384	response to glucocorticoid	BP
32	252	1.34349606813	-	7.41e-07	GO:0019904	protein domain specific binding	MF
10	79	1.33892333834	-	2.98e-03	GO:0051117	ATPase binding	MF
9	72	1.32077599163	-	4.84e-03	GO:0071347	cellular response to interleukin-1	BP
8	64	1.32077599163	-	5.72e-03	GO:0032868	response to insulin	BP
8	64	1.32077599163	-	7.90e-03	GO:0035019	somatic stem cell population maintenance	BP
5	40	1.32077599163	-	3.23e-02	GO:0043434	response to peptide hormone	BP
5	40	1.32077599163	-	3.58e-02	GO:0032024	positive regulation of insulin secretion	BP
4	32	1.32077599163	-	3.87e-02	GO:0071773	cellular response to BMP stimulus	BP
5	40	1.32077599163	-	3.96e-02	GO:0071364	cellular response to epidermal growth factor stimulus	BP
3	24	1.32077599163	-	4.29e-02	GO:0019369	arachidonic acid metabolic process	BP
4	32	1.32077599163	-	5.47e-02	GO:0071479	cellular response to ionizing radiation	BP
3	24	1.32077599163	-	6.65e-02	GO:0051899	membrane depolarization	BP
3	24	1.32077599163	-	6.65e-02	GO:0048589	developmental growth	BP
4	32	1.32077599163	-	6.71e-02	GO:0042594	response to starvation	BP
3	24	1.32077599163	-	7.55e-02	GO:0031334	positive regulation of protein complex assembly	BP
3	24	1.32077599163	-	9.48e-02	GO:0042327	positive regulation of phosphorylation	BP
2	16	1.32077599163	-	1.02e-01	GO:0086002	cardiac muscle cell action potential involved in contraction	BP
2	16	1.32077599163	-	1.18e-01	GO:0043409	negative regulation of MAPK cascade	BP
2	16	1.32077599163	-	1.53e-01	GO:0055117	regulation of cardiac muscle contraction	BP
2	16	1.32077599163	-	1.53e-01	GO:0001709	cell fate determination	BP
2	16	1.32077599163	-	1.53e-01	GO:0003222	ventricular trabecula myocardium morphogenesis	BP
2	16	1.32077599163	-	1.53e-01	GO:0030502	negative regulation of bone mineralization	BP
2	16	1.32077599163	-	1.53e-01	GO:0060292	long term synaptic depression	BP
2	16	1.32077599163	-	1.71e-01	GO:2000811	negative regulation of anoikis	BP
2	16	1.32077599163	-	1.71e-01	GO:0010259	multicellular organism aging	BP
2	16	1.32077599163	-	1.71e-01	GO:0043968	histone H2A acetylation	BP
2	16	1.32077599163	-	1.71e-01	GO:0007026	negative regulation of microtubule depolymerization	BP
1	8	1.32077599163	-	1.86e-01	GO:0015871	choline transport	BP
1	8	1.32077599163	-	1.86e-01	GO:2000781	positive regulation of double-strand break repair	BP
1	8	1.32077599163	-	1.86e-01	GO:0006690	icosanoid metabolic process	BP
2	16	1.32077599163	-	1.89e-01	GO:0046328	regulation of JNK cascade	BP
2	16	1.32077599163	-	1.89e-01	GO:0030889	negative regulation of B cell proliferation	BP
1	8	1.32077599163	-	2.26e-01	GO:0031666	positive regulation of lipopolysaccharide-mediated signaling pathway	BP
1	8	1.32077599163	-	2.26e-01	GO:0035865	cellular response to potassium ion	BP
1	8	1.32077599163	-	2.26e-01	GO:0006108	malate metabolic process	BP
1	8	1.32077599163	-	2.26e-01	GO:0044255	cellular lipid metabolic process	BP
1	8	1.32077599163	-	2.26e-01	GO:0046512	sphingosine biosynthetic process	BP
1	8	1.32077599163	-	2.26e-01	GO:0003085	negative regulation of systemic arterial blood pressure	BP
1	8	1.32077599163	-	2.65e-01	GO:0043031	negative regulation of macrophage activation	BP
1	8	1.32077599163	-	2.65e-01	GO:0009743	response to carbohydrate	BP
1	8	1.32077599163	-	2.65e-01	GO:0035137	hindlimb morphogenesis	BP
1	8	1.32077599163	-	2.65e-01	GO:0060137	maternal process involved in parturition	BP
1	8	1.32077599163	-	2.65e-01	GO:0060339	negative regulation of type I interferon-mediated signaling pathway	BP
1	8	1.32077599163	-	2.65e-01	GO:0042698	ovulation cycle	BP
1	8	1.32077599163	-	2.65e-01	GO:0007494	midgut development	BP
1	8	1.32077599163	-	2.65e-01	GO:0002827	positive regulation of T-helper 1 type immune response	BP
1	8	1.32077599163	-	2.65e-01	GO:0090140	regulation of mitochondrial fission	BP
1	8	1.32077599163	-	2.65e-01	GO:0048339	paraxial mesoderm development	BP
1	8	1.32077599163	-	2.65e-01	GO:0010898	positive regulation of triglyceride catabolic process	BP
1	8	1.32077599163	-	3.02e-01	GO:0035265	organ growth	BP
1	8	1.32077599163	-	3.02e-01	GO:0098909	regulation of cardiac muscle cell action potential involved in regulation of contraction	BP
1	8	1.32077599163	-	3.02e-01	GO:0040019	positive regulation of embryonic development	BP
1	8	1.32077599163	-	3.02e-01	GO:0033629	negative regulation of cell adhesion mediated by integrin	BP
1	8	1.32077599163	-	3.02e-01	GO:0045410	positive regulation of interleukin-6 biosynthetic process	BP
1	8	1.32077599163	-	3.02e-01	GO:0045416	positive regulation of interleukin-8 biosynthetic process	BP
1	8	1.32077599163	-	3.02e-01	GO:0006356	regulation of transcription from RNA polymerase I promoter	BP
1	8	1.32077599163	-	3.02e-01	GO:0034393	positive regulation of smooth muscle cell apoptotic process	BP
1	8	1.32077599163	-	3.02e-01	GO:0048312	intracellular distribution of mitochondria	BP
1	8	1.32077599163	-	3.02e-01	GO:0033993	response to lipid	BP
1	8	1.32077599163	-	3.02e-01	GO:0005979	regulation of glycogen biosynthetic process	BP
1	8	1.32077599163	-	3.02e-01	GO:1901380	negative regulation of potassium ion transmembrane transport	BP
1	8	1.32077599163	-	3.02e-01	GO:0050702	interleukin-1 beta secretion	BP
1	8	1.32077599163	-	3.02e-01	GO:0045059	positive thymic T cell selection	BP
1	8	1.32077599163	-	3.02e-01	GO:0009651	response to salt stress	BP
1	8	1.32077599163	-	3.02e-01	GO:0006729	tetrahydrobiopterin biosynthetic process	BP
1	8	1.32077599163	-	3.02e-01	GO:0000076	DNA replication checkpoint	BP
1	8	1.32077599163	-	3.02e-01	GO:0016264	gap junction assembly	BP
1	8	1.32077599163	-	3.02e-01	GO:0015889	cobalamin transport	BP
1	8	1.32077599163	-	3.02e-01	GO:1901409	positive regulation of phosphorylation of RNA polymerase II C-terminal domain	BP
1	8	1.32077599163	-	3.02e-01	GO:0016188	synaptic vesicle maturation	BP
1	8	1.32077599163	-	3.02e-01	GO:0060155	platelet dense granule organization	BP
1	8	1.32077599163	-	3.02e-01	GO:0051963	regulation of synapse assembly	BP
1	8	1.32077599163	-	3.02e-01	GO:0060059	embryonic retina morphogenesis in camera-type eye	BP
1	8	1.32077599163	-	3.02e-01	GO:0071394	cellular response to testosterone stimulus	BP
1	8	1.32077599163	-	3.02e-01	GO:0016584	nucleosome positioning	BP
1	8	1.32077599163	-	3.02e-01	GO:0035912	dorsal aorta morphogenesis	BP
1	8	1.32077599163	-	3.37e-01	GO:0060100	positive regulation of phagocytosis, engulfment	BP
1	8	1.32077599163	-	3.37e-01	GO:0070723	response to cholesterol	BP
1	8	1.32077599163	-	3.37e-01	GO:0018026	peptidyl-lysine monomethylation	BP
1	8	1.32077599163	-	3.37e-01	GO:0007097	nuclear migration	BP
1	8	1.32077599163	-	3.37e-01	GO:0006012	galactose metabolic process	BP
1	8	1.32077599163	-	3.37e-01	GO:0010882	regulation of cardiac muscle contraction by calcium ion signaling	BP
1	8	1.32077599163	-	3.37e-01	GO:0072577	endothelial cell apoptotic process	BP
1	8	1.32077599163	-	3.37e-01	GO:0010224	response to UV-B	BP
1	8	1.32077599163	-	3.37e-01	GO:0075713	establishment of integrated proviral latency	BP
1	8	1.32077599163	-	3.37e-01	GO:0001955	blood vessel maturation	BP
1	8	1.32077599163	-	3.37e-01	GO:0033173	calcineurin-NFAT signaling cascade	BP
1	8	1.32077599163	-	3.37e-01	GO:1901385	regulation of voltage-gated calcium channel activity	BP
1	8	1.32077599163	-	3.37e-01	GO:0006268	DNA unwinding involved in DNA replication	BP
1	8	1.32077599163	-	3.37e-01	GO:0045630	positive regulation of T-helper 2 cell differentiation	BP
1	8	1.32077599163	-	3.37e-01	GO:0060732	positive regulation of inositol phosphate biosynthetic process	BP
1	8	1.32077599163	-	3.37e-01	GO:0006975	DNA damage induced protein phosphorylation	BP
1	8	1.32077599163	-	3.37e-01	GO:0002903	negative regulation of B cell apoptotic process	BP
1	8	1.32077599163	-	3.37e-01	GO:0001960	negative regulation of cytokine-mediated signaling pathway	BP
1	8	1.32077599163	-	3.37e-01	GO:0033129	positive regulation of histone phosphorylation	BP
1	8	1.32077599163	-	3.37e-01	GO:0019934	cGMP-mediated signaling	BP
1	8	1.32077599163	-	3.37e-01	GO:0007289	spermatid nucleus differentiation	BP
1	8	1.32077599163	-	3.37e-01	GO:2000587	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	BP
1	8	1.32077599163	-	3.37e-01	GO:0007172	signal complex assembly	BP
1	8	1.32077599163	-	3.37e-01	GO:0016574	histone ubiquitination	BP
1	8	1.32077599163	-	3.37e-01	GO:0002011	morphogenesis of an epithelial sheet	BP
1	8	1.32077599163	-	3.37e-01	GO:0045830	positive regulation of isotype switching	BP
1	8	1.32077599163	-	3.37e-01	GO:0010467	gene expression	BP
1	8	1.32077599163	-	3.37e-01	GO:0070206	protein trimerization	BP
1	8	1.32077599163	-	3.37e-01	GO:0085020	protein K6-linked ubiquitination	BP
1	8	1.32077599163	-	3.37e-01	GO:0014732	skeletal muscle atrophy	BP
1	8	1.32077599163	-	3.37e-01	GO:1990000	amyloid fibril formation	BP
1	8	1.32077599163	-	3.37e-01	GO:0050691	regulation of defense response to virus by host	BP
1	8	1.32077599163	-	3.37e-01	GO:0072321	chaperone-mediated protein transport	BP
1	8	1.32077599163	-	3.37e-01	GO:0060711	labyrinthine layer development	BP
1	8	1.32077599163	-	3.37e-01	GO:0060712	spongiotrophoblast layer development	BP
1	8	1.32077599163	-	3.37e-01	GO:0071312	cellular response to alkaloid	BP
10	80	1.32077599163	-	2.68e-03	GO:0016301	kinase activity	MF
5	40	1.32077599163	-	4.79e-02	GO:0004407	histone deacetylase activity	MF
2	16	1.32077599163	-	7.13e-02	GO:0005216	ion channel activity	MF
1	8	1.32077599163	-	9.76e-02	GO:0016712	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	MF
3	24	1.32077599163	-	1.16e-01	GO:0030295	protein kinase activator activity	MF
1	8	1.32077599163	-	1.86e-01	GO:0003996	acyl-CoA ligase activity	MF
1	8	1.32077599163	-	1.86e-01	GO:0005243	gap junction channel activity	MF
1	8	1.32077599163	-	1.86e-01	GO:0047760	butyrate-CoA ligase activity	MF
1	8	1.32077599163	-	1.86e-01	GO:0038036	sphingosine-1-phosphate receptor activity	MF
2	16	1.32077599163	-	1.89e-01	GO:0008353	RNA polymerase II carboxy-terminal domain kinase activity	MF
2	16	1.32077599163	-	1.89e-01	GO:0070182	DNA polymerase binding	MF
1	8	1.32077599163	-	2.26e-01	GO:0004126	cytidine deaminase activity	MF
1	8	1.32077599163	-	2.65e-01	GO:0001162	RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding	MF
1	8	1.32077599163	-	3.02e-01	GO:0017110	nucleoside-diphosphatase activity	MF
1	8	1.32077599163	-	3.02e-01	GO:0017151	DEAD/H-box RNA helicase binding	MF
1	8	1.32077599163	-	3.02e-01	GO:0005113	patched binding	MF
1	8	1.32077599163	-	3.02e-01	GO:0102391	decanoate--CoA ligase activity	MF
1	8	1.32077599163	-	3.02e-01	GO:0004415	hyalurononglucosaminidase activity	MF
1	8	1.32077599163	-	3.37e-01	GO:0001094	TFIID-class transcription factor binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0030983	mismatched DNA binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0003857	3-hydroxyacyl-CoA dehydrogenase activity	MF
1	8	1.32077599163	-	3.37e-01	GO:0032036	myosin heavy chain binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0001164	RNA polymerase I CORE element sequence-specific DNA binding	MF
1	8	1.32077599163	-	3.37e-01	GO:0031386	protein tag	MF
1	8	1.32077599163	-	3.37e-01	GO:0001849	complement component C1q binding	MF
8	65	1.2984081786	-	2.76e-03	GO:0030512	negative regulation of transforming growth factor beta receptor signaling pathway	BP
7	57	1.29524089952	-	1.30e-02	GO:0071333	cellular response to glucose stimulus	BP
7	57	1.29524089952	-	1.75e-02	GO:0003684	damaged DNA binding	MF
20	164	1.2851520819	-	5.81e-05	GO:0007568	aging	BP
5	41	1.2851520819	-	2.89e-02	GO:0045071	negative regulation of viral genome replication	BP
5	41	1.2851520819	-	3.96e-02	GO:0097191	extrinsic apoptotic signaling pathway	BP
9	74	1.28124762745	-	7.90e-03	GO:0001843	neural tube closure	BP
4	33	1.27638187227	-	8.08e-02	GO:0043928	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	BP
4	33	1.27638187227	-	2.58e-02	GO:0017080	sodium channel regulator activity	MF
7	58	1.27014991856	-	9.38e-03	GO:0051216	cartilage development	BP
7	58	1.27014991856	-	1.05e-02	GO:0021766	hippocampus development	BP
3	25	1.26188230258	-	6.65e-02	GO:0032689	negative regulation of interferon-gamma production	BP
3	25	1.26188230258	-	7.55e-02	GO:0019433	triglyceride catabolic process	BP
3	25	1.26188230258	-	7.55e-02	GO:0050715	positive regulation of cytokine secretion	BP
3	25	1.26188230258	-	7.55e-02	GO:0015914	phospholipid transport	BP
3	25	1.26188230258	-	1.05e-01	GO:0007569	cell aging	BP
3	25	1.26188230258	-	1.05e-01	GO:0043542	endothelial cell migration	BP
3	25	1.26188230258	-	1.16e-01	GO:0055010	ventricular cardiac muscle tissue morphogenesis	BP
3	25	1.26188230258	-	1.16e-01	GO:0045737	positive regulation of cyclin-dependent protein serine/threonine kinase activity	BP
3	25	1.26188230258	-	1.27e-01	GO:0051149	positive regulation of muscle cell differentiation	BP
3	25	1.26188230258	-	1.27e-01	GO:0000188	inactivation of MAPK activity	BP
3	25	1.26188230258	-	1.27e-01	GO:0045742	positive regulation of epidermal growth factor receptor signaling pathway	BP
3	25	1.26188230258	-	7.55e-02	GO:0019838	growth factor binding	MF
11	92	1.25664565421	-	2.49e-03	GO:0032355	response to estradiol	BP
36	302	1.25229625375	-	7.24e-08	GO:0042493	response to drug	BP
5	42	1.25038666374	-	4.36e-02	GO:0014823	response to activity	BP
5	42	1.25038666374	-	7.13e-03	GO:0019825	oxygen binding	MF
15	126	1.25038666374	-	8.45e-06	GO:0020037	heme binding	MF
4	34	1.23331315038	-	5.47e-02	GO:0045540	regulation of cholesterol biosynthetic process	BP
2	17	1.23331315038	-	7.13e-02	GO:1904706	negative regulation of vascular smooth muscle cell proliferation	BP
4	34	1.23331315038	-	7.38e-02	GO:2001240	negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	BP
4	34	1.23331315038	-	8.81e-02	GO:0000731	DNA synthesis involved in DNA repair	BP
4	34	1.23331315038	-	8.81e-02	GO:0032212	positive regulation of telomere maintenance via telomerase	BP
2	17	1.23331315038	-	1.36e-01	GO:0009948	anterior/posterior axis specification	BP
2	17	1.23331315038	-	1.36e-01	GO:0048514	blood vessel morphogenesis	BP
2	17	1.23331315038	-	1.53e-01	GO:0010975	regulation of neuron projection development	BP
2	17	1.23331315038	-	1.53e-01	GO:1903506	regulation of nucleic acid-templated transcription	BP
2	17	1.23331315038	-	1.53e-01	GO:0050804	modulation of chemical synaptic transmission	BP
2	17	1.23331315038	-	1.53e-01	GO:0021537	telencephalon development	BP
2	17	1.23331315038	-	1.53e-01	GO:0006970	response to osmotic stress	BP
2	17	1.23331315038	-	1.53e-01	GO:0042462	eye photoreceptor cell development	BP
2	17	1.23331315038	-	1.71e-01	GO:0045956	positive regulation of calcium ion-dependent exocytosis	BP
2	17	1.23331315038	-	1.71e-01	GO:0071380	cellular response to prostaglandin E stimulus	BP
2	17	1.23331315038	-	1.71e-01	GO:0034199	activation of protein kinase A activity	BP
2	17	1.23331315038	-	1.89e-01	GO:0032479	regulation of type I interferon production	BP
2	17	1.23331315038	-	1.36e-01	GO:0008301	DNA binding, bending	MF
2	17	1.23331315038	-	1.71e-01	GO:0016597	amino acid binding	MF
2	17	1.23331315038	-	1.89e-01	GO:0034237	protein kinase A regulatory subunit binding	MF
6	51	1.23331315038	-	2.37e-02	GO:0097110	scaffold protein binding	MF
9	77	1.22391445238	-	7.90e-03	GO:0003690	double-stranded DNA binding	MF
7	60	1.22124031808	-	1.44e-02	GO:0050727	regulation of inflammatory response	BP
17	146	1.218414274	-	6.76e-04	GO:0018105	peptidyl-serine phosphorylation	BP
5	43	1.21643933182	-	2.29e-02	GO:0001756	somitogenesis	BP
3	26	1.20529877421	-	7.55e-02	GO:0010719	negative regulation of epithelial to mesenchymal transition	BP
3	26	1.20529877421	-	9.48e-02	GO:0060173	limb development	BP
3	26	1.20529877421	-	1.05e-01	GO:0032715	negative regulation of interleukin-6 production	BP
3	26	1.20529877421	-	1.27e-01	GO:0071480	cellular response to gamma radiation	BP
3	26	1.20529877421	-	1.39e-01	GO:0016239	positive regulation of macroautophagy	BP
20	175	1.19149297469	-	1.21e-04	GO:0001701	in utero embryonic development	BP
16	140	1.19149297469	-	5.43e-04	GO:0007050	cell cycle arrest	BP
4	35	1.19149297469	-	4.37e-02	GO:0035094	response to nicotine	BP
4	35	1.19149297469	-	8.08e-02	GO:0030544	Hsp70 protein binding	MF
4	35	1.19149297469	-	9.57e-02	GO:0001784	phosphotyrosine residue binding	MF
9	79	1.1869202449	-	5.37e-03	GO:0005543	phospholipid binding	MF
14	123	1.18561640835	-	1.06e-03	GO:0002223	stimulatory C-type lectin receptor signaling pathway	BP
5	44	1.18327246788	-	2.89e-02	GO:0006342	chromatin silencing	BP
46	407	1.17545296342	-	1.08e-09	GO:0008285	negative regulation of cell proliferation	BP
7	63	1.15085099019	-	2.29e-02	GO:0032092	positive regulation of protein binding	BP
7	63	1.15085099019	-	2.50e-02	GO:0017148	negative regulation of translation	BP
5	45	1.15085099019	-	3.23e-02	GO:0008015	blood circulation	BP
6	54	1.15085099019	-	3.76e-02	GO:0006325	chromatin organization	BP
5	45	1.15085099019	-	3.96e-02	GO:1903507	negative regulation of nucleic acid-templated transcription	BP
5	45	1.15085099019	-	4.36e-02	GO:0030900	forebrain development	BP
3	27	1.15085099019	-	6.65e-02	GO:0009755	hormone-mediated signaling pathway	BP
4	36	1.15085099019	-	7.38e-02	GO:0000079	regulation of cyclin-dependent protein serine/threonine kinase activity	BP
3	27	1.15085099019	-	7.55e-02	GO:0048791	calcium ion-regulated exocytosis of neurotransmitter	BP
4	36	1.15085099019	-	8.81e-02	GO:0051402	neuron apoptotic process	BP
3	27	1.15085099019	-	9.48e-02	GO:0008033	tRNA processing	BP
4	36	1.15085099019	-	9.57e-02	GO:0006953	acute-phase response	BP
3	27	1.15085099019	-	1.16e-01	GO:2000352	negative regulation of endothelial cell apoptotic process	BP
2	18	1.15085099019	-	1.36e-01	GO:0042157	lipoprotein metabolic process	BP
3	27	1.15085099019	-	1.39e-01	GO:0090314	positive regulation of protein targeting to membrane	BP
2	18	1.15085099019	-	1.53e-01	GO:0030279	negative regulation of ossification	BP
2	18	1.15085099019	-	1.53e-01	GO:0060037	pharyngeal system development	BP
2	18	1.15085099019	-	1.71e-01	GO:0008585	female gonad development	BP
2	18	1.15085099019	-	1.71e-01	GO:0016079	synaptic vesicle exocytosis	BP
1	9	1.15085099019	-	1.86e-01	GO:0090181	regulation of cholesterol metabolic process	BP
2	18	1.15085099019	-	1.89e-01	GO:0017015	regulation of transforming growth factor beta receptor signaling pathway	BP
2	18	1.15085099019	-	2.08e-01	GO:0035024	negative regulation of Rho protein signal transduction	BP
1	9	1.15085099019	-	2.26e-01	GO:0046549	retinal cone cell development	BP
1	9	1.15085099019	-	2.26e-01	GO:0097186	amelogenesis	BP
1	9	1.15085099019	-	2.26e-01	GO:0051205	protein insertion into membrane	BP
1	9	1.15085099019	-	2.26e-01	GO:0043583	ear development	BP
1	9	1.15085099019	-	2.26e-01	GO:0007567	parturition	BP
1	9	1.15085099019	-	2.26e-01	GO:0070286	axonemal dynein complex assembly	BP
2	18	1.15085099019	-	2.27e-01	GO:0035904	aorta development	BP
2	18	1.15085099019	-	2.27e-01	GO:0031333	negative regulation of protein complex assembly	BP
2	18	1.15085099019	-	2.27e-01	GO:1904380	endoplasmic reticulum mannose trimming	BP
2	18	1.15085099019	-	2.27e-01	GO:0010039	response to iron ion	BP
2	18	1.15085099019	-	2.27e-01	GO:0045821	positive regulation of glycolytic process	BP
1	9	1.15085099019	-	2.65e-01	GO:0003073	regulation of systemic arterial blood pressure	BP
1	9	1.15085099019	-	2.65e-01	GO:0060287	epithelial cilium movement involved in determination of left/right asymmetry	BP
1	9	1.15085099019	-	2.65e-01	GO:0060586	multicellular organismal iron ion homeostasis	BP
1	9	1.15085099019	-	2.65e-01	GO:0002315	marginal zone B cell differentiation	BP
1	9	1.15085099019	-	2.65e-01	GO:0046887	positive regulation of hormone secretion	BP
1	9	1.15085099019	-	2.65e-01	GO:0032099	negative regulation of appetite	BP
1	9	1.15085099019	-	2.65e-01	GO:2000304	positive regulation of ceramide biosynthetic process	BP
1	9	1.15085099019	-	2.65e-01	GO:0009972	cytidine deamination	BP
1	9	1.15085099019	-	3.02e-01	GO:2000648	positive regulation of stem cell proliferation	BP
1	9	1.15085099019	-	3.02e-01	GO:0086014	atrial cardiac muscle cell action potential	BP
1	9	1.15085099019	-	3.02e-01	GO:0046548	retinal rod cell development	BP
1	9	1.15085099019	-	3.02e-01	GO:0061549	sympathetic ganglion development	BP
1	9	1.15085099019	-	3.02e-01	GO:0038166	angiotensin-activated signaling pathway	BP
1	9	1.15085099019	-	3.02e-01	GO:0021702	cerebellar Purkinje cell differentiation	BP
1	9	1.15085099019	-	3.02e-01	GO:0007599	hemostasis	BP
1	9	1.15085099019	-	3.02e-01	GO:0072358	cardiovascular system development	BP
1	9	1.15085099019	-	3.02e-01	GO:0045124	regulation of bone resorption	BP
1	9	1.15085099019	-	3.02e-01	GO:0035313	wound healing, spreading of epidermal cells	BP
1	9	1.15085099019	-	3.02e-01	GO:0050713	negative regulation of interleukin-1 beta secretion	BP
1	9	1.15085099019	-	3.02e-01	GO:0060253	negative regulation of glial cell proliferation	BP
1	9	1.15085099019	-	3.02e-01	GO:0035767	endothelial cell chemotaxis	BP
1	9	1.15085099019	-	3.37e-01	GO:1900027	regulation of ruffle assembly	BP
1	9	1.15085099019	-	3.37e-01	GO:0060068	vagina development	BP
1	9	1.15085099019	-	3.37e-01	GO:0032731	positive regulation of interleukin-1 beta production	BP
1	9	1.15085099019	-	3.37e-01	GO:0048193	Golgi vesicle transport	BP
1	9	1.15085099019	-	3.37e-01	GO:0042119	neutrophil activation	BP
1	9	1.15085099019	-	3.37e-01	GO:0036500	ATF6-mediated unfolded protein response	BP
1	9	1.15085099019	-	3.37e-01	GO:0045591	positive regulation of regulatory T cell differentiation	BP
1	9	1.15085099019	-	3.37e-01	GO:0032206	positive regulation of telomere maintenance	BP
1	9	1.15085099019	-	3.37e-01	GO:0060231	mesenchymal to epithelial transition	BP
1	9	1.15085099019	-	3.37e-01	GO:0002544	chronic inflammatory response	BP
1	9	1.15085099019	-	3.37e-01	GO:0000733	DNA strand renaturation	BP
1	9	1.15085099019	-	3.37e-01	GO:0006105	succinate metabolic process	BP
1	9	1.15085099019	-	3.37e-01	GO:0070886	positive regulation of calcineurin-NFAT signaling cascade	BP
1	9	1.15085099019	-	3.37e-01	GO:1990314	cellular response to insulin-like growth factor stimulus	BP
1	9	1.15085099019	-	3.37e-01	GO:0090073	positive regulation of protein homodimerization activity	BP
1	9	1.15085099019	-	3.37e-01	GO:0032886	regulation of microtubule-based process	BP
1	9	1.15085099019	-	3.37e-01	GO:0035562	negative regulation of chromatin binding	BP
1	9	1.15085099019	-	3.37e-01	GO:0042908	xenobiotic transport	BP
1	9	1.15085099019	-	3.37e-01	GO:0042754	negative regulation of circadian rhythm	BP
1	9	1.15085099019	-	3.37e-01	GO:0009410	response to xenobiotic stimulus	BP
1	9	1.15085099019	-	3.37e-01	GO:0072089	stem cell proliferation	BP
1	9	1.15085099019	-	3.37e-01	GO:0042088	T-helper 1 type immune response	BP
1	9	1.15085099019	-	3.37e-01	GO:0050795	regulation of behavior	BP
1	9	1.15085099019	-	3.37e-01	GO:0030299	intestinal cholesterol absorption	BP
1	9	1.15085099019	-	3.37e-01	GO:0070493	thrombin-activated receptor signaling pathway	BP
1	9	1.15085099019	-	3.70e-01	GO:0045657	positive regulation of monocyte differentiation	BP
1	9	1.15085099019	-	3.70e-01	GO:0043030	regulation of macrophage activation	BP
1	9	1.15085099019	-	3.70e-01	GO:1901030	positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	BP
1	9	1.15085099019	-	3.70e-01	GO:0050687	negative regulation of defense response to virus	BP
1	9	1.15085099019	-	3.70e-01	GO:0048489	synaptic vesicle transport	BP
1	9	1.15085099019	-	3.70e-01	GO:0050774	negative regulation of dendrite morphogenesis	BP
1	9	1.15085099019	-	3.70e-01	GO:0010225	response to UV-C	BP
1	9	1.15085099019	-	3.70e-01	GO:0010761	fibroblast migration	BP
1	9	1.15085099019	-	3.70e-01	GO:0006390	transcription from mitochondrial promoter	BP
1	9	1.15085099019	-	3.70e-01	GO:0006903	vesicle targeting	BP
1	9	1.15085099019	-	3.70e-01	GO:0032463	negative regulation of protein homooligomerization	BP
1	9	1.15085099019	-	3.70e-01	GO:0061157	mRNA destabilization	BP
1	9	1.15085099019	-	3.70e-01	GO:2000008	regulation of protein localization to cell surface	BP
1	9	1.15085099019	-	3.70e-01	GO:0010863	positive regulation of phospholipase C activity	BP
1	9	1.15085099019	-	3.70e-01	GO:0008608	attachment of spindle microtubules to kinetochore	BP
1	9	1.15085099019	-	3.70e-01	GO:0033689	negative regulation of osteoblast proliferation	BP
1	9	1.15085099019	-	3.70e-01	GO:0031497	chromatin assembly	BP
1	9	1.15085099019	-	3.70e-01	GO:0034333	adherens junction assembly	BP
1	9	1.15085099019	-	3.70e-01	GO:0006000	fructose metabolic process	BP
1	9	1.15085099019	-	3.70e-01	GO:0043281	regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
3	27	1.15085099019	-	3.62e-02	GO:0019706	protein-cysteine S-palmitoyltransferase activity	MF
2	18	1.15085099019	-	8.62e-02	GO:0016409	palmitoyltransferase activity	MF
3	27	1.15085099019	-	1.16e-01	GO:0001106	RNA polymerase II transcription corepressor activity	MF
2	18	1.15085099019	-	1.18e-01	GO:0016746	transferase activity, transferring acyl groups	MF
2	18	1.15085099019	-	2.08e-01	GO:0070577	lysine-acetylated histone binding	MF
1	9	1.15085099019	-	2.65e-01	GO:0016702	oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen	MF
1	9	1.15085099019	-	3.02e-01	GO:0031404	chloride ion binding	MF
1	9	1.15085099019	-	3.02e-01	GO:0008035	high-density lipoprotein particle binding	MF
1	9	1.15085099019	-	3.02e-01	GO:0031419	cobalamin binding	MF
1	9	1.15085099019	-	3.02e-01	GO:0016709	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen	MF
1	9	1.15085099019	-	3.37e-01	GO:0030291	protein serine/threonine kinase inhibitor activity	MF
1	9	1.15085099019	-	3.37e-01	GO:0070679	inositol 1,4,5 trisphosphate binding	MF
1	9	1.15085099019	-	3.37e-01	GO:0046790	virion binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0016595	glutamate binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0019215	intermediate filament binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0034713	type I transforming growth factor beta receptor binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0001075	transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly	MF
1	9	1.15085099019	-	3.70e-01	GO:0005522	profilin binding	MF
1	9	1.15085099019	-	3.70e-01	GO:0019887	protein kinase regulator activity	MF
1	9	1.15085099019	-	3.70e-01	GO:0004716	signal transducer, downstream of receptor, with protein tyrosine kinase activity	MF
1	9	1.15085099019	-	3.70e-01	GO:0061578	Lys63-specific deubiquitinase activity	MF
8	73	1.13095143275	-	1.17e-02	GO:0008144	drug binding	MF
15	137	1.12963450428	-	4.03e-03	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP
12	110	1.12437877883	-	5.71e-03	GO:0016569	covalent chromatin modification	BP
6	55	1.12437877883	-	2.88e-02	GO:0042733	embryonic digit morphogenesis	BP
6	55	1.12437877883	-	2.88e-02	GO:0001570	vasculogenesis	BP
6	55	1.12437877883	-	4.44e-02	GO:0043621	protein self-association	MF
5	46	1.11914213046	-	5.72e-02	GO:0019902	phosphatase binding	MF
8	74	1.111322626	-	2.50e-02	GO:0043154	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	BP
4	37	1.111322626	-	8.08e-02	GO:0042149	cellular response to glucose starvation	BP
7	65	1.10576310066	-	2.10e-02	GO:0050796	regulation of insulin secretion	BP
19	177	1.10109795499	-	7.65e-05	GO:0051607	defense response to virus	BP
6	56	1.0983835703	-	3.45e-02	GO:0060041	retina development in camera-type eye	BP
3	28	1.0983835703	-	8.49e-02	GO:0060338	regulation of type I interferon-mediated signaling pathway	BP
3	28	1.0983835703	-	1.16e-01	GO:0016358	dendrite development	BP
3	28	1.0983835703	-	1.63e-01	GO:0010332	response to gamma radiation	BP
17	159	1.0953558776	-	2.36e-04	GO:0010629	negative regulation of gene expression	BP
16	150	1.09195730114	-	2.43e-03	GO:0050821	protein stabilization	BP
14	132	1.08373679433	-	2.67e-03	GO:0043524	negative regulation of neuron apoptotic process	BP
42	398	1.07646879387	-	7.41e-07	GO:0019901	protein kinase binding	MF
4	38	1.07284847819	-	2.97e-02	GO:0009409	response to cold	BP
8	76	1.07284847819	-	5.44e-02	GO:1900034	regulation of cellular response to heat	BP
4	38	1.07284847819	-	6.71e-02	GO:0001657	ureteric bud development	BP
2	19	1.07284847819	-	1.02e-01	GO:2000649	regulation of sodium ion transmembrane transporter activity	BP
2	19	1.07284847819	-	1.02e-01	GO:0018345	protein palmitoylation	BP
2	19	1.07284847819	-	1.36e-01	GO:0033280	response to vitamin D	BP
2	19	1.07284847819	-	1.36e-01	GO:0007141	male meiosis I	BP
2	19	1.07284847819	-	1.89e-01	GO:0007263	nitric oxide mediated signal transduction	BP
2	19	1.07284847819	-	2.08e-01	GO:0008589	regulation of smoothened signaling pathway	BP
2	19	1.07284847819	-	2.08e-01	GO:0036120	cellular response to platelet-derived growth factor stimulus	BP
2	19	1.07284847819	-	2.27e-01	GO:0090190	positive regulation of branching involved in ureteric bud morphogenesis	BP
2	19	1.07284847819	-	2.27e-01	GO:0098586	cellular response to virus	BP
2	19	1.07284847819	-	2.27e-01	GO:0046716	muscle cell cellular homeostasis	BP
2	19	1.07284847819	-	2.27e-01	GO:0046597	negative regulation of viral entry into host cell	BP
2	19	1.07284847819	-	2.27e-01	GO:0042311	vasodilation	BP
2	19	1.07284847819	-	2.46e-01	GO:1900182	positive regulation of protein localization to nucleus	BP
2	19	1.07284847819	-	2.46e-01	GO:0006509	membrane protein ectodomain proteolysis	BP
2	19	1.07284847819	-	2.46e-01	GO:0008637	apoptotic mitochondrial changes	BP
2	19	1.07284847819	-	1.53e-01	GO:0043395	heparan sulfate proteoglycan binding	MF
2	19	1.07284847819	-	1.89e-01	GO:0051018	protein kinase A binding	MF
7	67	1.06204172323	-	4.62e-02	GO:0038061	NIK/NF-kappaB signaling	BP
5	48	1.0577415858	-	6.21e-02	GO:0008542	visual learning	BP
8	77	1.05398945094	-	3.11e-02	GO:0071260	cellular response to mechanical stimulus	BP
6	58	1.04775749723	-	6.44e-02	GO:0045732	positive regulation of protein catabolic process	BP
3	29	1.04775749723	-	1.27e-01	GO:2000379	positive regulation of reactive oxygen species metabolic process	BP
3	29	1.04775749723	-	1.39e-01	GO:0010033	response to organic substance	BP
3	29	1.04775749723	-	1.51e-01	GO:1903146	regulation of autophagy of mitochondrion	BP
3	29	1.04775749723	-	1.63e-01	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	BP
3	29	1.04775749723	-	1.63e-01	GO:0004712	protein serine/threonine/tyrosine kinase activity	MF
13	126	1.04393578627	-	8.69e-04	GO:0006629	lipid metabolic process	BP
4	39	1.03537377277	-	1.20e-01	GO:0030155	regulation of cell adhesion	BP
4	39	1.03537377277	-	4.90e-02	GO:0015459	potassium channel regulator activity	MF
5	49	1.0279942424	-	9.05e-02	GO:0042542	response to hydrogen peroxide	BP
30	294	1.0279942424	-	1.28e-05	GO:0010628	positive regulation of gene expression	BP
22	216	1.02532010811	-	2.42e-04	GO:0001525	angiogenesis	BP
15	148	1.01821322161	-	4.20e-03	GO:0050852	T cell receptor signaling pathway	BP
8	79	1.01699524345	-	2.90e-02	GO:0032869	cellular response to insulin stimulus	BP
9	89	1.01496756211	-	2.10e-02	GO:1990830	cellular response to leukemia inhibitory factor	BP
21	208	1.01265369627	-	6.39e-04	GO:0006974	cellular response to DNA damage stimulus	BP
13	129	1.00998845435	-	1.41e-03	GO:0008289	lipid binding	MF
10	100	0.998847896744	-	1.14e-02	GO:0006979	response to oxidative stress	BP
7	70	0.998847896744	-	4.01e-02	GO:0032088	negative regulation of NF-kappaB transcription factor activity	BP
5	50	0.998847896744	-	4.79e-02	GO:0006906	vesicle fusion	BP
5	50	0.998847896744	-	8.44e-02	GO:0019827	stem cell population maintenance	BP
3	30	0.998847896744	-	8.49e-02	GO:0045930	negative regulation of mitotic cell cycle	BP
3	30	0.998847896744	-	1.05e-01	GO:0002088	lens development in camera-type eye	BP
3	30	0.998847896744	-	1.27e-01	GO:0060325	face morphogenesis	BP
3	30	0.998847896744	-	1.51e-01	GO:0007281	germ cell development	BP
3	30	0.998847896744	-	1.63e-01	GO:0042177	negative regulation of protein catabolic process	BP
3	30	0.998847896744	-	1.39e-01	GO:0004693	cyclin-dependent protein serine/threonine kinase activity	MF
8	80	0.998847896744	-	5.57e-02	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP
2	20	0.998847896744	-	1.18e-01	GO:0010460	positive regulation of heart rate	BP
2	20	0.998847896744	-	1.18e-01	GO:0055074	calcium ion homeostasis	BP
2	20	0.998847896744	-	1.18e-01	GO:0043046	DNA methylation involved in gamete generation	BP
2	20	0.998847896744	-	1.53e-01	GO:0001659	temperature homeostasis	BP
1	10	0.998847896744	-	1.86e-01	GO:0030728	ovulation	BP
2	20	0.998847896744	-	2.08e-01	GO:0035584	calcium-mediated signaling using intracellular calcium source	BP
2	20	0.998847896744	-	2.08e-01	GO:0061436	establishment of skin barrier	BP
2	20	0.998847896744	-	2.27e-01	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP
2	20	0.998847896744	-	2.27e-01	GO:0019882	antigen processing and presentation	BP
2	20	0.998847896744	-	2.27e-01	GO:0002230	positive regulation of defense response to virus by host	BP
2	20	0.998847896744	-	2.64e-01	GO:0042326	negative regulation of phosphorylation	BP
2	20	0.998847896744	-	2.64e-01	GO:0008361	regulation of cell size	BP
2	20	0.998847896744	-	2.64e-01	GO:0071526	semaphorin-plexin signaling pathway	BP
1	10	0.998847896744	-	2.65e-01	GO:0007168	receptor guanylyl cyclase signaling pathway	BP
1	10	0.998847896744	-	3.02e-01	GO:0006517	protein deglycosylation	BP
1	10	0.998847896744	-	3.02e-01	GO:0060452	positive regulation of cardiac muscle contraction	BP
1	10	0.998847896744	-	3.02e-01	GO:0048935	peripheral nervous system neuron development	BP
1	10	0.998847896744	-	3.02e-01	GO:0051983	regulation of chromosome segregation	BP
1	10	0.998847896744	-	3.02e-01	GO:0032525	somite rostral/caudal axis specification	BP
1	10	0.998847896744	-	3.02e-01	GO:0042359	vitamin D metabolic process	BP
1	10	0.998847896744	-	3.37e-01	GO:0048096	chromatin-mediated maintenance of transcription	BP
1	10	0.998847896744	-	3.37e-01	GO:0031665	negative regulation of lipopolysaccharide-mediated signaling pathway	BP
1	10	0.998847896744	-	3.37e-01	GO:0060411	cardiac septum morphogenesis	BP
1	10	0.998847896744	-	3.37e-01	GO:2000480	negative regulation of cAMP-dependent protein kinase activity	BP
1	10	0.998847896744	-	3.37e-01	GO:0050966	detection of mechanical stimulus involved in sensory perception of pain	BP
1	10	0.998847896744	-	3.37e-01	GO:0007216	G-protein coupled glutamate receptor signaling pathway	BP
1	10	0.998847896744	-	3.37e-01	GO:0031638	zymogen activation	BP
1	10	0.998847896744	-	3.37e-01	GO:0071168	protein localization to chromatin	BP
1	10	0.998847896744	-	3.37e-01	GO:0031953	negative regulation of protein autophosphorylation	BP
1	10	0.998847896744	-	3.37e-01	GO:0002237	response to molecule of bacterial origin	BP
1	10	0.998847896744	-	3.37e-01	GO:0016322	neuron remodeling	BP
1	10	0.998847896744	-	3.70e-01	GO:0006497	protein lipidation	BP
1	10	0.998847896744	-	3.70e-01	GO:0090197	positive regulation of chemokine secretion	BP
1	10	0.998847896744	-	3.70e-01	GO:0010226	response to lithium ion	BP
1	10	0.998847896744	-	3.70e-01	GO:0042532	negative regulation of tyrosine phosphorylation of STAT protein	BP
1	10	0.998847896744	-	3.70e-01	GO:0000290	deadenylation-dependent decapping of nuclear-transcribed mRNA	BP
1	10	0.998847896744	-	3.70e-01	GO:0003181	atrioventricular valve morphogenesis	BP
1	10	0.998847896744	-	3.70e-01	GO:0090084	negative regulation of inclusion body assembly	BP
1	10	0.998847896744	-	3.70e-01	GO:0010470	regulation of gastrulation	BP
1	10	0.998847896744	-	3.70e-01	GO:0002218	activation of innate immune response	BP
1	10	0.998847896744	-	3.70e-01	GO:0048711	positive regulation of astrocyte differentiation	BP
1	10	0.998847896744	-	3.70e-01	GO:0010739	positive regulation of protein kinase A signaling	BP
1	10	0.998847896744	-	3.70e-01	GO:0010820	positive regulation of T cell chemotaxis	BP
1	10	0.998847896744	-	3.70e-01	GO:0010469	regulation of receptor activity	BP
1	10	0.998847896744	-	3.70e-01	GO:0045475	locomotor rhythm	BP
1	10	0.998847896744	-	3.70e-01	GO:0060484	lung-associated mesenchyme development	BP
1	10	0.998847896744	-	3.70e-01	GO:0032940	secretion by cell	BP
1	10	0.998847896744	-	4.02e-01	GO:0034063	stress granule assembly	BP
1	10	0.998847896744	-	4.02e-01	GO:0031115	negative regulation of microtubule polymerization	BP
1	10	0.998847896744	-	4.02e-01	GO:0034145	positive regulation of toll-like receptor 4 signaling pathway	BP
1	10	0.998847896744	-	4.02e-01	GO:0031571	mitotic G1 DNA damage checkpoint	BP
1	10	0.998847896744	-	4.02e-01	GO:0060546	negative regulation of necroptotic process	BP
1	10	0.998847896744	-	4.02e-01	GO:0043114	regulation of vascular permeability	BP
1	10	0.998847896744	-	4.02e-01	GO:0044320	cellular response to leptin stimulus	BP
1	10	0.998847896744	-	4.02e-01	GO:0032802	low-density lipoprotein particle receptor catabolic process	BP
1	10	0.998847896744	-	4.02e-01	GO:0007178	transmembrane receptor protein serine/threonine kinase signaling pathway	BP
1	10	0.998847896744	-	4.02e-01	GO:0016572	histone phosphorylation	BP
1	10	0.998847896744	-	4.02e-01	GO:0060009	Sertoli cell development	BP
1	10	0.998847896744	-	4.02e-01	GO:0042053	regulation of dopamine metabolic process	BP
1	10	0.998847896744	-	4.02e-01	GO:0060252	positive regulation of glial cell proliferation	BP
1	10	0.998847896744	-	4.02e-01	GO:2000637	positive regulation of gene silencing by miRNA	BP
1	10	0.998847896744	-	4.02e-01	GO:2001020	regulation of response to DNA damage stimulus	BP
1	10	0.998847896744	-	4.02e-01	GO:2000772	regulation of cellular senescence	BP
1	10	0.998847896744	-	4.02e-01	GO:0035067	negative regulation of histone acetylation	BP
1	10	0.998847896744	-	4.02e-01	GO:0006081	cellular aldehyde metabolic process	BP
8	80	0.998847896744	-	2.90e-02	GO:0030674	protein binding, bridging	MF
2	20	0.998847896744	-	1.89e-01	GO:0004601	peroxidase activity	MF
1	10	0.998847896744	-	2.26e-01	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	MF
2	20	0.998847896744	-	2.46e-01	GO:0030159	receptor signaling complex scaffold activity	MF
1	10	0.998847896744	-	2.65e-01	GO:0017128	phospholipid scramblase activity	MF
1	10	0.998847896744	-	2.65e-01	GO:0030215	semaphorin receptor binding	MF
1	10	0.998847896744	-	2.65e-01	GO:0038191	neuropilin binding	MF
1	10	0.998847896744	-	3.37e-01	GO:0017111	nucleoside-triphosphatase activity	MF
1	10	0.998847896744	-	3.37e-01	GO:0047372	acylglycerol lipase activity	MF
1	10	0.998847896744	-	3.70e-01	GO:1990380	Lys48-specific deubiquitinase activity	MF
1	10	0.998847896744	-	3.70e-01	GO:0043142	single-stranded DNA-dependent ATPase activity	MF
1	10	0.998847896744	-	3.70e-01	GO:0051428	peptide hormone receptor binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0048156	tau protein binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0045294	alpha-catenin binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0045295	gamma-catenin binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0030957	Tat protein binding	MF
1	10	0.998847896744	-	4.02e-01	GO:0034452	dynactin binding	MF
49	492	0.992971330408	-	4.75e-08	GO:0046982	protein heterodimerization activity	MF
32	322	0.989859113517	-	1.08e-04	GO:0016032	viral process	BP
17	172	0.98197407818	-	1.65e-03	GO:0042127	regulation of cell proliferation	BP
7	71	0.978383794185	-	2.72e-02	GO:0009791	post-embryonic development	BP
46	467	0.977059207979	-	3.72e-07	GO:0043066	negative regulation of apoptotic process	BP
5	51	0.970278744548	-	4.79e-02	GO:0048666	neuron development	BP
5	51	0.970278744548	-	5.72e-02	GO:0008344	adult locomotory behavior	BP
5	51	0.970278744548	-	7.28e-02	GO:0048146	positive regulation of fibroblast proliferation	BP
13	133	0.965933274272	-	2.34e-02	GO:1901796	regulation of signal transduction by p53 class mediator	BP
79	809	0.964560847379	-	2.49e-10	GO:0008270	zinc ion binding	MF
8	82	0.963223987014	-	2.50e-02	GO:0035264	multicellular organism growth	BP
4	41	0.963223987014	-	9.57e-02	GO:0043010	camera-type eye development	BP
4	41	0.963223987014	-	1.38e-01	GO:0010508	positive regulation of autophagy	BP
10	103	0.956203559336	-	6.99e-03	GO:0010468	regulation of gene expression	BP
3	31	0.951542181966	-	1.39e-01	GO:0048286	lung alveolus development	BP
3	31	0.951542181966	-	1.63e-01	GO:0030217	T cell differentiation	BP
3	31	0.951542181966	-	2.01e-01	GO:0097421	liver regeneration	BP
3	31	0.951542181966	-	1.88e-01	GO:0042169	SH2 domain binding	MF
8	83	0.945736560285	-	1.98e-02	GO:0009887	animal organ morphogenesis	BP
7	73	0.938306354809	-	9.25e-02	GO:0006283	transcription-coupled nucleotide-excision repair	BP
18	188	0.936112141397	-	4.62e-03	GO:0004672	protein kinase activity	MF
2	21	0.928458568853	-	1.36e-01	GO:0007369	gastrulation	BP
2	21	0.928458568853	-	1.36e-01	GO:0032094	response to food	BP
2	21	0.928458568853	-	2.08e-01	GO:0030162	regulation of proteolysis	BP
2	21	0.928458568853	-	2.27e-01	GO:0051493	regulation of cytoskeleton organization	BP
2	21	0.928458568853	-	2.46e-01	GO:0042346	positive regulation of NF-kappaB import into nucleus	BP
2	21	0.928458568853	-	2.46e-01	GO:0043113	receptor clustering	BP
2	21	0.928458568853	-	2.64e-01	GO:0071901	negative regulation of protein serine/threonine kinase activity	BP
2	21	0.928458568853	-	2.83e-01	GO:0001836	release of cytochrome c from mitochondria	BP
2	21	0.928458568853	-	1.89e-01	GO:0005112	Notch binding	MF
2	21	0.928458568853	-	2.27e-01	GO:0043539	protein serine/threonine kinase activator activity	MF
2	21	0.928458568853	-	2.83e-01	GO:0048027	mRNA 5'-UTR binding	MF
2	21	0.928458568853	-	2.83e-01	GO:0051019	mitogen-activated protein kinase binding	MF
6	63	0.928458568853	-	4.44e-02	GO:0007613	memory	BP
13	138	0.912691252995	-	9.86e-03	GO:0001934	positive regulation of protein phosphorylation	BP
15	160	0.905738492353	-	4.84e-03	GO:0032496	response to lipopolysaccharide	BP
6	64	0.905738492353	-	5.58e-02	GO:0008217	regulation of blood pressure	BP
6	64	0.905738492353	-	7.36e-02	GO:0035690	cellular response to drug	BP
3	32	0.905738492353	-	1.51e-01	GO:0048147	negative regulation of fibroblast proliferation	BP
3	32	0.905738492353	-	1.51e-01	GO:0032007	negative regulation of TOR signaling	BP
3	32	0.905738492353	-	1.75e-01	GO:0007585	respiratory gaseous exchange	BP
3	32	0.905738492353	-	1.88e-01	GO:0001974	blood vessel remodeling	BP
3	32	0.905738492353	-	2.01e-01	GO:0071549	cellular response to dexamethasone stimulus	BP
3	32	0.905738492353	-	2.14e-01	GO:0070911	global genome nucleotide-excision repair	BP
138	1479	0.898894111311	-	1.65e-10	GO:0003677	DNA binding	MF
4	43	0.89451123693	-	7.38e-02	GO:0045165	cell fate commitment	BP
4	43	0.89451123693	-	8.08e-02	GO:0050885	neuromuscular process controlling balance	BP
5	54	0.887816584356	-	7.85e-02	GO:0045665	negative regulation of neuron differentiation	BP
5	54	0.887816584356	-	7.85e-02	GO:0019233	sensory perception of pain	BP
5	54	0.887816584356	-	9.69e-02	GO:0031072	heat shock protein binding	MF
6	65	0.883370679325	-	4.80e-02	GO:0030183	B cell differentiation	BP
27	295	0.871092349546	-	1.53e-03	GO:0031625	ubiquitin protein ligase binding	MF
15	164	0.870114582622	-	5.93e-03	GO:0007507	heart development	BP
7	77	0.861344372995	-	2.10e-02	GO:0045666	positive regulation of neuron differentiation	BP
9	99	0.861344372995	-	2.10e-02	GO:0030182	neuron differentiation	BP
7	77	0.861344372995	-	4.01e-02	GO:0043085	positive regulation of catalytic activity	BP
4	44	0.861344372995	-	7.38e-02	GO:0061337	cardiac conduction	BP
3	33	0.861344372995	-	9.48e-02	GO:0006656	phosphatidylcholine biosynthetic process	BP
5	55	0.861344372995	-	1.10e-01	GO:0006417	regulation of translation	BP
1	11	0.861344372995	-	1.43e-01	GO:0060285	cilium-dependent cell motility	BP
3	33	0.861344372995	-	1.63e-01	GO:0003007	heart morphogenesis	BP
2	22	0.861344372995	-	1.71e-01	GO:0045333	cellular respiration	BP
1	11	0.861344372995	-	1.86e-01	GO:0006071	glycerol metabolic process	BP
2	22	0.861344372995	-	1.89e-01	GO:0019915	lipid storage	BP
1	11	0.861344372995	-	2.26e-01	GO:0006590	thyroid hormone generation	BP
1	11	0.861344372995	-	2.26e-01	GO:0010529	negative regulation of transposition	BP
2	22	0.861344372995	-	2.27e-01	GO:0048488	synaptic vesicle endocytosis	BP
2	22	0.861344372995	-	2.27e-01	GO:0045671	negative regulation of osteoclast differentiation	BP
3	33	0.861344372995	-	2.27e-01	GO:0006361	transcription initiation from RNA polymerase I promoter	BP
2	22	0.861344372995	-	2.46e-01	GO:0001816	cytokine production	BP
2	22	0.861344372995	-	2.64e-01	GO:0060999	positive regulation of dendritic spine development	BP
1	11	0.861344372995	-	2.65e-01	GO:1902260	negative regulation of delayed rectifier potassium channel activity	BP
2	22	0.861344372995	-	2.83e-01	GO:0006607	NLS-bearing protein import into nucleus	BP
2	22	0.861344372995	-	2.83e-01	GO:0048278	vesicle docking	BP
1	11	0.861344372995	-	3.02e-01	GO:0006702	androgen biosynthetic process	BP
1	11	0.861344372995	-	3.02e-01	GO:0050884	neuromuscular process controlling posture	BP
1	11	0.861344372995	-	3.02e-01	GO:0008406	gonad development	BP
1	11	0.861344372995	-	3.02e-01	GO:0048703	embryonic viscerocranium morphogenesis	BP
1	11	0.861344372995	-	3.02e-01	GO:0042551	neuron maturation	BP
1	11	0.861344372995	-	3.02e-01	GO:0002064	epithelial cell development	BP
1	11	0.861344372995	-	3.02e-01	GO:0015867	ATP transport	BP
1	11	0.861344372995	-	3.02e-01	GO:0031284	positive regulation of guanylate cyclase activity	BP
1	11	0.861344372995	-	3.02e-01	GO:1903672	positive regulation of sprouting angiogenesis	BP
2	22	0.861344372995	-	3.02e-01	GO:0016050	vesicle organization	BP
2	22	0.861344372995	-	3.02e-01	GO:0030316	osteoclast differentiation	BP
1	11	0.861344372995	-	3.37e-01	GO:0002089	lens morphogenesis in camera-type eye	BP
1	11	0.861344372995	-	3.37e-01	GO:0045446	endothelial cell differentiation	BP
1	11	0.861344372995	-	3.37e-01	GO:0009268	response to pH	BP
1	11	0.861344372995	-	3.70e-01	GO:0030431	sleep	BP
1	11	0.861344372995	-	3.70e-01	GO:0050673	epithelial cell proliferation	BP
1	11	0.861344372995	-	3.70e-01	GO:0022038	corpus callosum development	BP
1	11	0.861344372995	-	3.70e-01	GO:0070365	hepatocyte differentiation	BP
1	11	0.861344372995	-	3.70e-01	GO:0043666	regulation of phosphoprotein phosphatase activity	BP
1	11	0.861344372995	-	3.70e-01	GO:0022409	positive regulation of cell-cell adhesion	BP
1	11	0.861344372995	-	4.02e-01	GO:0032434	regulation of proteasomal ubiquitin-dependent protein catabolic process	BP
1	11	0.861344372995	-	4.02e-01	GO:0071223	cellular response to lipoteichoic acid	BP
1	11	0.861344372995	-	4.02e-01	GO:0048484	enteric nervous system development	BP
1	11	0.861344372995	-	4.02e-01	GO:0050732	negative regulation of peptidyl-tyrosine phosphorylation	BP
1	11	0.861344372995	-	4.02e-01	GO:0006937	regulation of muscle contraction	BP
1	11	0.861344372995	-	4.02e-01	GO:0055015	ventricular cardiac muscle cell development	BP
1	11	0.861344372995	-	4.02e-01	GO:1903428	positive regulation of reactive oxygen species biosynthetic process	BP
1	11	0.861344372995	-	4.02e-01	GO:0030033	microvillus assembly	BP
1	11	0.861344372995	-	4.02e-01	GO:0030816	positive regulation of cAMP metabolic process	BP
1	11	0.861344372995	-	4.02e-01	GO:0031915	positive regulation of synaptic plasticity	BP
1	11	0.861344372995	-	4.02e-01	GO:0021756	striatum development	BP
1	11	0.861344372995	-	4.02e-01	GO:0032688	negative regulation of interferon-beta production	BP
1	11	0.861344372995	-	4.02e-01	GO:0043517	positive regulation of DNA damage response, signal transduction by p53 class mediator	BP
1	11	0.861344372995	-	4.02e-01	GO:0045792	negative regulation of cell size	BP
1	11	0.861344372995	-	4.32e-01	GO:0071803	positive regulation of podosome assembly	BP
1	11	0.861344372995	-	4.32e-01	GO:0042347	negative regulation of NF-kappaB import into nucleus	BP
1	11	0.861344372995	-	4.32e-01	GO:0045762	positive regulation of adenylate cyclase activity	BP
1	11	0.861344372995	-	4.32e-01	GO:0050927	positive regulation of positive chemotaxis	BP
1	11	0.861344372995	-	4.32e-01	GO:0070914	UV-damage excision repair	BP
1	11	0.861344372995	-	4.32e-01	GO:0032786	positive regulation of DNA-templated transcription, elongation	BP
1	11	0.861344372995	-	4.32e-01	GO:0032700	negative regulation of interleukin-17 production	BP
1	11	0.861344372995	-	4.32e-01	GO:0045806	negative regulation of endocytosis	BP
1	11	0.861344372995	-	4.32e-01	GO:0006266	DNA ligation	BP
1	11	0.861344372995	-	4.32e-01	GO:0060544	regulation of necroptotic process	BP
1	11	0.861344372995	-	4.32e-01	GO:0043306	positive regulation of mast cell degranulation	BP
1	11	0.861344372995	-	4.32e-01	GO:0048712	negative regulation of astrocyte differentiation	BP
1	11	0.861344372995	-	4.32e-01	GO:0090136	epithelial cell-cell adhesion	BP
1	11	0.861344372995	-	4.32e-01	GO:0071372	cellular response to follicle-stimulating hormone stimulus	BP
1	11	0.861344372995	-	4.32e-01	GO:0035563	positive regulation of chromatin binding	BP
1	11	0.861344372995	-	4.32e-01	GO:0060765	regulation of androgen receptor signaling pathway	BP
1	11	0.861344372995	-	4.32e-01	GO:0090331	negative regulation of platelet aggregation	BP
1	11	0.861344372995	-	4.32e-01	GO:0033197	response to vitamin E	BP
1	11	0.861344372995	-	4.32e-01	GO:0016064	immunoglobulin mediated immune response	BP
1	11	0.861344372995	-	4.32e-01	GO:0061001	regulation of dendritic spine morphogenesis	BP
1	11	0.861344372995	-	4.32e-01	GO:0051382	kinetochore assembly	BP
1	11	0.861344372995	-	4.32e-01	GO:0006853	carnitine shuttle	BP
1	11	0.861344372995	-	3.02e-01	GO:0015278	calcium-release channel activity	MF
1	11	0.861344372995	-	3.02e-01	GO:0016175	superoxide-generating NADPH oxidase activity	MF
2	22	0.861344372995	-	3.02e-01	GO:0001671	ATPase activator activity	MF
1	11	0.861344372995	-	3.37e-01	GO:0015643	toxic substance binding	MF
1	11	0.861344372995	-	3.37e-01	GO:0015075	ion transmembrane transporter activity	MF
1	11	0.861344372995	-	3.37e-01	GO:0035925	mRNA 3'-UTR AU-rich region binding	MF
1	11	0.861344372995	-	3.37e-01	GO:0043394	proteoglycan binding	MF
1	11	0.861344372995	-	3.70e-01	GO:0043225	ATPase-coupled anion transmembrane transporter activity	MF
1	11	0.861344372995	-	4.02e-01	GO:0048407	platelet-derived growth factor binding	MF
1	11	0.861344372995	-	4.02e-01	GO:0050786	RAGE receptor binding	MF
1	11	0.861344372995	-	4.02e-01	GO:0000339	RNA cap binding	MF
1	11	0.861344372995	-	4.32e-01	GO:0043560	insulin receptor substrate binding	MF
1	11	0.861344372995	-	4.32e-01	GO:0031432	titin binding	MF
1	11	0.861344372995	-	4.32e-01	GO:0005092	GDP-dissociation inhibitor activity	MF
1	11	0.861344372995	-	4.32e-01	GO:0030371	translation repressor activity	MF
1	11	0.861344372995	-	4.32e-01	GO:0017154	semaphorin receptor activity	MF
112	1240	0.852006508415	-	1.73e-10	GO:0006355	regulation of transcription, DNA-templated	BP
9	100	0.846844803299	-	6.03e-02	GO:0000082	G1/S transition of mitotic cell cycle	BP
5	56	0.835349164462	-	1.10e-01	GO:0009267	cellular response to starvation	BP
4	45	0.828922895302	-	1.57e-01	GO:0006094	gluconeogenesis	BP
4	45	0.828922895302	-	9.57e-02	GO:0030276	clathrin binding	MF
11	124	0.826011299882	-	5.07e-02	GO:0006461	protein complex assembly	BP
3	34	0.818275651103	-	1.39e-01	GO:0008016	regulation of heart contraction	BP
3	34	0.818275651103	-	1.63e-01	GO:0030501	positive regulation of bone mineralization	BP
3	34	0.818275651103	-	1.75e-01	GO:0042130	negative regulation of T cell proliferation	BP
153	1744	0.809979509548	-	1.89e-10	GO:0006351	transcription, DNA-templated	BP
5	57	0.809814072354	-	5.72e-02	GO:0060395	SMAD protein signal transduction	BP
5	57	0.809814072354	-	6.21e-02	GO:1903779	regulation of cardiac conduction	BP
5	57	0.809814072354	-	1.90e-01	GO:0007173	epidermal growth factor receptor signaling pathway	BP
6	69	0.797214035575	-	1.45e-01	GO:0097190	apoptotic signaling pathway	BP
8	92	0.797214035575	-	3.11e-02	GO:0009636	response to toxic substance	BP
4	46	0.797214035575	-	1.47e-01	GO:0030968	endoplasmic reticulum unfolded protein response	BP
2	23	0.797214035575	-	2.46e-01	GO:0048741	skeletal muscle fiber development	BP
2	23	0.797214035575	-	2.46e-01	GO:0030488	tRNA methylation	BP
2	23	0.797214035575	-	2.64e-01	GO:0008306	associative learning	BP
2	23	0.797214035575	-	2.83e-01	GO:0048675	axon extension	BP
2	23	0.797214035575	-	3.02e-01	GO:0003009	skeletal muscle contraction	BP
2	23	0.797214035575	-	3.21e-01	GO:0030866	cortical actin cytoskeleton organization	BP
2	23	0.797214035575	-	3.21e-01	GO:0001954	positive regulation of cell-matrix adhesion	BP
2	23	0.797214035575	-	2.83e-01	GO:0030742	GTP-dependent protein binding	MF
5	58	0.784723091392	-	9.05e-02	GO:0050680	negative regulation of epithelial cell proliferation	BP
5	58	0.784723091392	-	9.05e-02	GO:0050679	positive regulation of epithelial cell proliferation	BP
5	58	0.784723091392	-	1.04e-01	GO:0003730	mRNA 3'-UTR binding	MF
3	35	0.776455475408	-	1.39e-01	GO:0051480	regulation of cytosolic calcium ion concentration	BP
3	35	0.776455475408	-	1.63e-01	GO:0002062	chondrocyte differentiation	BP
3	35	0.776455475408	-	2.55e-01	GO:0070534	protein K63-linked ubiquitination	BP
14	164	0.770578909071	-	1.94e-02	GO:0090090	negative regulation of canonical Wnt signaling pathway	BP
7	82	0.770578909071	-	8.51e-02	GO:0060021	palate development	BP
4	47	0.766187139954	-	2.21e-02	GO:0045596	negative regulation of cell differentiation	BP
4	47	0.766187139954	-	1.04e-01	GO:0006631	fatty acid metabolic process	BP
4	47	0.766187139954	-	2.86e-01	GO:0038083	peptidyl-tyrosine autophosphorylation	BP
4	47	0.766187139954	-	2.86e-01	GO:0016575	histone deacetylation	BP
4	47	0.766187139954	-	8.81e-02	GO:0005544	calcium-dependent phospholipid binding	MF
5	59	0.760061037157	-	7.28e-02	GO:0050660	flavin adenine dinucleotide binding	MF
16	190	0.750920383301	-	7.85e-03	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP
8	96	0.735813490911	-	7.19e-02	GO:0042593	glucose homeostasis	BP
5	60	0.735813490911	-	2.03e-01	GO:0030334	regulation of cell migration	BP
2	24	0.735813490911	-	2.46e-01	GO:0032967	positive regulation of collagen biosynthetic process	BP
2	24	0.735813490911	-	2.46e-01	GO:0006182	cGMP biosynthetic process	BP
1	12	0.735813490911	-	2.65e-01	GO:0003376	sphingosine-1-phosphate signaling pathway	BP
1	12	0.735813490911	-	2.65e-01	GO:0036066	protein O-linked fucosylation	BP
1	12	0.735813490911	-	3.02e-01	GO:0086012	membrane depolarization during cardiac muscle cell action potential	BP
2	24	0.735813490911	-	3.02e-01	GO:0042113	B cell activation	BP
2	24	0.735813490911	-	3.02e-01	GO:0002040	sprouting angiogenesis	BP
1	12	0.735813490911	-	3.37e-01	GO:0060294	cilium movement involved in cell motility	BP
2	24	0.735813490911	-	3.40e-01	GO:0035235	ionotropic glutamate receptor signaling pathway	BP
2	24	0.735813490911	-	3.40e-01	GO:2001238	positive regulation of extrinsic apoptotic signaling pathway	BP
1	12	0.735813490911	-	3.70e-01	GO:0000050	urea cycle	BP
1	12	0.735813490911	-	3.70e-01	GO:0010524	positive regulation of calcium ion transport into cytosol	BP
1	12	0.735813490911	-	3.70e-01	GO:0060416	response to growth hormone	BP
1	12	0.735813490911	-	3.70e-01	GO:0046834	lipid phosphorylation	BP
1	12	0.735813490911	-	3.70e-01	GO:0030277	maintenance of gastrointestinal epithelium	BP
1	12	0.735813490911	-	3.70e-01	GO:0007041	lysosomal transport	BP
1	12	0.735813490911	-	3.70e-01	GO:0032963	collagen metabolic process	BP
1	12	0.735813490911	-	3.70e-01	GO:0001655	urogenital system development	BP
1	12	0.735813490911	-	3.70e-01	GO:0030595	leukocyte chemotaxis	BP
1	12	0.735813490911	-	3.70e-01	GO:0009395	phospholipid catabolic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0045078	positive regulation of interferon-gamma biosynthetic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0006554	lysine catabolic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0097028	dendritic cell differentiation	BP
1	12	0.735813490911	-	4.02e-01	GO:0010447	response to acidic pH	BP
1	12	0.735813490911	-	4.02e-01	GO:0046949	fatty-acyl-CoA biosynthetic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0021846	cell proliferation in forebrain	BP
1	12	0.735813490911	-	4.02e-01	GO:0033674	positive regulation of kinase activity	BP
1	12	0.735813490911	-	4.02e-01	GO:0032695	negative regulation of interleukin-12 production	BP
1	12	0.735813490911	-	4.02e-01	GO:0034116	positive regulation of heterotypic cell-cell adhesion	BP
1	12	0.735813490911	-	4.02e-01	GO:0030516	regulation of axon extension	BP
1	12	0.735813490911	-	4.02e-01	GO:0046622	positive regulation of organ growth	BP
1	12	0.735813490911	-	4.02e-01	GO:0048333	mesodermal cell differentiation	BP
1	12	0.735813490911	-	4.02e-01	GO:0030195	negative regulation of blood coagulation	BP
1	12	0.735813490911	-	4.02e-01	GO:2000279	negative regulation of DNA biosynthetic process	BP
1	12	0.735813490911	-	4.02e-01	GO:0090399	replicative senescence	BP
1	12	0.735813490911	-	4.02e-01	GO:0072520	seminiferous tubule development	BP
1	12	0.735813490911	-	4.32e-01	GO:0001946	lymphangiogenesis	BP
1	12	0.735813490911	-	4.32e-01	GO:0050435	amyloid-beta metabolic process	BP
1	12	0.735813490911	-	4.32e-01	GO:0008340	determination of adult lifespan	BP
1	12	0.735813490911	-	4.32e-01	GO:0002687	positive regulation of leukocyte migration	BP
1	12	0.735813490911	-	4.32e-01	GO:0007512	adult heart development	BP
1	12	0.735813490911	-	4.32e-01	GO:0032495	response to muramyl dipeptide	BP
1	12	0.735813490911	-	4.32e-01	GO:0006107	oxaloacetate metabolic process	BP
1	12	0.735813490911	-	4.32e-01	GO:0045744	negative regulation of G-protein coupled receptor protein signaling pathway	BP
1	12	0.735813490911	-	4.60e-01	GO:0055003	cardiac myofibril assembly	BP
1	12	0.735813490911	-	4.60e-01	GO:0055008	cardiac muscle tissue morphogenesis	BP
1	12	0.735813490911	-	4.60e-01	GO:0047496	vesicle transport along microtubule	BP
1	12	0.735813490911	-	4.60e-01	GO:0045724	positive regulation of cilium assembly	BP
1	12	0.735813490911	-	4.60e-01	GO:0046902	regulation of mitochondrial membrane permeability	BP
1	12	0.735813490911	-	4.60e-01	GO:0035970	peptidyl-threonine dephosphorylation	BP
1	12	0.735813490911	-	4.60e-01	GO:0046710	GDP metabolic process	BP
1	12	0.735813490911	-	4.60e-01	GO:0048747	muscle fiber development	BP
1	12	0.735813490911	-	4.60e-01	GO:0035418	protein localization to synapse	BP
1	12	0.735813490911	-	4.60e-01	GO:0042994	cytoplasmic sequestering of transcription factor	BP
1	12	0.735813490911	-	4.60e-01	GO:0040007	growth	BP
1	12	0.735813490911	-	4.60e-01	GO:0090656	t-circle formation	BP
1	12	0.735813490911	-	4.60e-01	GO:2000146	negative regulation of cell motility	BP
1	12	0.735813490911	-	4.60e-01	GO:0070528	protein kinase C signaling	BP
5	60	0.735813490911	-	7.28e-02	GO:0008237	metallopeptidase activity	MF
1	12	0.735813490911	-	3.02e-01	GO:0004065	arylsulfatase activity	MF
2	24	0.735813490911	-	3.21e-01	GO:0032452	histone demethylase activity	MF
1	12	0.735813490911	-	3.70e-01	GO:0016829	lyase activity	MF
1	12	0.735813490911	-	4.02e-01	GO:0043495	protein membrane anchor	MF
1	12	0.735813490911	-	4.60e-01	GO:0050998	nitric-oxide synthase binding	MF
3	36	0.735813490911	-	2.55e-01	GO:0043407	negative regulation of MAP kinase activity	BP
20	241	0.729814750289	-	5.97e-03	GO:0042981	regulation of apoptotic process	BP
13	157	0.726594960881	-	7.79e-03	GO:0046983	protein dimerization activity	MF
6	73	0.715913933473	-	1.27e-01	GO:0006816	calcium ion transport	BP
22	269	0.708745247713	-	6.50e-03	GO:0016579	protein deubiquitination	BP
17	208	0.707799114741	-	3.11e-02	GO:0043161	proteasome-mediated ubiquitin-dependent protein catabolic process	BP
4	49	0.706066147517	-	8.81e-02	GO:0051898	negative regulation of protein kinase B signaling	BP
11	135	0.703392013218	-	2.30e-02	GO:0001501	skeletal system development	BP
39	480	0.699287614886	-	4.96e-05	GO:0008284	positive regulation of cell proliferation	BP
3	37	0.696285126724	-	2.14e-01	GO:0032720	negative regulation of tumor necrosis factor production	BP
3	37	0.696285126724	-	2.27e-01	GO:0009790	embryo development	BP
26	322	0.690298831658	-	3.30e-03	GO:0043065	positive regulation of apoptotic process	BP
5	62	0.688507776132	-	3.58e-02	GO:0001523	retinoid metabolic process	BP
9	112	0.683346071017	-	4.10e-02	GO:0007417	central nervous system development	BP
2	25	0.676919801857	-	2.46e-01	GO:0060349	bone morphogenesis	BP
2	25	0.676919801857	-	2.83e-01	GO:0034383	low-density lipoprotein particle clearance	BP
2	25	0.676919801857	-	3.02e-01	GO:0050772	positive regulation of axonogenesis	BP
2	25	0.676919801857	-	3.02e-01	GO:0048709	oligodendrocyte differentiation	BP
2	25	0.676919801857	-	3.21e-01	GO:0030511	positive regulation of transforming growth factor beta receptor signaling pathway	BP
2	25	0.676919801857	-	3.21e-01	GO:0001975	response to amphetamine	BP
2	25	0.676919801857	-	3.40e-01	GO:0032757	positive regulation of interleukin-8 production	BP
2	25	0.676919801857	-	3.40e-01	GO:0060976	coronary vasculature development	BP
4	50	0.676919801857	-	8.81e-02	GO:0005044	scavenger receptor activity	MF
2	25	0.676919801857	-	3.02e-01	GO:0005246	calcium channel regulator activity	MF
2	25	0.676919801857	-	3.40e-01	GO:0030332	cyclin binding	MF
7	88	0.668699295052	-	9.25e-02	GO:0007565	female pregnancy	BP
5	63	0.665424163019	-	2.39e-01	GO:0007059	chromosome segregation	BP
3	38	0.657810978909	-	4.31e-01	GO:0006289	nucleotide-excision repair	BP
3	38	0.657810978909	-	4.38e-01	GO:0031623	receptor internalization	BP
8	102	0.64835064966	-	1.48e-01	GO:0038111	interleukin-7-mediated signaling pathway	BP
4	51	0.64835064966	-	2.91e-01	GO:0045860	positive regulation of protein kinase activity	BP
4	51	0.64835064966	-	3.03e-01	GO:0010977	negative regulation of neuron projection development	BP
13	166	0.646176278426	-	1.02e-01	GO:0046777	protein autophosphorylation	BP
5	64	0.642704086519	-	1.94e-01	GO:0072659	protein localization to plasma membrane	BP
5	64	0.642704086519	-	1.99e-01	GO:0070373	negative regulation of ERK1 and ERK2 cascade	BP
5	64	0.642704086519	-	2.39e-01	GO:0019903	protein phosphatase binding	MF
6	77	0.638951951658	-	1.54e-01	GO:0042060	wound healing	BP
8	103	0.634275464449	-	1.43e-01	GO:0031175	neuron projection development	BP
3	39	0.620336273491	-	2.14e-01	GO:0048704	embryonic skeletal system morphogenesis	BP
2	26	0.620336273491	-	2.46e-01	GO:0090102	cochlea development	BP
2	26	0.620336273491	-	2.64e-01	GO:0030534	adult behavior	BP
2	26	0.620336273491	-	2.83e-01	GO:0007202	activation of phospholipase C activity	BP
1	13	0.620336273491	-	3.02e-01	GO:0021527	spinal cord association neuron differentiation	BP
1	13	0.620336273491	-	3.02e-01	GO:0042574	retinal metabolic process	BP
2	26	0.620336273491	-	3.21e-01	GO:0033077	T cell differentiation in thymus	BP
2	26	0.620336273491	-	3.21e-01	GO:0015758	glucose transport	BP
1	13	0.620336273491	-	3.37e-01	GO:0048599	oocyte development	BP
1	13	0.620336273491	-	3.37e-01	GO:0006044	N-acetylglucosamine metabolic process	BP
1	13	0.620336273491	-	3.37e-01	GO:0006957	complement activation, alternative pathway	BP
2	26	0.620336273491	-	3.40e-01	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP
2	26	0.620336273491	-	3.58e-01	GO:0000732	strand displacement	BP
1	13	0.620336273491	-	3.70e-01	GO:0043568	positive regulation of insulin-like growth factor receptor signaling pathway	BP
1	13	0.620336273491	-	3.70e-01	GO:0010001	glial cell differentiation	BP
1	13	0.620336273491	-	3.70e-01	GO:0072001	renal system development	BP
1	13	0.620336273491	-	3.70e-01	GO:0071318	cellular response to ATP	BP
2	26	0.620336273491	-	3.76e-01	GO:0051225	spindle assembly	BP
1	13	0.620336273491	-	4.02e-01	GO:0090501	RNA phosphodiester bond hydrolysis	BP
1	13	0.620336273491	-	4.02e-01	GO:0002087	regulation of respiratory gaseous exchange by neurological system process	BP
1	13	0.620336273491	-	4.02e-01	GO:0071397	cellular response to cholesterol	BP
1	13	0.620336273491	-	4.02e-01	GO:0042554	superoxide anion generation	BP
1	13	0.620336273491	-	4.02e-01	GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase	BP
1	13	0.620336273491	-	4.02e-01	GO:0060389	pathway-restricted SMAD protein phosphorylation	BP
1	13	0.620336273491	-	4.32e-01	GO:0010763	positive regulation of fibroblast migration	BP
1	13	0.620336273491	-	4.32e-01	GO:0051258	protein polymerization	BP
1	13	0.620336273491	-	4.32e-01	GO:0001967	suckling behavior	BP
1	13	0.620336273491	-	4.32e-01	GO:0007171	activation of transmembrane receptor protein tyrosine kinase activity	BP
1	13	0.620336273491	-	4.32e-01	GO:0071280	cellular response to copper ion	BP
1	13	0.620336273491	-	4.32e-01	GO:0097320	plasma membrane tubulation	BP
1	13	0.620336273491	-	4.32e-01	GO:0036109	alpha-linolenic acid metabolic process	BP
1	13	0.620336273491	-	4.32e-01	GO:0045943	positive regulation of transcription from RNA polymerase I promoter	BP
1	13	0.620336273491	-	4.32e-01	GO:0045995	regulation of embryonic development	BP
3	39	0.620336273491	-	4.38e-01	GO:0030890	positive regulation of B cell proliferation	BP
1	13	0.620336273491	-	4.60e-01	GO:1900181	negative regulation of protein localization to nucleus	BP
1	13	0.620336273491	-	4.60e-01	GO:0090162	establishment of epithelial cell polarity	BP
1	13	0.620336273491	-	4.60e-01	GO:0035909	aorta morphogenesis	BP
1	13	0.620336273491	-	4.60e-01	GO:0033962	cytoplasmic mRNA processing body assembly	BP
1	13	0.620336273491	-	4.60e-01	GO:0046685	response to arsenic-containing substance	BP
1	13	0.620336273491	-	4.60e-01	GO:0019725	cellular homeostasis	BP
1	13	0.620336273491	-	4.60e-01	GO:0051085	chaperone mediated protein folding requiring cofactor	BP
1	13	0.620336273491	-	4.60e-01	GO:0006878	cellular copper ion homeostasis	BP
1	13	0.620336273491	-	4.60e-01	GO:0016226	iron-sulfur cluster assembly	BP
1	13	0.620336273491	-	4.60e-01	GO:0006883	cellular sodium ion homeostasis	BP
1	13	0.620336273491	-	4.60e-01	GO:0009062	fatty acid catabolic process	BP
1	13	0.620336273491	-	4.60e-01	GO:2000010	positive regulation of protein localization to cell surface	BP
1	13	0.620336273491	-	4.60e-01	GO:0071285	cellular response to lithium ion	BP
1	13	0.620336273491	-	4.60e-01	GO:0071361	cellular response to ethanol	BP
1	13	0.620336273491	-	4.60e-01	GO:0030194	positive regulation of blood coagulation	BP
1	13	0.620336273491	-	4.87e-01	GO:0097296	activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	BP
1	13	0.620336273491	-	4.87e-01	GO:0001774	microglial cell activation	BP
1	13	0.620336273491	-	4.87e-01	GO:1900025	negative regulation of substrate adhesion-dependent cell spreading	BP
1	13	0.620336273491	-	4.87e-01	GO:0016242	negative regulation of macroautophagy	BP
1	13	0.620336273491	-	4.87e-01	GO:0042176	regulation of protein catabolic process	BP
1	13	0.620336273491	-	4.87e-01	GO:0006379	mRNA cleavage	BP
1	13	0.620336273491	-	4.87e-01	GO:0061099	negative regulation of protein tyrosine kinase activity	BP
1	13	0.620336273491	-	4.87e-01	GO:0002756	MyD88-independent toll-like receptor signaling pathway	BP
1	13	0.620336273491	-	4.87e-01	GO:0010498	proteasomal protein catabolic process	BP
1	13	0.620336273491	-	2.65e-01	GO:0031402	sodium ion binding	MF
1	13	0.620336273491	-	3.70e-01	GO:0015464	acetylcholine receptor activity	MF
1	13	0.620336273491	-	4.02e-01	GO:0004467	long-chain fatty acid-CoA ligase activity	MF
1	13	0.620336273491	-	4.02e-01	GO:0003995	acyl-CoA dehydrogenase activity	MF
1	13	0.620336273491	-	4.02e-01	GO:0004527	exonuclease activity	MF
1	13	0.620336273491	-	4.02e-01	GO:0004518	nuclease activity	MF
1	13	0.620336273491	-	4.87e-01	GO:0051787	misfolded protein binding	MF
1	13	0.620336273491	-	4.87e-01	GO:0044548	S100 protein binding	MF
1	13	0.620336273491	-	4.87e-01	GO:0004385	guanylate kinase activity	MF
1	13	0.620336273491	-	4.87e-01	GO:0017160	Ral GTPase binding	MF
8	105	0.606530473966	-	1.76e-01	GO:0043488	regulation of mRNA stability	BP
5	66	0.598309967161	-	2.32e-01	GO:0014068	positive regulation of phosphatidylinositol 3-kinase signaling	BP
4	53	0.592855537069	-	2.97e-01	GO:0043406	positive regulation of MAP kinase activity	BP
8	106	0.592855537069	-	1.41e-01	GO:0002020	protease binding	MF
12	160	0.583810397466	-	8.68e-02	GO:0043123	positive regulation of I-kappaB kinase/NF-kappaB signaling	BP
3	40	0.583810397466	-	4.31e-01	GO:0021549	cerebellum development	BP
5	67	0.576614896061	-	2.46e-01	GO:0051259	protein oligomerization	BP
2	27	0.565888489468	-	3.02e-01	GO:0030030	cell projection organization	BP
2	27	0.565888489468	-	3.02e-01	GO:0035774	positive regulation of insulin secretion involved in cellular response to glucose stimulus	BP
4	54	0.565888489468	-	3.09e-01	GO:0008104	protein localization	BP
2	27	0.565888489468	-	3.58e-01	GO:0040014	regulation of multicellular organism growth	BP
2	27	0.565888489468	-	3.94e-01	GO:0043278	response to morphine	BP
6	81	0.565888489468	-	1.50e-01	GO:0006874	cellular calcium ion homeostasis	BP
6	82	0.548186487735	-	1.75e-01	GO:0007229	integrin-mediated signaling pathway	BP
6	82	0.548186487735	-	2.80e-01	GO:0030307	positive regulation of cell growth	BP
4	55	0.539416278107	-	3.03e-01	GO:0060548	negative regulation of cell death	BP
10	138	0.534179629741	-	9.00e-03	GO:0005506	iron ion binding	MF
55	766	0.520935123232	-	2.33e-04	GO:0042803	protein homodimerization activity	MF
5	70	0.513421069574	-	3.96e-01	GO:0042795	snRNA transcription from RNA polymerase II promoter	BP
5	70	0.513421069574	-	4.01e-01	GO:0016241	regulation of macroautophagy	BP
4	56	0.513421069574	-	1.04e-01	GO:0042472	inner ear morphogenesis	BP
3	42	0.513421069574	-	2.27e-01	GO:0001658	branching involved in ureteric bud morphogenesis	BP
1	14	0.513421069574	-	2.65e-01	GO:0006790	sulfur compound metabolic process	BP
1	14	0.513421069574	-	2.65e-01	GO:0052695	cellular glucuronidation	BP
2	28	0.513421069574	-	2.83e-01	GO:0006520	cellular amino acid metabolic process	BP
1	14	0.513421069574	-	3.02e-01	GO:0006665	sphingolipid metabolic process	BP
1	14	0.513421069574	-	3.02e-01	GO:0051481	negative regulation of cytosolic calcium ion concentration	BP
1	14	0.513421069574	-	3.02e-01	GO:0048149	behavioral response to ethanol	BP
1	14	0.513421069574	-	3.37e-01	GO:0006693	prostaglandin metabolic process	BP
1	14	0.513421069574	-	3.37e-01	GO:0051967	negative regulation of synaptic transmission, glutamatergic	BP
2	28	0.513421069574	-	3.40e-01	GO:0045595	regulation of cell differentiation	BP
2	28	0.513421069574	-	3.40e-01	GO:0032148	activation of protein kinase B activity	BP
1	14	0.513421069574	-	3.70e-01	GO:1901223	negative regulation of NIK/NF-kappaB signaling	BP
2	28	0.513421069574	-	3.76e-01	GO:0001662	behavioral fear response	BP
2	28	0.513421069574	-	3.76e-01	GO:0007528	neuromuscular junction development	BP
1	14	0.513421069574	-	4.02e-01	GO:0031103	axon regeneration	BP
1	14	0.513421069574	-	4.02e-01	GO:0048172	regulation of short-term neuronal synaptic plasticity	BP
1	14	0.513421069574	-	4.02e-01	GO:0002063	chondrocyte development	BP
1	14	0.513421069574	-	4.32e-01	GO:0043303	mast cell degranulation	BP
1	14	0.513421069574	-	4.32e-01	GO:0090280	positive regulation of calcium ion import	BP
1	14	0.513421069574	-	4.32e-01	GO:0045947	negative regulation of translational initiation	BP
3	42	0.513421069574	-	4.52e-01	GO:0006986	response to unfolded protein	BP
1	14	0.513421069574	-	4.60e-01	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP
1	14	0.513421069574	-	4.60e-01	GO:1903078	positive regulation of protein localization to plasma membrane	BP
1	14	0.513421069574	-	4.60e-01	GO:1901185	negative regulation of ERBB signaling pathway	BP
1	14	0.513421069574	-	4.60e-01	GO:0071425	hematopoietic stem cell proliferation	BP
1	14	0.513421069574	-	4.60e-01	GO:0060038	cardiac muscle cell proliferation	BP
1	14	0.513421069574	-	4.60e-01	GO:0045056	transcytosis	BP
1	14	0.513421069574	-	4.60e-01	GO:0045055	regulated exocytosis	BP
1	14	0.513421069574	-	4.60e-01	GO:1900006	positive regulation of dendrite development	BP
1	14	0.513421069574	-	4.87e-01	GO:0030837	negative regulation of actin filament polymerization	BP
1	14	0.513421069574	-	4.87e-01	GO:0001817	regulation of cytokine production	BP
1	14	0.513421069574	-	4.87e-01	GO:0001921	positive regulation of receptor recycling	BP
1	14	0.513421069574	-	4.87e-01	GO:0045589	regulation of regulatory T cell differentiation	BP
1	14	0.513421069574	-	5.13e-01	GO:0045088	regulation of innate immune response	BP
1	14	0.513421069574	-	5.13e-01	GO:1902187	negative regulation of viral release from host cell	BP
1	14	0.513421069574	-	5.13e-01	GO:0051492	regulation of stress fiber assembly	BP
1	14	0.513421069574	-	5.13e-01	GO:0022904	respiratory electron transport chain	BP
1	14	0.513421069574	-	5.13e-01	GO:0010243	response to organonitrogen compound	BP
1	14	0.513421069574	-	5.13e-01	GO:0048009	insulin-like growth factor receptor signaling pathway	BP
1	14	0.513421069574	-	5.13e-01	GO:0043518	negative regulation of DNA damage response, signal transduction by p53 class mediator	BP
2	28	0.513421069574	-	6.49e-01	GO:0014047	glutamate secretion	BP
1	14	0.513421069574	-	3.37e-01	GO:0008499	UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity	MF
1	14	0.513421069574	-	3.70e-01	GO:0000900	translation repressor activity, nucleic acid binding	MF
1	14	0.513421069574	-	4.32e-01	GO:0004029	aldehyde dehydrogenase (NAD) activity	MF
3	42	0.513421069574	-	4.52e-01	GO:0032947	protein complex scaffold activity	MF
1	14	0.513421069574	-	4.60e-01	GO:0043274	phospholipase binding	MF
1	14	0.513421069574	-	4.60e-01	GO:0008528	G-protein coupled peptide receptor activity	MF
1	14	0.513421069574	-	4.60e-01	GO:0010181	FMN binding	MF
1	14	0.513421069574	-	4.87e-01	GO:0030169	low-density lipoprotein particle binding	MF
1	14	0.513421069574	-	4.87e-01	GO:0005095	GTPase inhibitor activity	MF
1	14	0.513421069574	-	4.87e-01	GO:0016538	cyclin-dependent protein serine/threonine kinase regulator activity	MF
1	14	0.513421069574	-	5.13e-01	GO:0031434	mitogen-activated protein kinase kinase binding	MF
1	14	0.513421069574	-	5.13e-01	GO:0070063	RNA polymerase binding	MF
1	14	0.513421069574	-	5.13e-01	GO:0032794	GTPase activating protein binding	MF
1	14	0.513421069574	-	5.13e-01	GO:0035198	miRNA binding	MF
2	28	0.513421069574	-	6.49e-01	GO:0046875	ephrin receptor binding	MF
13	183	0.505515871489	-	9.82e-02	GO:0007596	blood coagulation	BP
13	185	0.489834249257	-	6.47e-02	GO:0007411	axon guidance	BP
4	57	0.487885977467	-	1.57e-01	GO:0006959	humoral immune response	BP
3	43	0.479473737651	-	4.38e-01	GO:0042110	T cell activation	BP
3	43	0.479473737651	-	4.67e-01	GO:0051496	positive regulation of stress fiber assembly	BP
5	72	0.472779085077	-	2.53e-01	GO:0045454	cell redox homeostasis	BP
2	29	0.462794996504	-	2.46e-01	GO:0048477	oogenesis	BP
2	29	0.462794996504	-	2.83e-01	GO:0030163	protein catabolic process	BP
2	29	0.462794996504	-	3.21e-01	GO:0045776	negative regulation of blood pressure	BP
4	58	0.462794996504	-	3.39e-01	GO:0050729	positive regulation of inflammatory response	BP
2	29	0.462794996504	-	3.40e-01	GO:0019933	cAMP-mediated signaling	BP
2	29	0.462794996504	-	6.55e-01	GO:0006294	nucleotide-excision repair, preincision complex assembly	BP
4	58	0.462794996504	-	3.23e-01	GO:0048306	calcium-dependent protein binding	MF
2	29	0.462794996504	-	3.76e-01	GO:0008234	cysteine-type peptidase activity	MF
13	189	0.458973285552	-	1.05e-01	GO:0005516	calmodulin binding	MF
30	438	0.452879527639	-	3.63e-02	GO:0006468	protein phosphorylation	BP
12	176	0.446306873716	-	3.35e-02	GO:0038095	Fc-epsilon receptor signaling pathway	BP
6	88	0.446306873716	-	1.81e-01	GO:0007517	muscle organ development	BP
4	59	0.43813294227	-	1.47e-01	GO:0007338	single fertilization	BP
4	59	0.43813294227	-	2.97e-01	GO:0042277	peptide binding	MF
24	354	0.43813294227	-	5.34e-02	GO:0008283	cell proliferation	BP
4	60	0.413885396023	-	1.38e-01	GO:0006869	lipid transport	BP
5	75	0.413885396023	-	1.99e-01	GO:0001503	ossification	BP
2	30	0.413885396023	-	2.83e-01	GO:0046676	negative regulation of insulin secretion	BP
2	30	0.413885396023	-	3.21e-01	GO:0042476	odontogenesis	BP
1	15	0.413885396023	-	3.37e-01	GO:0045603	positive regulation of endothelial cell differentiation	BP
2	30	0.413885396023	-	3.58e-01	GO:0009953	dorsal/ventral pattern formation	BP
1	15	0.413885396023	-	3.70e-01	GO:0042633	hair cycle	BP
1	15	0.413885396023	-	3.70e-01	GO:1903206	negative regulation of hydrogen peroxide-induced cell death	BP
1	15	0.413885396023	-	3.70e-01	GO:0001963	synaptic transmission, dopaminergic	BP
1	15	0.413885396023	-	3.70e-01	GO:2000311	regulation of AMPA receptor activity	BP
1	15	0.413885396023	-	3.70e-01	GO:0046928	regulation of neurotransmitter secretion	BP
1	15	0.413885396023	-	3.70e-01	GO:0080111	DNA demethylation	BP
1	15	0.413885396023	-	4.02e-01	GO:0003382	epithelial cell morphogenesis	BP
1	15	0.413885396023	-	4.32e-01	GO:0007340	acrosome reaction	BP
1	15	0.413885396023	-	4.32e-01	GO:0034656	nucleobase-containing small molecule catabolic process	BP
1	15	0.413885396023	-	4.32e-01	GO:0060314	regulation of ryanodine-sensitive calcium-release channel activity	BP
1	15	0.413885396023	-	4.60e-01	GO:0051276	chromosome organization	BP
1	15	0.413885396023	-	4.60e-01	GO:0048485	sympathetic nervous system development	BP
1	15	0.413885396023	-	4.60e-01	GO:0010765	positive regulation of sodium ion transport	BP
1	15	0.413885396023	-	4.60e-01	GO:0006940	regulation of smooth muscle contraction	BP
1	15	0.413885396023	-	4.60e-01	GO:1901379	regulation of potassium ion transmembrane transport	BP
1	15	0.413885396023	-	4.60e-01	GO:0032461	positive regulation of protein oligomerization	BP
1	15	0.413885396023	-	4.60e-01	GO:0030517	negative regulation of axon extension	BP
1	15	0.413885396023	-	4.60e-01	GO:0086005	ventricular cardiac muscle cell action potential	BP
1	15	0.413885396023	-	4.60e-01	GO:0006750	glutathione biosynthetic process	BP
1	15	0.413885396023	-	4.87e-01	GO:0060347	heart trabecula formation	BP
1	15	0.413885396023	-	4.87e-01	GO:0001824	blastocyst development	BP
1	15	0.413885396023	-	4.87e-01	GO:0050965	detection of temperature stimulus involved in sensory perception of pain	BP
1	15	0.413885396023	-	4.87e-01	GO:0070542	response to fatty acid	BP
1	15	0.413885396023	-	4.87e-01	GO:0006309	apoptotic DNA fragmentation	BP
1	15	0.413885396023	-	4.87e-01	GO:0050995	negative regulation of lipid catabolic process	BP
1	15	0.413885396023	-	5.13e-01	GO:0048872	homeostasis of number of cells	BP
1	15	0.413885396023	-	5.13e-01	GO:0031573	intra-S DNA damage checkpoint	BP
1	15	0.413885396023	-	5.13e-01	GO:0032743	positive regulation of interleukin-2 production	BP
1	15	0.413885396023	-	5.13e-01	GO:2000251	positive regulation of actin cytoskeleton reorganization	BP
1	15	0.413885396023	-	5.13e-01	GO:2000353	positive regulation of endothelial cell apoptotic process	BP
1	15	0.413885396023	-	5.13e-01	GO:0060122	inner ear receptor stereocilium organization	BP
1	15	0.413885396023	-	5.13e-01	GO:0034162	toll-like receptor 9 signaling pathway	BP
1	15	0.413885396023	-	5.13e-01	GO:0043162	ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway	BP
1	15	0.413885396023	-	5.13e-01	GO:0010288	response to lead ion	BP
1	15	0.413885396023	-	5.13e-01	GO:0043254	regulation of protein complex assembly	BP
1	15	0.413885396023	-	5.37e-01	GO:0051895	negative regulation of focal adhesion assembly	BP
1	15	0.413885396023	-	5.37e-01	GO:2000484	positive regulation of interleukin-8 secretion	BP
1	15	0.413885396023	-	5.37e-01	GO:1903543	positive regulation of exosomal secretion	BP
1	15	0.413885396023	-	5.37e-01	GO:0045190	isotype switching	BP
1	15	0.413885396023	-	5.37e-01	GO:0007215	glutamate receptor signaling pathway	BP
1	15	0.413885396023	-	5.37e-01	GO:0006376	mRNA splice site selection	BP
1	15	0.413885396023	-	5.37e-01	GO:0048168	regulation of neuronal synaptic plasticity	BP
1	15	0.413885396023	-	5.37e-01	GO:0048011	neurotrophin TRK receptor signaling pathway	BP
2	30	0.413885396023	-	6.55e-01	GO:0046627	negative regulation of insulin receptor signaling pathway	BP
2	30	0.413885396023	-	6.61e-01	GO:0006362	transcription elongation from RNA polymerase I promoter	BP
1	15	0.413885396023	-	3.37e-01	GO:0004180	carboxypeptidase activity	MF
2	30	0.413885396023	-	3.40e-01	GO:0016874	ligase activity	MF
1	15	0.413885396023	-	4.32e-01	GO:0005230	extracellular ligand-gated ion channel activity	MF
1	15	0.413885396023	-	4.60e-01	GO:0000062	fatty-acyl-CoA binding	MF
1	15	0.413885396023	-	4.87e-01	GO:0017016	Ras GTPase binding	MF
1	15	0.413885396023	-	4.87e-01	GO:0005545	1-phosphatidylinositol binding	MF
1	15	0.413885396023	-	5.13e-01	GO:0004438	phosphatidylinositol-3-phosphatase activity	MF
1	15	0.413885396023	-	5.13e-01	GO:0036002	pre-mRNA binding	MF
3	45	0.413885396023	-	4.59e-01	GO:0014070	response to organic cyclic compound	BP
5	76	0.394776573076	-	2.03e-01	GO:0016525	negative regulation of angiogenesis	BP
5	76	0.394776573076	-	4.10e-01	GO:0016925	protein sumoylation	BP
4	61	0.390038654069	-	3.16e-01	GO:0006879	cellular iron ion homeostasis	BP
4	61	0.390038654069	-	5.40e-01	GO:0031398	positive regulation of protein ubiquitination	BP
8	122	0.390038654069	-	2.86e-01	GO:0004713	protein tyrosine kinase activity	MF
4	61	0.390038654069	-	3.16e-01	GO:0005518	collagen binding	MF
24	368	0.382176536296	-	2.07e-02	GO:0006954	inflammatory response	BP
8	123	0.378261486293	-	2.67e-01	GO:0002576	platelet degranulation	BP
2	31	0.366579681245	-	1.71e-01	GO:0010667	negative regulation of cardiac muscle cell apoptotic process	BP
4	62	0.366579681245	-	3.55e-01	GO:0045727	positive regulation of translation	BP
4	62	0.366579681245	-	3.55e-01	GO:0042531	positive regulation of tyrosine phosphorylation of STAT protein	BP
2	31	0.366579681245	-	3.94e-01	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	BP
2	31	0.366579681245	-	3.94e-01	GO:0014065	phosphatidylinositol 3-kinase signaling	BP
4	62	0.366579681245	-	5.53e-01	GO:0045815	positive regulation of gene expression, epigenetic	BP
2	31	0.366579681245	-	6.49e-01	GO:0046326	positive regulation of glucose import	BP
2	31	0.366579681245	-	6.49e-01	GO:0021510	spinal cord development	BP
2	31	0.366579681245	-	6.55e-01	GO:0034504	protein localization to nucleus	BP
2	31	0.366579681245	-	6.61e-01	GO:0045773	positive regulation of axon extension	BP
2	31	0.366579681245	-	6.67e-01	GO:0006363	termination of RNA polymerase I transcription	BP
2	31	0.366579681245	-	6.67e-01	GO:0042059	negative regulation of epidermal growth factor receptor signaling pathway	BP
2	31	0.366579681245	-	3.02e-01	GO:0015276	ligand-gated ion channel activity	MF
7	109	0.359946588913	-	3.62e-01	GO:0000187	activation of MAPK activity	BP
6	94	0.351149640675	-	2.80e-01	GO:0051897	positive regulation of protein kinase B signaling	BP
3	47	0.351149640675	-	4.25e-01	GO:0065009	regulation of molecular function	BP
3	47	0.351149640675	-	4.83e-01	GO:0032760	positive regulation of tumor necrosis factor production	BP
3	47	0.351149640675	-	5.09e-01	GO:0007254	JNK cascade	BP
7	110	0.346771200165	-	3.45e-01	GO:0030168	platelet activation	BP
8	126	0.343496068132	-	3.95e-01	GO:0033209	tumor necrosis factor-mediated signaling pathway	BP
4	63	0.343496068132	-	5.53e-01	GO:0006303	double-strand break repair via nonhomologous end joining	BP
13	205	0.341735610267	-	1.74e-01	GO:0004871	signal transducer activity	MF
5	79	0.338923338342	-	2.60e-01	GO:0031295	T cell costimulation	BP
7	111	0.333715047339	-	3.37e-01	GO:0044325	ion channel binding	MF
3	48	0.320775991632	-	2.27e-01	GO:0061844	antimicrobial humoral immune response mediated by antimicrobial peptide	BP
1	16	0.320775991632	-	3.02e-01	GO:0030500	regulation of bone mineralization	BP
1	16	0.320775991632	-	3.37e-01	GO:0019432	triglyceride biosynthetic process	BP
1	16	0.320775991632	-	3.37e-01	GO:0050909	sensory perception of taste	BP
2	32	0.320775991632	-	3.40e-01	GO:0048701	embryonic cranial skeleton morphogenesis	BP
2	32	0.320775991632	-	3.58e-01	GO:0007498	mesoderm development	BP
1	16	0.320775991632	-	4.32e-01	GO:0048566	embryonic digestive tract development	BP
1	16	0.320775991632	-	4.87e-01	GO:0021522	spinal cord motor neuron differentiation	BP
1	16	0.320775991632	-	4.87e-01	GO:0032012	regulation of ARF protein signal transduction	BP
1	16	0.320775991632	-	4.87e-01	GO:0045616	regulation of keratinocyte differentiation	BP
1	16	0.320775991632	-	5.13e-01	GO:0043032	positive regulation of macrophage activation	BP
1	16	0.320775991632	-	5.13e-01	GO:0061036	positive regulation of cartilage development	BP
1	16	0.320775991632	-	5.13e-01	GO:0042307	positive regulation of protein import into nucleus	BP
1	16	0.320775991632	-	5.37e-01	GO:0046037	GMP metabolic process	BP
1	16	0.320775991632	-	5.37e-01	GO:0061136	regulation of proteasomal protein catabolic process	BP
1	16	0.320775991632	-	5.37e-01	GO:0021772	olfactory bulb development	BP
1	16	0.320775991632	-	5.37e-01	GO:0051131	chaperone-mediated protein complex assembly	BP
1	16	0.320775991632	-	5.37e-01	GO:0006261	DNA-dependent DNA replication	BP
1	16	0.320775991632	-	5.37e-01	GO:0006349	regulation of gene expression by genetic imprinting	BP
1	16	0.320775991632	-	5.37e-01	GO:0016571	histone methylation	BP
1	16	0.320775991632	-	5.37e-01	GO:0071732	cellular response to nitric oxide	BP
1	16	0.320775991632	-	5.60e-01	GO:0045725	positive regulation of glycogen biosynthetic process	BP
1	16	0.320775991632	-	5.60e-01	GO:0036503	ERAD pathway	BP
1	16	0.320775991632	-	5.60e-01	GO:0031396	regulation of protein ubiquitination	BP
1	16	0.320775991632	-	5.60e-01	GO:0007212	dopamine receptor signaling pathway	BP
1	16	0.320775991632	-	5.60e-01	GO:0034142	toll-like receptor 4 signaling pathway	BP
1	16	0.320775991632	-	5.60e-01	GO:0000380	alternative mRNA splicing, via spliceosome	BP
2	32	0.320775991632	-	6.49e-01	GO:0003091	renal water homeostasis	BP
2	32	0.320775991632	-	6.55e-01	GO:0043200	response to amino acid	BP
2	32	0.320775991632	-	6.55e-01	GO:0042220	response to cocaine	BP
2	32	0.320775991632	-	6.61e-01	GO:0001932	regulation of protein phosphorylation	BP
2	32	0.320775991632	-	6.67e-01	GO:1900026	positive regulation of substrate adhesion-dependent cell spreading	BP
1	16	0.320775991632	-	3.70e-01	GO:0022848	acetylcholine-gated cation-selective channel activity	MF
1	16	0.320775991632	-	4.60e-01	GO:0004806	triglyceride lipase activity	MF
1	16	0.320775991632	-	5.37e-01	GO:0031435	mitogen-activated protein kinase kinase kinase binding	MF
2	32	0.320775991632	-	6.61e-01	GO:0008536	Ran GTPase binding	MF
22	355	0.308532395877	-	2.01e-01	GO:0004674	protein serine/threonine kinase activity	MF
27	436	0.307479169018	-	2.71e-03	GO:0045087	innate immune response	BP
3	49	0.291028648238	-	4.52e-01	GO:0000049	tRNA binding	MF
5	82	0.285152081901	-	4.21e-01	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	BP
5	82	0.285152081901	-	4.38e-01	GO:0008543	fibroblast growth factor receptor signaling pathway	BP
2	33	0.276381872273	-	2.83e-01	GO:0043330	response to exogenous dsRNA	BP
2	33	0.276381872273	-	6.55e-01	GO:0070830	bicellular tight junction assembly	BP
2	33	0.276381872273	-	6.55e-01	GO:2001244	positive regulation of intrinsic apoptotic signaling pathway	BP
2	33	0.276381872273	-	6.74e-01	GO:0043491	protein kinase B signaling	BP
2	33	0.276381872273	-	6.80e-01	GO:0097192	extrinsic apoptotic signaling pathway in absence of ligand	BP
2	33	0.276381872273	-	6.61e-01	GO:0016791	phosphatase activity	MF
12	198	0.276381872273	-	1.28e-01	GO:0004872	receptor activity	MF
16	266	0.265493556131	-	3.07e-01	GO:0000165	MAPK cascade	BP
3	50	0.261882302578	-	5.01e-01	GO:0007269	neurotransmitter secretion	BP
4	67	0.254686801174	-	2.97e-01	GO:0005262	calcium channel activity	MF
30	505	0.247527009601	-	6.49e-03	GO:0030154	cell differentiation	BP
9	152	0.242773479631	-	4.39e-01	GO:0018108	peptidyl-tyrosine phosphorylation	BP
2	34	0.233313150382	-	3.02e-01	GO:0007194	negative regulation of adenylate cyclase activity	BP
2	34	0.233313150382	-	3.02e-01	GO:0060045	positive regulation of cardiac muscle cell proliferation	BP
2	34	0.233313150382	-	3.94e-01	GO:0001890	placenta development	BP
1	17	0.233313150382	-	4.32e-01	GO:0007276	gamete generation	BP
1	17	0.233313150382	-	4.32e-01	GO:0042310	vasoconstriction	BP
1	17	0.233313150382	-	4.60e-01	GO:0043537	negative regulation of blood vessel endothelial cell migration	BP
1	17	0.233313150382	-	4.60e-01	GO:0097009	energy homeostasis	BP
1	17	0.233313150382	-	4.87e-01	GO:0043171	peptide catabolic process	BP
1	17	0.233313150382	-	5.13e-01	GO:0030902	hindbrain development	BP
1	17	0.233313150382	-	5.13e-01	GO:0007043	cell-cell junction assembly	BP
1	17	0.233313150382	-	5.13e-01	GO:0045582	positive regulation of T cell differentiation	BP
1	17	0.233313150382	-	5.37e-01	GO:0006103	2-oxoglutarate metabolic process	BP
1	17	0.233313150382	-	5.37e-01	GO:0031290	retinal ganglion cell axon guidance	BP
1	17	0.233313150382	-	5.37e-01	GO:0048255	mRNA stabilization	BP
1	17	0.233313150382	-	5.37e-01	GO:1901800	positive regulation of proteasomal protein catabolic process	BP
1	17	0.233313150382	-	5.37e-01	GO:0070935	3'-UTR-mediated mRNA stabilization	BP
1	17	0.233313150382	-	5.37e-01	GO:0006893	Golgi to plasma membrane transport	BP
1	17	0.233313150382	-	5.37e-01	GO:0071404	cellular response to low-density lipoprotein particle stimulus	BP
1	17	0.233313150382	-	5.37e-01	GO:0032722	positive regulation of chemokine production	BP
4	68	0.233313150382	-	5.53e-01	GO:0034976	response to endoplasmic reticulum stress	BP
1	17	0.233313150382	-	5.60e-01	GO:0048535	lymph node development	BP
1	17	0.233313150382	-	5.60e-01	GO:0031589	cell-substrate adhesion	BP
1	17	0.233313150382	-	5.60e-01	GO:2000249	regulation of actin cytoskeleton reorganization	BP
1	17	0.233313150382	-	5.60e-01	GO:0090201	negative regulation of release of cytochrome c from mitochondria	BP
1	17	0.233313150382	-	5.60e-01	GO:0008045	motor neuron axon guidance	BP
1	17	0.233313150382	-	5.82e-01	GO:0007094	mitotic spindle assembly checkpoint	BP
1	17	0.233313150382	-	5.82e-01	GO:0007020	microtubule nucleation	BP
2	34	0.233313150382	-	6.61e-01	GO:0007040	lysosome organization	BP
2	34	0.233313150382	-	6.67e-01	GO:0032480	negative regulation of type I interferon production	BP
2	34	0.233313150382	-	6.80e-01	GO:0006383	transcription from RNA polymerase III promoter	BP
2	34	0.233313150382	-	6.80e-01	GO:0097194	execution phase of apoptosis	BP
1	17	0.233313150382	-	3.02e-01	GO:0008028	monocarboxylic acid transmembrane transporter activity	MF
1	17	0.233313150382	-	4.02e-01	GO:0042166	acetylcholine binding	MF
1	17	0.233313150382	-	4.60e-01	GO:0003951	NAD+ kinase activity	MF
1	17	0.233313150382	-	4.87e-01	GO:0017049	GTP-Rho binding	MF
1	17	0.233313150382	-	5.13e-01	GO:0004540	ribonuclease activity	MF
1	17	0.233313150382	-	5.13e-01	GO:0004383	guanylate cyclase activity	MF
1	17	0.233313150382	-	5.60e-01	GO:0050431	transforming growth factor beta binding	MF
1	17	0.233313150382	-	5.82e-01	GO:0003678	DNA helicase activity	MF
1	17	0.233313150382	-	5.82e-01	GO:0008266	poly(U) RNA binding	MF
11	187	0.233313150382	-	2.73e-01	GO:0030335	positive regulation of cell migration	BP
6	102	0.233313150382	-	4.60e-01	GO:0001649	osteoblast differentiation	BP
3	51	0.233313150382	-	4.92e-01	GO:0006091	generation of precursor metabolites and energy	BP
3	51	0.233313150382	-	5.09e-01	GO:0051592	response to calcium ion	BP
3	51	0.233313150382	-	5.09e-01	GO:0040008	regulation of growth	BP
3	51	0.233313150382	-	7.39e-01	GO:0051865	protein autoubiquitination	BP
3	51	0.233313150382	-	4.59e-01	GO:0030145	manganese ion binding	MF
3	51	0.233313150382	-	7.33e-01	GO:0004715	non-membrane spanning protein tyrosine kinase activity	MF
31	528	0.23057818266	-	1.31e-01	GO:0006915	apoptotic process	BP
15	256	0.22766658724	-	2.87e-01	GO:0007049	cell cycle	BP
23	393	0.22595244543	-	2.87e-02	GO:0007283	spermatogenesis	BP
5	86	0.216439331817	-	2.46e-01	GO:0036459	thiol-dependent ubiquitinyl hydrolase activity	MF
4	69	0.212251534854	-	3.47e-01	GO:0060079	excitatory postsynaptic potential	BP
3	52	0.205298774212	-	2.27e-01	GO:0030148	sphingolipid biosynthetic process	BP
3	52	0.205298774212	-	5.01e-01	GO:0060326	cell chemotaxis	BP
10	175	0.191492974687	-	3.35e-01	GO:0016055	Wnt signaling pathway	BP
2	35	0.191492974687	-	3.94e-01	GO:0009306	protein secretion	BP
4	70	0.191492974687	-	5.73e-01	GO:0007584	response to nutrient	BP
2	35	0.191492974687	-	6.94e-01	GO:0008094	DNA-dependent ATPase activity	MF
5	88	0.183272467882	-	3.85e-01	GO:0030509	BMP signaling pathway	BP
3	53	0.17781803779	-	7.36e-01	GO:0035064	methylated histone binding	MF
63	1114	0.176522397792	-	2.13e-03	GO:0007165	signal transduction	BP
9	160	0.168772898187	-	2.01e-01	GO:0008201	heparin binding	MF
5	89	0.166970655553	-	6.10e-01	GO:0051087	chaperone binding	MF
11	198	0.15085099019	-	6.08e-02	GO:0007601	visual perception	BP
1	18	0.15085099019	-	1.86e-01	GO:0098664	G-protein coupled serotonin receptor signaling pathway	BP
3	54	0.15085099019	-	2.55e-01	GO:0019730	antimicrobial humoral response	BP
2	36	0.15085099019	-	3.94e-01	GO:0086091	regulation of heart rate by cardiac conduction	BP
1	18	0.15085099019	-	4.02e-01	GO:0048240	sperm capacitation	BP
1	18	0.15085099019	-	4.32e-01	GO:0030539	male genitalia development	BP
1	18	0.15085099019	-	4.32e-01	GO:0060044	negative regulation of cardiac muscle cell proliferation	BP
1	18	0.15085099019	-	4.60e-01	GO:0046907	intracellular transport	BP
1	18	0.15085099019	-	4.60e-01	GO:0035435	phosphate ion transmembrane transport	BP
1	18	0.15085099019	-	4.60e-01	GO:0036342	post-anal tail morphogenesis	BP
1	18	0.15085099019	-	4.87e-01	GO:0035338	long-chain fatty-acyl-CoA biosynthetic process	BP
1	18	0.15085099019	-	5.13e-01	GO:1903861	positive regulation of dendrite extension	BP
1	18	0.15085099019	-	5.13e-01	GO:0035249	synaptic transmission, glutamatergic	BP
1	18	0.15085099019	-	5.13e-01	GO:0001556	oocyte maturation	BP
1	18	0.15085099019	-	5.13e-01	GO:0071294	cellular response to zinc ion	BP
1	18	0.15085099019	-	5.13e-01	GO:2000377	regulation of reactive oxygen species metabolic process	BP
4	72	0.15085099019	-	5.36e-01	GO:0098869	cellular oxidant detoxification	BP
1	18	0.15085099019	-	5.37e-01	GO:0061512	protein localization to cilium	BP
1	18	0.15085099019	-	5.37e-01	GO:0007597	blood coagulation, intrinsic pathway	BP
1	18	0.15085099019	-	5.37e-01	GO:0090026	positive regulation of monocyte chemotaxis	BP
1	18	0.15085099019	-	5.37e-01	GO:0030318	melanocyte differentiation	BP
1	18	0.15085099019	-	5.37e-01	GO:1901214	regulation of neuron death	BP
1	18	0.15085099019	-	5.37e-01	GO:0046427	positive regulation of JAK-STAT cascade	BP
1	18	0.15085099019	-	5.60e-01	GO:0032418	lysosome localization	BP
4	72	0.15085099019	-	5.62e-01	GO:0051289	protein homotetramerization	BP
1	18	0.15085099019	-	5.82e-01	GO:0045653	negative regulation of megakaryocyte differentiation	BP
1	18	0.15085099019	-	5.82e-01	GO:0007250	activation of NF-kappaB-inducing kinase activity	BP
1	18	0.15085099019	-	5.82e-01	GO:0046579	positive regulation of Ras protein signal transduction	BP
1	18	0.15085099019	-	5.82e-01	GO:0030490	maturation of SSU-rRNA	BP
1	18	0.15085099019	-	5.82e-01	GO:2000114	regulation of establishment of cell polarity	BP
1	18	0.15085099019	-	5.82e-01	GO:0050860	negative regulation of T cell receptor signaling pathway	BP
1	18	0.15085099019	-	5.82e-01	GO:0035307	positive regulation of protein dephosphorylation	BP
1	18	0.15085099019	-	6.03e-01	GO:0000132	establishment of mitotic spindle orientation	BP
1	18	0.15085099019	-	6.03e-01	GO:0002026	regulation of the force of heart contraction	BP
6	108	0.15085099019	-	6.37e-01	GO:0048015	phosphatidylinositol-mediated signaling	BP
2	36	0.15085099019	-	6.67e-01	GO:0051209	release of sequestered calcium ion into cytosol	BP
2	36	0.15085099019	-	7.01e-01	GO:0032781	positive regulation of ATPase activity	BP
3	54	0.15085099019	-	7.36e-01	GO:0030097	hemopoiesis	BP
1	18	0.15085099019	-	3.37e-01	GO:0004745	retinol dehydrogenase activity	MF
2	36	0.15085099019	-	3.76e-01	GO:0008138	protein tyrosine/serine/threonine phosphatase activity	MF
1	18	0.15085099019	-	5.13e-01	GO:0016706	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors	MF
1	18	0.15085099019	-	5.37e-01	GO:0016279	protein-lysine N-methyltransferase activity	MF
1	18	0.15085099019	-	5.82e-01	GO:0019955	cytokine binding	MF
1	18	0.15085099019	-	6.03e-01	GO:0005234	extracellular-glutamate-gated ion channel activity	MF
3	54	0.15085099019	-	7.42e-01	GO:0004386	helicase activity	MF
4	73	0.130951432752	-	2.86e-01	GO:0030216	keratinocyte differentiation	BP
4	73	0.130951432752	-	5.62e-01	GO:0001618	virus receptor activity	MF
3	55	0.124378778828	-	4.52e-01	GO:0007368	determination of left/right symmetry	BP
3	55	0.124378778828	-	4.59e-01	GO:0090502	RNA phosphodiester bond hydrolysis, endonucleolytic	BP
3	55	0.124378778828	-	7.33e-01	GO:0048812	neuron projection morphogenesis	BP
5	92	0.119142130462	-	3.96e-01	GO:0007160	cell-matrix adhesion	BP
2	37	0.111322626003	-	6.80e-01	GO:0010507	negative regulation of autophagy	BP
2	37	0.111322626003	-	6.94e-01	GO:0006605	protein targeting	BP
2	37	0.111322626003	-	3.58e-01	GO:0005245	voltage-gated calcium channel activity	MF
2	37	0.111322626003	-	6.80e-01	GO:0005547	phosphatidylinositol-3,4,5-trisphosphate binding	MF
7	130	0.105763100661	-	2.33e-01	GO:0007605	sensory perception of sound	BP
10	186	0.103545275411	-	3.59e-01	GO:0007420	brain development	BP
3	56	0.0983835702954	-	2.41e-01	GO:0030317	flagellated sperm motility	BP
3	56	0.0983835702954	-	7.48e-01	GO:0004197	cysteine-type endopeptidase activity	MF
4	75	0.091957301136	-	5.53e-01	GO:0043086	negative regulation of catalytic activity	BP
4	75	0.091957301136	-	7.78e-01	GO:0002479	antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent	BP
17	320	0.0863107379948	-	1.25e-01	GO:0007399	nervous system development	BP
2	38	0.0728484781883	-	3.02e-01	GO:0009566	fertilization	BP
2	38	0.0728484781883	-	3.21e-01	GO:0048468	cell development	BP
1	19	0.0728484781883	-	4.87e-01	GO:0042744	hydrogen peroxide catabolic process	BP
1	19	0.0728484781883	-	5.13e-01	GO:0048148	behavioral response to cocaine	BP
1	19	0.0728484781883	-	5.13e-01	GO:0033198	response to ATP	BP
1	19	0.0728484781883	-	5.37e-01	GO:0014032	neural crest cell development	BP
1	19	0.0728484781883	-	5.37e-01	GO:0045216	cell-cell junction organization	BP
1	19	0.0728484781883	-	5.37e-01	GO:0048557	embryonic digestive tract morphogenesis	BP
1	19	0.0728484781883	-	5.37e-01	GO:0007520	myoblast fusion	BP
1	19	0.0728484781883	-	5.37e-01	GO:0002028	regulation of sodium ion transport	BP
1	19	0.0728484781883	-	5.60e-01	GO:0032502	developmental process	BP
1	19	0.0728484781883	-	6.03e-01	GO:0031954	positive regulation of protein autophosphorylation	BP
1	19	0.0728484781883	-	6.03e-01	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP
2	38	0.0728484781883	-	7.15e-01	GO:0033683	nucleotide-excision repair, DNA incision	BP
3	57	0.0728484781883	-	7.33e-01	GO:0007612	learning	BP
3	57	0.0728484781883	-	7.33e-01	GO:0043087	regulation of GTPase activity	BP
3	57	0.0728484781883	-	7.51e-01	GO:0035722	interleukin-12-mediated signaling pathway	BP
4	76	0.0728484781883	-	7.81e-01	GO:0043410	positive regulation of MAPK cascade	BP
1	19	0.0728484781883	-	1.00e+00	GO:2001243	negative regulation of intrinsic apoptotic signaling pathway	BP
1	19	0.0728484781883	-	1.00e+00	GO:0070987	error-free translesion synthesis	BP
2	38	0.0728484781883	-	3.40e-01	GO:0004519	endonuclease activity	MF
1	19	0.0728484781883	-	4.02e-01	GO:0004190	aspartic-type endopeptidase activity	MF
1	19	0.0728484781883	-	4.32e-01	GO:0004653	polypeptide N-acetylgalactosaminyltransferase activity	MF
1	19	0.0728484781883	-	4.60e-01	GO:0046914	transition metal ion binding	MF
3	57	0.0728484781883	-	4.67e-01	GO:0001664	G-protein coupled receptor binding	MF
1	19	0.0728484781883	-	5.82e-01	GO:0070530	K63-linked polyubiquitin modification-dependent protein binding	MF
1	19	0.0728484781883	-	6.03e-01	GO:0001965	G-protein alpha-subunit binding	MF
1	19	0.0728484781883	-	6.03e-01	GO:0017075	syntaxin-1 binding	MF
6	114	0.0728484781883	-	6.43e-01	GO:0051082	unfolded protein binding	MF
2	38	0.0728484781883	-	6.67e-01	GO:0001786	phosphatidylserine binding	MF
1	19	0.0728484781883	-	1.00e+00	GO:0070064	proline-rich region binding	MF
1	19	0.0728484781883	-	1.00e+00	GO:0031491	nucleosome binding	MF
473	9019	0.0677205997131	-	2.09e-04	GO:0005515	protein binding	MF
42	801	0.0674349820019	-	4.38e-01	GO:0042802	identical protein binding	MF
12	229	0.0665347042561	-	6.34e-01	GO:0061024	membrane organization	BP
11	211	0.059108421562	-	7.42e-01	GO:0061630	ubiquitin protein ligase activity	MF
3	58	0.0477574972254	-	7.33e-01	GO:0032981	mitochondrial respiratory chain complex I assembly	BP
3	58	0.0477574972254	-	7.51e-01	GO:0036498	IRE1-mediated unfolded protein response	BP
10	195	0.0353737727696	-	3.47e-01	GO:0030198	extracellular matrix organization	BP
2	39	0.0353737727696	-	3.21e-01	GO:0007631	feeding behavior	BP
2	39	0.0353737727696	-	6.74e-01	GO:0006633	fatty acid biosynthetic process	BP
2	39	0.0353737727696	-	6.74e-01	GO:0030819	positive regulation of cAMP biosynthetic process	BP
2	39	0.0353737727696	-	6.87e-01	GO:0060291	long-term synaptic potentiation	BP
2	39	0.0353737727696	-	7.08e-01	GO:0071377	cellular response to glucagon stimulus	BP
4	78	0.0353737727696	-	7.81e-01	GO:0008286	insulin receptor signaling pathway	BP
5	98	0.027994242404	-	6.01e-01	GO:0016310	phosphorylation	BP
5	98	0.027994242404	-	8.16e-01	GO:1902036	regulation of hematopoietic stem cell differentiation	BP
3	59	0.0230954429912	-	4.31e-01	GO:0016266	O-glycan processing	BP
3	59	0.0230954429912	-	5.01e-01	GO:0006952	defense response	BP
3	59	0.0230954429912	-	7.33e-01	GO:0006968	cellular defense response	BP
3	59	0.0230954429912	-	7.39e-01	GO:0004175	endopeptidase activity	MF
10	197	0.0206522670628	-	1.39e-01	GO:0003676	nucleic acid binding	MF
10	197	0.0206522670628	-	5.97e-01	GO:0000287	magnesium ion binding	MF
18	355	0.0190257786821	-	5.08e-01	GO:0043687	post-translational protein modification	BP
11	217	0.0186563778247	-	6.11e-01	GO:0044267	cellular protein metabolic process	BP
4	79	0.0169952434547	-	7.83e-01	GO:0004843	thiol-dependent ubiquitin-specific protease activity	MF
23	457	0.00828759263079	-	1.29e-01	GO:0007275	multicellular organism development	BP
